Details of Disease

General Information of Disease (ID: DISQVIFL)

• Disease Name: Squamous cell carcinoma
• Synonyms: squamous carcinoma; carcinoma, squamous cell, malignant; squamous cell carcinoma NOS (morphologic abnormality); malignant epidermoid cell neoplasm; malignant epidermoid cell tumor; malignant squamous cell neoplasm; epidermoid cell cancer; squamous cell epithelioma; malignant squamous cell tumor; squamous cell carcinoma; squamous cell carcinoma (morphologic abnormality); squamous cell cancer; malignant epidermoid cell tumour; epidermoid carcinoma; malignant squamous cell tumour
• Disease Class: 2B60-2D01: Squamous cell carcinoma
• Definition: A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.
• Disease Hierarchy:
  DISKBRLI: Squamous cell neoplasm
  DISH9F1N: Carcinoma
  DISQVIFL: Squamous cell carcinoma
• ICD Code:
  ICD-11: ICD-11: 2B60-2D01
  ICD-10: ICD-10: C44
  ICD-9: ICD-9: 199
  Expand ICD-11: 'XH0945
  Expand ICD-9: 199
• Disease Identifiers:
  MONDO ID: MONDO_0005096
  MESH ID: D002294
  UMLS CUI: C0007137
  MedGen ID: 2874
  HPO ID: HP:0002860
  SNOMED CT ID: 1162767002

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Atezolizumab	DMMF8U0	Approved	Monoclonal antibody	[1]
Bavencio	DMU9C8F	Approved	Monoclonal antibody	[1]
Coenzyme Q10	DM8D9H5	Phase 4	Small molecular drug	[2]

This Disease is Treated as An Indication in 23 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BGB-A317	DM7NJYC	Phase 3	NA	[1]
Gilotrif	DM6NIZD	Phase 3	NA	[1]
LEO 43204	DMKMCP8	Phase 3	NA	[1]
SD-101	DMAMTGI	Phase 3	Oligonucleotide	[1]
CDX-3379	DM5GKYD	Phase 2	NA	[1]
Ficlatuzumab	DMG65WH	Phase 2	Monoclonal antibody	[1]
GL-0817	DM17OZM	Phase 2	Small molecular drug	[3]
IRX-2	DMODLN7	Phase 2	NA	[1]
ISA101	DM4R5EC	Phase 2	Vaccine	[4]
LN-145	DMYNWAV	Phase 2	NA	[1]
TH-302	DMFU0JY	Phase 2	Small molecular drug	[1]
VB4-847	DM8HD8P	Phase 2	NA	[5]
CLL442	DMFUXSP	Phase 1/2	NA	[2]
HB-201	DM9YDPY	Phase 1/2	NA	[6]
HB-202	DM5P72L	Phase 1/2	NA	[6]
NANT squamous cell carcinoma vaccine	DMOOIYW	Phase 1/2	NA	[2]
C31510	DMUKK9B	Phase 1	NA	[7]
CV8102	DMYD37G	Phase 1	NA	[8]
GL-0810	DMSBHSX	Phase 1	Small molecular drug	[9]
IMA201	DMKLMV9	Phase 1	NA	[1]
IN0-3106	DMVGRSQ	Phase 1	NA	[10]
Proxinium	DMDDGWQ	Phase 1	NA	[1]
TTI-621	DMDNPAV	Phase 1	Recombinant protein	[2]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 657 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ACLY	TT0Z6Y2	Limited	Biomarker	[11]
ACVR1B	TTPKHTZ	Limited	Genetic Variation	[12]
ALDH2	TTFLN4T	Limited	Genetic Variation	[13]
ANTXR2	TTOD34I	Limited	Altered Expression	[14]
ANXA2	TT4YANI	Limited	Biomarker	[15]
APC2	TTSMK36	Limited	Biomarker	[16]
APOE	TTKS9CB	Limited	Biomarker	[17]
AZGP1	TTUPYLV	Limited	Biomarker	[18]
BRCA2	TTUARD6	Limited	Genetic Variation	[19]
C5AR1	TTHXFA1	Limited	Biomarker	[20]
CCND3	TT1JXNR	Limited	Biomarker	[21]
CDC25B	TTR0SWN	Limited	Biomarker	[22]
CEACAM6	TTIGH2W	Limited	Biomarker	[23]
CHRNA1	TT54JVQ	Limited	Biomarker	[24]
CIT	TT3BKTU	Limited	Biomarker	[25]
CTSB	TTF2LRI	Limited	Biomarker	[26]
CYP24A1	TT82UI1	Limited	Altered Expression	[27]
DDX5	TTZKPVC	Limited	Biomarker	[28]
EGFL6	TTXJGAR	Limited	Biomarker	[29]
EPHA2	TTRJB2G	Limited	Biomarker	[30]
EPHA8	TTHZ2LW	Limited	Biomarker	[31]
EPHB4	TTI4ZX2	Limited	Biomarker	[32]
FANCF	TTNZKFJ	Limited	Biomarker	[33]
FCER2	TTCH6MU	Limited	Biomarker	[34]
FHIT	TTMS54D	Limited	Biomarker	[35]
FKBP4	TTHY0FT	Limited	Altered Expression	[36]
FKBP5	TT0J5KQ	Limited	Altered Expression	[36]
FOSL1	TTY8LZG	Limited	Altered Expression	[37]
FOXQ1	TTEJZOL	Limited	Altered Expression	[38]
FTH1	TT975ZT	Limited	Biomarker	[39]
GGH	TTZJRL0	Limited	Altered Expression	[40]
GGT1	TTZVT7O	Limited	Altered Expression	[41]
GJB2	TTRGZX3	Limited	Genetic Variation	[42]
GPR137	TTATO6X	Limited	Genetic Variation	[43]
GRHL2	TTUGH4C	Limited	Biomarker	[44]
HDAC8	TTT6LFV	Limited	Biomarker	[45]
HSPE1	TTWYMFE	Limited	Biomarker	[46]
IGFBP3	TTZHNQA	Limited	Biomarker	[47]
IL3RA	TTENHJ0	Limited	Biomarker	[48]
IL7	TT8FRMO	Limited	Altered Expression	[49]
IRF3	TTYR7OH	Limited	Altered Expression	[50]
KDM6B	TTDIJUQ	Limited	Biomarker	[51]
KHDRBS1	TTAT6C7	Limited	Altered Expression	[52]
KLRK1	TTLRN4A	Limited	Biomarker	[53]
LASP1	TTZJA87	Limited	Biomarker	[54]
LGR4	TTY6C71	Limited	Biomarker	[55]
LRP6	TTSXOWE	Limited	Biomarker	[56]
LTF	TTSZDQU	Limited	Biomarker	[57]
MAGEA1	TT63M7Q	Limited	Biomarker	[58]
MAGEA4	TT9EQUY	Limited	Biomarker	[58]
MAGEA6	TTJIWMO	Limited	Biomarker	[58]
MLANA	TT362RB	Limited	Biomarker	[59]
MVD	TTE5J6X	Limited	Biomarker	[60]
NLRP1	TTQX29T	Limited	Biomarker	[61]
PAH	TTGSVH2	Limited	Altered Expression	[62]
PAK2	TT279WO	Limited	Altered Expression	[63]
PFKFB3	TTTHMQJ	Limited	Biomarker	[64]
PRMT5	TTR1D7X	Limited	Biomarker	[65]
PSCA	TT9T4AV	Limited	Altered Expression	[66]
PSMD10	TT2H4LN	Limited	Altered Expression	[67]
PTAFR	TTQL5VC	Limited	Altered Expression	[68]
PTPN2	TTY8PUS	Limited	Genetic Variation	[69]
QPCT	TTJ7YTV	Limited	Biomarker	[70]
RIPK2	TTCQ2E5	Limited	Biomarker	[71]
ROCK2	TTGWKQJ	Limited	Altered Expression	[72]
RORA	TT1TYN7	Limited	Biomarker	[73]
RRM2	TT1S4LJ	Limited	Biomarker	[74]
SATB1	TTLFRIC	Limited	Altered Expression	[75]
SDC2	TT5H2F0	Limited	Altered Expression	[76]
SFTPD	TTGLMU7	Limited	Biomarker	[77]
SIRPA	TTBRJS9	Limited	Biomarker	[78]
SIRT3	TTVZLIJ	Limited	Altered Expression	[79]
SIRT5	TTH0IOD	Limited	Altered Expression	[80]
SIRT6	TTUXYWF	Limited	Biomarker	[81]
SLC19A1	TT09I7D	Limited	Altered Expression	[82]
SLC1A5	TTF7WRM	Limited	Biomarker	[83]
SLK	TT8K4DE	Limited	Biomarker	[84]
STXBP4	TTKS60G	Limited	Biomarker	[85]
TACR3	TTBPGLU	Limited	Biomarker	[86]
TFF1	TTNOJIZ	Limited	Altered Expression	[87]
TMPRSS6	TTL9KE7	Limited	Biomarker	[88]
TRAF6	TTCDR6M	Limited	Biomarker	[89]
UBE3A	TTUZX6V	Limited	Biomarker	[90]
VIPR1	TTCL30I	Limited	Altered Expression	[91]
WDR5	TT7OFWB	Limited	Altered Expression	[92]
ARRB1	TTMVD4A	Disputed	Altered Expression	[93]
ARRB2	TT8SO2I	Disputed	Altered Expression	[93]
CHUK	TT1F8OQ	Disputed	Biomarker	[94]
CYP2A6	TTAQ6ZW	Disputed	Genetic Variation	[95]
HOXA11	TTEX4ZA	Disputed	Posttranslational Modification	[96]
NFE2L2	TTA6ZN2	Disputed	Genetic Variation	[97]
PLA2G4A	TTT1JVS	Disputed	Biomarker	[98]
RASA1	TTPNZ1F	Disputed	Biomarker	[99]
AKR1C3	TT5ZWB6	moderate	Altered Expression	[100]
AKT1	TTWTSCV	moderate	Biomarker	[101]
ALOX12B	TTQ4QQH	moderate	Biomarker	[102]
AREG	TT76B3W	moderate	Biomarker	[103]
ATM	TTKBM7V	moderate	Posttranslational Modification	[104]
BRD7	TT07ZS1	moderate	Posttranslational Modification	[105]
C1QBP	TTWTD7F	moderate	Biomarker	[106]
CBL	TT7QT13	moderate	Genetic Variation	[107]
CCL2	TTNAY0P	moderate	Biomarker	[108]
CCL21	TTLZK1U	moderate	Altered Expression	[109]
CD33	TTJVYO3	moderate	Biomarker	[110]
CD46	TTMS7DF	moderate	Altered Expression	[111]
CD6	TTMF6KC	moderate	Biomarker	[112]
CD74	TTCMYP9	moderate	Biomarker	[113]
CDH1	TTLAWO6	moderate	Genetic Variation	[114]
CR2	TT0HUN7	moderate	Altered Expression	[115]
CRYAB	TT7RUHB	moderate	Biomarker	[116]
CSNK2A1	TTER6YH	moderate	Biomarker	[117]
CSNK2A2	TT7GR5W	moderate	Biomarker	[117]
CTCFL	TTY0RZT	moderate	Altered Expression	[118]
CXCL13	TT0NIZ1	moderate	Biomarker	[119]
CYP1B1	TTI84H7	moderate	Biomarker	[120]
CYP2J2	TTNE1C7	moderate	Altered Expression	[121]
DSG3	TTEO4P8	moderate	Biomarker	[122]
EBP	TT4VQZX	moderate	Altered Expression	[123]
EP300	TTGH73N	moderate	Biomarker	[124]
EPHB3	TT5LM7U	moderate	Biomarker	[125]
ESRRA	TTPNQAC	moderate	Biomarker	[126]
FABP4	TTHWMFZ	moderate	Altered Expression	[127]
FANCA	TTV5HJS	moderate	Biomarker	[128]
FOLR2	TTT54CI	moderate	Altered Expression	[129]
FOXC2	TTLBAP1	moderate	Biomarker	[130]
GHRHR	TTG4R8V	moderate	Altered Expression	[131]
GPC3	TTJTSX4	moderate	Altered Expression	[132]
GPNMB	TT7315J	moderate	Biomarker	[133]
GPRC6A	TTI1PRE	moderate	Biomarker	[134]
GRIK2	TT0K5RG	moderate	Biomarker	[135]
GRK2	TTAZ3MN	moderate	Biomarker	[136]
GSK3A	TTQWAU1	moderate	Altered Expression	[137]
HCAR2	TTWNV8U	moderate	Biomarker	[138]
HCAR3	TT8WFXV	moderate	Biomarker	[138]
HRH1	TTTIBOJ	moderate	Altered Expression	[139]
HSPA9	TTMTPG3	moderate	Altered Expression	[140]
IKBKB	TTJ3E9X	moderate	Biomarker	[141]
IL16	TTW4R0B	moderate	Biomarker	[142]
IL17F	TT2B6PS	moderate	Genetic Variation	[143]
IL6	TTT1V78	moderate	Biomarker	[144]
IL7R	TTAWI51	moderate	Biomarker	[145]
ITGB3	TTJA1ZO	moderate	Altered Expression	[146]
JAG2	TTOJY1B	moderate	Biomarker	[147]
KCNH5	TTX8LQ0	moderate	Biomarker	[148]
KDM4C	TTV8CRH	moderate	Altered Expression	[149]
KDM5B	TTCLI75	moderate	Altered Expression	[150]
KIR2DS1	TTVWAGF	moderate	Biomarker	[151]
KIR3DL2	TTQH3N0	moderate	Biomarker	[151]
KITLG	TTDJ51N	moderate	Altered Expression	[152]
KLK7	TTE6GTB	moderate	Altered Expression	[153]
LAG3	TTNVXAW	moderate	Biomarker	[154]
LATS2	TTML7FG	moderate	Biomarker	[155]
LCK	TT860QF	moderate	Genetic Variation	[156]
LIPA	TTS8T1M	moderate	Genetic Variation	[157]
LOXL2	TTFSUHX	moderate	Biomarker	[158]
LPAR3	TTE2YJR	moderate	Biomarker	[134]
MAP3K11	TTETX6Q	moderate	Posttranslational Modification	[159]
MAPK7	TTU6FSC	moderate	Altered Expression	[160]
MFGE8	TT1GLAJ	moderate	Genetic Variation	[161]
MGAM	TTXWASR	moderate	Altered Expression	[162]
MMP21	TTYRF5E	moderate	Altered Expression	[163]
MRGPRX1	TTIX6PK	moderate	Biomarker	[134]
MS4A1	TTUE541	moderate	Biomarker	[164]
MTNR1A	TT0WAIE	moderate	Biomarker	[165]
MUTYH	TTNB0ZK	moderate	Genetic Variation	[166]
MYC	TTNQ5ZP	moderate	Biomarker	[167]
NDUFA13	TTRU1NG	moderate	Altered Expression	[168]
NECTIN4	TTPO9EG	moderate	Biomarker	[169]
NFKBIA	TTSHAEB	moderate	Biomarker	[170]
NKX3-1	TT1E0JK	moderate	Biomarker	[171]
NSD1	TTTSJ3H	moderate	Altered Expression	[172]
OXER1	TT7WBSV	moderate	Biomarker	[134]
PAK4	TT7Y3BZ	moderate	Biomarker	[173]
PLCG1	TT6T4JI	moderate	Posttranslational Modification	[174]
PLD2	TTRLMKF	moderate	Altered Expression	[175]
PMEL	TT8MK59	moderate	Biomarker	[176]
PMS1	TTX1ISF	moderate	Altered Expression	[177]
POR	TTOQ9GZ	moderate	Altered Expression	[178]
PRG4	TTSKF4V	moderate	Genetic Variation	[179]
PTGS1	TT8NGED	moderate	Altered Expression	[180]
PTPN13	TT405FP	moderate	Altered Expression	[181]
RNASEL	TT7V0K4	moderate	Biomarker	[182]
RPS6KA1	TTIXKA4	moderate	Altered Expression	[183]
RPS6KA2	TT0ZW9O	moderate	Altered Expression	[183]
RPS6KA3	TTUM2ZR	moderate	Altered Expression	[183]
RRM1	TTWP0NS	moderate	Altered Expression	[184]
RTN4	TT7GXMU	moderate	Altered Expression	[185]
RTN4R	TTVRZUO	moderate	Biomarker	[186]
SCT	TTOBVIN	moderate	Altered Expression	[187]
SERPINB5	TT1KW50	moderate	Biomarker	[188]
SFRP4	TTX8I1Y	moderate	Posttranslational Modification	[189]
SLC5A1	TT2UE56	moderate	Biomarker	[190]
SMAD6	TTON5JB	moderate	Biomarker	[191]
SOX2	TTCNOT6	moderate	Biomarker	[192]
ST8SIA4	TTDP8YM	moderate	Biomarker	[193]
SYVN1	TT8XKYM	moderate	Altered Expression	[194]
TAGLN	TTDRZ9H	moderate	Altered Expression	[195]
TERF2	TT5XSLT	moderate	Altered Expression	[196]
TGFBR2	TTZE3P7	moderate	Altered Expression	[197]
TK1	TTP3QRF	moderate	Genetic Variation	[198]
TLN1	TTQSMFG	moderate	Altered Expression	[199]
TMEM97	TT9NXW4	moderate	Altered Expression	[200]
TPP2	TTQ7R2V	moderate	Biomarker	[201]
TRPM2	TTEBMN7	moderate	Biomarker	[202]
TRPM8	TTXDKTO	moderate	Biomarker	[203]
TYRP1	TTFRV98	moderate	Biomarker	[203]
UMPS	TTAFJUD	moderate	Altered Expression	[204]
ABCC1	TTOI92F	Strong	Genetic Variation	[205]
ABCC3	TTVLG21	Strong	Biomarker	[206]
ACVR1	TTJNBQA	Strong	Altered Expression	[207]
ADAM10	TTVXEGU	Strong	Altered Expression	[208]
ADAM17	TT6AZXG	Strong	Biomarker	[209]
ADAM9	TTTYQNS	Strong	Biomarker	[210]
ADH7	TT3LE7P	Strong	Genetic Variation	[211]
AGK	TTJETQC	Strong	Biomarker	[212]
AKT3	TTO6SGY	Strong	Biomarker	[213]
ALCAM	TT2AFT6	Strong	Altered Expression	[214]
ALOX12	TT12ABZ	Strong	Altered Expression	[215]
AMACR	TTLN1AP	Strong	Altered Expression	[216]
ANO1	TTOJI4S	Strong	Biomarker	[217]
ANXA1	TTUCK4B	Strong	Altered Expression	[218]
ANXA5	TT2Z83I	Strong	Biomarker	[219]
ANXA8	TTSW16P	Strong	Altered Expression	[220]
APEX1	TTHGL48	Strong	Biomarker	[221]
APP	TTE4KHA	Strong	Biomarker	[222]
AQP1	TTSF1KH	Strong	Biomarker	[223]
AQP3	TTLDNMQ	Strong	Altered Expression	[224]
ATF4	TTQCKWT	Strong	Biomarker	[225]
ATP2A2	TTE6THL	Strong	Genetic Variation	[226]
ATP7B	TTOPO51	Strong	Altered Expression	[227]
AURKB	TT9RTBL	Strong	Altered Expression	[228]
AXL	TTZPY6J	Strong	Altered Expression	[229]
BAK1	TTFM7V0	Strong	Altered Expression	[230]
BBC3	TT7JUKC	Strong	Altered Expression	[231]
BCL2L1	TTRE6AX	Strong	Biomarker	[232]
BIRC3	TTAIWZN	Strong	Altered Expression	[233]
BIRC5	TTTPU1G	Strong	Altered Expression	[234]
BMI1	TTIPNSR	Strong	Altered Expression	[235]
CA9	TT2LVK8	Strong	Biomarker	[236]
CAMP	TTULOB6	Strong	Biomarker	[237]
CAPN1	TT1WBIJ	Strong	Altered Expression	[238]
CAPN2	TTG5QB7	Strong	Biomarker	[238]
CCL17	TTMPHAE	Strong	Biomarker	[239]
CCNB1	TT9P6OW	Strong	Biomarker	[240]
CCNE1	TTCEJ4F	Strong	Altered Expression	[241]
CCR1	TTC24WT	Strong	Biomarker	[242]
CCR7	TT2GIDQ	Strong	Altered Expression	[109]
CD163	TTTZ9DE	Strong	Biomarker	[64]
CD1A	TTBGTFN	Strong	Posttranslational Modification	[243]
CD24	TTCTYNP	Strong	Biomarker	[244]
CD248	TTYJWT7	Strong	Biomarker	[245]
CD4	TTN2JFW	Strong	Altered Expression	[246]
CD80	TT89Z17	Strong	Altered Expression	[247]
CDA	TTQ12RK	Strong	Biomarker	[248]
CDC25A	TTLZS4Q	Strong	Biomarker	[249]
CDC25C	TTESBNC	Strong	Biomarker	[22]
CDC7	TTSMTDI	Strong	Biomarker	[250]
CDH2	TT1WS0T	Strong	Altered Expression	[251]
CDK1	TTH6V3D	Strong	Biomarker	[252]
CDK2	TT7HF4W	Strong	Altered Expression	[253]
CDK6	TTO0FDJ	Strong	Biomarker	[254]
CDK7	TTQYF7G	Strong	Biomarker	[192]
CEACAM1	TTA9CK4	Strong	Biomarker	[255]
CEACAM3	TTPX7I5	Strong	Altered Expression	[256]
CEBPA	TT5LWG1	Strong	Biomarker	[257]
CEBPB	TTUI35N	Strong	Biomarker	[123]
CFLAR	TTJZQYH	Strong	Altered Expression	[258]
CGB3	TTUH273	Strong	Altered Expression	[259]
CHEK1	TTTU902	Strong	Biomarker	[260]
CHEK2	TT9ABMF	Strong	Genetic Variation	[261]
CHKA	TT10AWB	Strong	Altered Expression	[262]
CHRNA9	TTQACP9	Strong	Genetic Variation	[263]
CLDN4	TTMTS9H	Strong	Biomarker	[264]
CLIC1	TT8KZG6	Strong	Biomarker	[265]
CLU	TTRL76H	Strong	Biomarker	[266]
CMA1	TT8VUE0	Strong	Altered Expression	[267]
COL7A1	TTBCOKN	Strong	Genetic Variation	[268]
COPS5	TTSTNJR	Strong	Altered Expression	[269]
CREBBP	TTFRCTK	Strong	Biomarker	[99]
CSF1	TT0IQER	Strong	Biomarker	[270]
CTAG1A	TTE5ITK	Strong	Altered Expression	[271]
CTLA4	TTI2S1D	Strong	Biomarker	[272]
CTSK	TTDZN01	Strong	Altered Expression	[273]
CUL3	TTPCU0Q	Strong	Altered Expression	[274]
CXCL1	TTLK1RW	Strong	Biomarker	[275]
CXCL11	TTWG0RE	Strong	Biomarker	[276]
CXCL12	TT4UGTF	Strong	Altered Expression	[277]
CXCR4	TTBID49	Strong	Altered Expression	[277]
CYP1A2	TTS1DTU	Strong	Biomarker	[278]
CYP26A1	TTD7Q0R	Strong	Altered Expression	[279]
CYP2E1	TTWVHQ5	Strong	Genetic Variation	[280]
DAG1	TT4X7PG	Strong	Altered Expression	[281]
DCN	TTB3XAN	Strong	Biomarker	[282]
DDC	TTN451K	Strong	Altered Expression	[283]
DDIT4	TTVEOY6	Strong	Biomarker	[284]
DDR2	TTU98HG	Strong	Genetic Variation	[285]
DEK	TT1NMGV	Strong	Altered Expression	[286]
DGKA	TTGL8F0	Strong	Altered Expression	[287]
DIABLO	TTN74LE	Strong	Biomarker	[288]
DKK3	TTY2ZV6	Strong	Altered Expression	[289]
DNMT3A	TTJUALD	Strong	Biomarker	[290]
DNMT3B	TT6VZ78	Strong	Posttranslational Modification	[247]
DPYD	TTZPS91	Strong	Biomarker	[204]
DUSP1	TTG8HIM	Strong	Altered Expression	[291]
E2F3	TTWIJYH	Strong	Altered Expression	[292]
ECE1	TTQ9RYT	Strong	Altered Expression	[293]
EDNRB	TT3ZTGU	Strong	Altered Expression	[294]
EED	TTFNJ4R	Strong	Biomarker	[295]
EGLN1	TT9ISBX	Strong	Altered Expression	[296]
EIF2AK2	TTXEZJ4	Strong	Altered Expression	[297]
EIF4E	TTZGCP6	Strong	Biomarker	[298]
ELAVL1	TTPC9D0	Strong	Altered Expression	[299]
EML4	TT92GY4	Strong	Genetic Variation	[12]
ENPEP	TT9PBIL	Strong	Altered Expression	[300]
EPCAM	TTZ8WH4	Strong	Altered Expression	[301]
EPHA1	TTLFZVU	Strong	Altered Expression	[302]
EPOR	TTAUX24	Strong	Altered Expression	[303]
ERBB3	TTSINU2	Strong	Posttranslational Modification	[304]
ERBB4	TTWALCO	Strong	Altered Expression	[305]
EREG	TTYSB89	Strong	Altered Expression	[306]
ETS2	TT9AH0M	Strong	Altered Expression	[307]
EZH2	TT9MZCQ	Strong	Biomarker	[308]
EZR	TTE47YC	Strong	Altered Expression	[309]
F11R	TT3C8EG	Strong	Biomarker	[310]
F2RL1	TTQR74A	Strong	Altered Expression	[311]
F2RL3	TTD0652	Strong	Altered Expression	[312]
F9	TTFEZ5Q	Strong	Genetic Variation	[313]
FABP5	TTNT2S6	Strong	Altered Expression	[314]
FASN	TT7AOUD	Strong	Altered Expression	[315]
FBXW7	TT29KY7	Strong	Genetic Variation	[316]
FGF19	TTGCH11	Strong	Biomarker	[317]
FGF7	TTFY134	Strong	Biomarker	[318]
FGFBP1	TTV1YFT	Strong	Altered Expression	[319]
FGFR3	TTST7KB	Strong	Genetic Variation	[320]
FGFR4	TT1KX2S	Strong	Genetic Variation	[321]
FN1	TTPJ921	Strong	Genetic Variation	[179]
FOLH1	TT9G4N0	Strong	Biomarker	[322]
FOLR1	TTVC37M	Strong	Biomarker	[323]
FOXM1	TTD3KOX	Strong	Altered Expression	[324]
FOXP1	TT0MUCI	Strong	Genetic Variation	[325]
FOXP3	TT1X3QF	Strong	Biomarker	[326]
FSCN1	TTTRS9B	Strong	Altered Expression	[327]
FURIN	TTH9WF6	Strong	Biomarker	[328]
FUT4	TTNV1KZ	Strong	Biomarker	[329]
G3BP1	TTG0R8Z	Strong	Altered Expression	[330]
GAL	TTXZAJ5	Strong	Biomarker	[331]
GALC	TT5IZRB	Strong	Posttranslational Modification	[332]
GALR1	TTX3HNZ	Strong	Biomarker	[333]
GAPDH	TTUGSWA	Strong	Altered Expression	[334]
GDF15	TT4MXVG	Strong	Biomarker	[335]
GEM	TTAZF9M	Strong	Genetic Variation	[336]
GJB5	TTL9MHP	Strong	Altered Expression	[337]
GLRX	TTRJCNG	Strong	Biomarker	[338]
GMNN	TT390KA	Strong	Biomarker	[339]
GPBAR1	TTSDVTR	Strong	Biomarker	[340]
GPR55	TTNET8J	Strong	Altered Expression	[341]
GPR87	TTO897C	Strong	Altered Expression	[342]
GPX1	TTYAHBP	Strong	Biomarker	[343]
GRIN2B	TTN9D8E	Strong	Biomarker	[344]
GRK5	TTTCXO0	Strong	Altered Expression	[345]
GSN	TTUH7OM	Strong	Genetic Variation	[346]
GSR	TTEP6RV	Strong	Altered Expression	[41]
GSTA1	TT4P8DE	Strong	Altered Expression	[41]
HAL	TTXQOZW	Strong	Genetic Variation	[347]
HBB	TTM6HK1	Strong	Biomarker	[348]
HBEGF	TT15SL0	Strong	Altered Expression	[349]
HDAC1	TT6R7JZ	Strong	Altered Expression	[350]
HDAC2	TTSHTOI	Strong	Altered Expression	[350]
HDAC9	TT8M4E1	Strong	Genetic Variation	[351]
HDC	TTV9GOF	Strong	Altered Expression	[352]
HIPK2	TTOB49C	Strong	Altered Expression	[353]
HLA-DQA1	TTU2I3J	Strong	Genetic Variation	[325]
HLA-G	TTLKFB3	Strong	Genetic Variation	[354]
HMGA2	TTSTVM0	Strong	Biomarker	[355]
HMGCR	TTPADOQ	Strong	Genetic Variation	[356]
HOXA7	TTMRE4Q	Strong	Altered Expression	[357]
HPGDS	TTCYE56	Strong	Biomarker	[358]
HPSE	TTR7GJO	Strong	Altered Expression	[359]
HRAS	TT28ZON	Strong	Genetic Variation	[360]
HSD17B1	TTIWB6L	Strong	Altered Expression	[361]
HSF1	TTN6STZ	Strong	Biomarker	[362]
HSP90AB1	TTH5YN2	Strong	Altered Expression	[363]
HSP90B1	TTFPKXQ	Strong	Altered Expression	[363]
HSPA8	TTMQL3K	Strong	Biomarker	[364]
HSPB3	TTLH8WG	Strong	Altered Expression	[365]
HSPG2	TT5UM29	Strong	Altered Expression	[366]
HTATIP2	TTC6IX5	Strong	Altered Expression	[367]
ID1	TTBXVDE	Strong	Altered Expression	[368]
ID2	TTW8A5N	Strong	Altered Expression	[369]
IDO1	TTZJYKH	Strong	Altered Expression	[370]
IFNA2	TTSIUJ9	Strong	Therapeutic	[371]
IFNGR2	TT13TL0	Strong	Genetic Variation	[372]
IGF2R	TTPNE41	Strong	Altered Expression	[373]
IGFBP1	TTCJTWF	Strong	Altered Expression	[374]
IGFBP2	TTU4QSN	Strong	Altered Expression	[374]
IGFBP5	TTDWEA8	Strong	Biomarker	[375]
IL19	TT87RWS	Strong	Biomarker	[376]
IL24	TT1EPXZ	Strong	Biomarker	[377]
IL2RB	TT9721Y	Strong	Biomarker	[378]
IL32	TTD4G7L	Strong	Biomarker	[379]
IL33	TT5MD4P	Strong	Biomarker	[380]
ILK	TT7ALZG	Strong	Biomarker	[381]
IMP3	TTEJA2R	Strong	Altered Expression	[382]
INHBA	TTVB30D	Strong	Altered Expression	[383]
IRS1	TTAJSQ0	Strong	Biomarker	[384]
IRS2	TTF95B8	Strong	Biomarker	[384]
ISG15	TTVOH3T	Strong	Biomarker	[385]
ITGA2	TTSJ542	Strong	Biomarker	[386]
ITGA4	TTJMF9P	Strong	Posttranslational Modification	[387]
ITGAV	TTT1R2L	Strong	Biomarker	[388]
JUP	TTREN0G	Strong	Altered Expression	[389]
KCNH1	TT9XKUC	Strong	Altered Expression	[390]
KCNK18	TTHT87J	Strong	Biomarker	[391]
KDM4A	TTZHPB8	Strong	Biomarker	[392]
KDR	TTUTJGQ	Strong	Genetic Variation	[393]
KEAP1	TT3Z6Y9	Strong	Genetic Variation	[97]
KIF20B	TTQECT2	Strong	Biomarker	[394]
KISS1	TTU2O6T	Strong	Altered Expression	[395]
KISS1R	TT3KBZY	Strong	Altered Expression	[396]
KIT	TTX41N9	Strong	Biomarker	[397]
KLF4	TTTI53X	Strong	Altered Expression	[398]
KLK4	TT4319X	Strong	Biomarker	[399]
KLK5	TTULSEW	Strong	Altered Expression	[153]
KLK6	TTLPF4X	Strong	Biomarker	[400]
KRAS	TTM8FR7	Strong	Genetic Variation	[401]
KRT17	TTKV0EC	Strong	Biomarker	[402]
KRT19	TT3JF9E	Strong	Biomarker	[403]
KRT6A	TT2FX8W	Strong	Biomarker	[404]
LAMB3	TT2WOUQ	Strong	Biomarker	[405]
LCN2	TTKTLAI	Strong	Altered Expression	[406]
LDLR	TTH0DUS	Strong	Genetic Variation	[356]
LGALS1	TTO3NYT	Strong	Altered Expression	[407]
LGR5	TTTSGRH	Strong	Biomarker	[408]
LIF	TTGZ5WN	Strong	Biomarker	[409]
LIN28A	TTO50LN	Strong	Biomarker	[410]
LONP1	TTM1VPZ	Strong	Altered Expression	[411]
LOX	TTQHNAM	Strong	Biomarker	[412]
LPA	TTU9LGY	Strong	Genetic Variation	[356]
LSS	TT7O8ZA	Strong	Biomarker	[413]
LTA4H	TTXZEAJ	Strong	Biomarker	[414]
LY6K	TT5GKHN	Strong	Biomarker	[415]
MAGEA2	TTOZT28	Strong	Biomarker	[416]
MAGEA3	TTWSKHD	Strong	Biomarker	[58]
MAGEC2	TTKGUEB	Strong	Biomarker	[417]
MAP2K7	TT6QY3J	Strong	Biomarker	[418]
MAP3K7	TTJQT60	Strong	Altered Expression	[419]
MAP3K8	TTGECUM	Strong	Altered Expression	[420]
MAPK3	TT1MG9E	Strong	Altered Expression	[421]
MAPK8	TT0K6EO	Strong	Biomarker	[422]
MAPK9	TT3IVG2	Strong	Altered Expression	[423]
MAPKAP1	TTWDKCL	Strong	Altered Expression	[424]
MARCKS	TTHRM39	Strong	Biomarker	[425]
MARK2	TTAJ45Y	Strong	Altered Expression	[426]
MC1R	TT0MV2T	Strong	Genetic Variation	[19]
MCAM	TTHRE05	Strong	Altered Expression	[427]
MCL1	TTL53M6	Strong	Biomarker	[428]
MCM7	TT1RM3F	Strong	Biomarker	[429]
MDK	TTV8UE7	Strong	Altered Expression	[430]
MDM4	TT9OUDQ	Strong	Genetic Variation	[205]
METAP2	TTZL0OI	Strong	Biomarker	[431]
MGLL	TTZ963I	Strong	Altered Expression	[432]
MGMT	TTJ8DV7	Strong	Biomarker	[433]
MIA	TT5HNVS	Strong	Altered Expression	[434]
MLH1	TTISG27	Strong	Genetic Variation	[435]
MMP1	TTMX39J	Strong	Biomarker	[436]
MMP10	TTXLEG7	Strong	Genetic Variation	[437]
MMP11	TTZW4MV	Strong	Altered Expression	[438]
MMP12	TTXZ0KQ	Strong	Altered Expression	[237]
MMP13	TTHY57M	Strong	Genetic Variation	[439]
MMP14	TTJ4QE7	Strong	Altered Expression	[440]
MMP3	TTUZ2L5	Strong	Biomarker	[441]
MMP7	TTMTWOS	Strong	Altered Expression	[17]
MMP8	TTGA1IV	Strong	Altered Expression	[442]
MRC1	TTKV8W5	Strong	Altered Expression	[443]
MRC2	TTYVR8M	Strong	Biomarker	[444]
MSH2	TTCAWRT	Strong	Genetic Variation	[445]
MSI1	TTSM4BA	Strong	Biomarker	[446]
MSLN	TT4RXME	Strong	Biomarker	[447]
MST1R	TTBQ3OC	Strong	Altered Expression	[448]
MTA1	TTO4HUS	Strong	Biomarker	[449]
MTAP	TTDBX7N	Strong	Biomarker	[450]
MTDH	TTH6SA5	Strong	Biomarker	[451]
MUC1	TTBHFYQ	Strong	Biomarker	[452]
MUC16	TTC1PS3	Strong	Biomarker	[453]
MUC5AC	TTEL90S	Strong	Altered Expression	[454]
NCAM1	TTVXPHT	Strong	Biomarker	[404]
NCK1	TTMA3VF	Strong	Biomarker	[455]
NCOA3	TT124R0	Strong	Biomarker	[456]
NDUFAF2	TTCHGVF	Strong	Altered Expression	[457]
NEDD8	TTNDC4K	Strong	Biomarker	[458]
NEDD9	TT1UREA	Strong	Biomarker	[459]
NELL1	TT7H4BF	Strong	Genetic Variation	[460]
NFKB1	TTUIZKC	Strong	Biomarker	[461]
NGFR	TTEDJN4	Strong	Biomarker	[378]
NOP2	TTBLG3H	Strong	Biomarker	[462]
NPM1	TTHBS98	Strong	Biomarker	[463]
NPR1	TTM9IYA	Strong	Altered Expression	[464]
NR1H2	TTXA6PH	Strong	Genetic Variation	[465]
NRP1	TTIPJCB	Strong	Biomarker	[466]
NT5E	TTK0O6Y	Strong	Biomarker	[467]
NTSR1	TTTUMEP	Strong	Biomarker	[468]
OGFR	TT6IEYX	Strong	Altered Expression	[469]
OGG1	TTRU01G	Strong	Genetic Variation	[470]
OSM	TTIVXSE	Strong	Biomarker	[471]
OSMR	TTAH0KM	Strong	Biomarker	[471]
PAK1	TTFN95D	Strong	Altered Expression	[472]
PCNA	TTLG1PD	Strong	Altered Expression	[473]
PDCD1LG2	TTW14O3	Strong	Biomarker	[474]
PDE3A	TT06AWU	Strong	Altered Expression	[475]
PDE3B	TTN34SQ	Strong	Biomarker	[476]
PDE4D	TTSKMI8	Strong	Biomarker	[477]
PDF	TT9SL3Q	Strong	Altered Expression	[478]
PDX1	TT8SGZK	Strong	Genetic Variation	[479]
PDXP	TT9UYG4	Strong	Biomarker	[480]
PGD	TTZ3IFB	Strong	Biomarker	[481]
PHGDH	TT8DRCK	Strong	Biomarker	[481]
PIK3CB	TT9H4P3	Strong	Biomarker	[482]
PIM1	TTTN5QW	Strong	Altered Expression	[411]
PIN1	TTJNTSI	Strong	Biomarker	[483]
PINX1	TT4FJ3A	Strong	Altered Expression	[484]
PKM	TT4LOT8	Strong	Altered Expression	[485]
PKN2	TTTHO0M	Strong	Biomarker	[486]
PLAUR	TTNOSTX	Strong	Biomarker	[487]
PLG	TTP86E2	Strong	Biomarker	[488]
PLK1	TTH4IP0	Strong	Biomarker	[489]
PLK2	TT976FS	Strong	Altered Expression	[490]
PPIA	TTL2ADK	Strong	Biomarker	[364]
PPP1CA	TTFLH0E	Strong	Altered Expression	[491]
PRKCD	TT7A1BO	Strong	Altered Expression	[492]
PRKCI	TTWJTHX	Strong	Genetic Variation	[401]
PRKDC	TTK3PY9	Strong	Biomarker	[493]
PSIP1	TTH9LDP	Strong	Biomarker	[378]
PTBP1	TTWMX0U	Strong	Biomarker	[494]
PTGDR	TTNVEIR	Strong	Biomarker	[495]
PTGER1	TTG1QMU	Strong	Biomarker	[496]
PTGES	TTYLQ8V	Strong	Biomarker	[497]
PTGIS	TTLXKZR	Strong	Altered Expression	[498]
PTK6	TT6TH8V	Strong	Altered Expression	[499]
PTK7	TTXH2ZN	Strong	Altered Expression	[500]
PTP4A1	TTA8GFO	Strong	Altered Expression	[501]
PTP4A3	TT7YM8D	Strong	Altered Expression	[502]
PTPN11	TT7WUAV	Strong	Biomarker	[503]
PTPRJ	TTWMKXP	Strong	Altered Expression	[504]
RACK1	TTJ10AL	Strong	Biomarker	[364]
RARA	TTW38KT	Strong	Altered Expression	[505]
RARG	TT1Q3IE	Strong	Biomarker	[506]
RBPJ	TT72D4Z	Strong	Biomarker	[507]
RHBDF2	TTH1ZOP	Strong	Biomarker	[508]
RHOB	TT6LPFO	Strong	Biomarker	[509]
RIPK4	TTB4S01	Strong	Biomarker	[510]
ROS1	TTSZ6Y3	Strong	Genetic Variation	[511]
RPS12	TTD81N3	Strong	Biomarker	[512]
RPS6KA5	TTYXEPL	Strong	Biomarker	[513]
RSF1	TTMP86V	Strong	Altered Expression	[514]
RSPO1	TTI9HL4	Strong	Genetic Variation	[515]
RXRA	TT6PEUO	Strong	Altered Expression	[505]
RXRG	TTH029C	Strong	Altered Expression	[516]
S100A4	TTPR5SX	Strong	Genetic Variation	[517]
S100A6	TT716MY	Strong	Altered Expression	[518]
S100A8	TT4AF6N	Strong	Altered Expression	[519]
SCARB1	TTRE324	Strong	Biomarker	[520]
SCGB1A1	TTONPVW	Strong	Biomarker	[521]
SELE	TT1PL7M	Strong	Altered Expression	[110]
SEMA4D	TT5UT28	Strong	Altered Expression	[522]
SERPINB3	TT6QLPX	Strong	Biomarker	[523]
SETD2	TTPC3H4	Strong	Biomarker	[524]
SGPP1	TTN0VRB	Strong	Altered Expression	[525]
SIRT2	TTLKF5M	Strong	Altered Expression	[526]
SKP2	TT5B2EO	Strong	Altered Expression	[527]
SLC12A3	TTP362L	Strong	Altered Expression	[528]
SLC16A1	TTN1J82	Strong	Altered Expression	[267]
SLC16A3	TTG6VD5	Strong	Biomarker	[529]
SLC22A1	TTM5Q4V	Strong	Altered Expression	[530]
SLC2A4	TTP6MT5	Strong	Altered Expression	[531]
SLC39A6	TTZN1CF	Strong	Genetic Variation	[532]
SLC6A8	TTYUHB5	Strong	Biomarker	[533]
SLC7A5	TTPH2JB	Strong	Altered Expression	[534]
SLCO1B1	TTFGXEB	Strong	Genetic Variation	[356]
SLIT2	TTDWK85	Strong	Biomarker	[535]
SMAD1	TT9GR53	Strong	Genetic Variation	[536]
SNCG	TT5TQNZ	Strong	Altered Expression	[537]
SP1	TTZEP6S	Strong	Biomarker	[538]
SPHK1	TTOHFIY	Strong	Altered Expression	[539]
SQSTM1	TTOT2RY	Strong	Biomarker	[507]
SRC	TT6PKBN	Strong	Genetic Variation	[540]
SRPK1	TTU3WV6	Strong	Biomarker	[541]
SSTR1	TTIND6G	Strong	Altered Expression	[542]
ST14	TTPRO7W	Strong	Biomarker	[543]
STAT1	TTN7R6K	Strong	Biomarker	[544]
STAT6	TTWOE1T	Strong	Altered Expression	[545]
STC1	TTDLUER	Strong	Altered Expression	[546]
STK33	TTP34DQ	Strong	Altered Expression	[547]
STMN1	TT7W5OT	Strong	Biomarker	[548]
STOML2	TTOI329	Strong	Altered Expression	[549]
SULF2	TTLQTHB	Strong	Biomarker	[550]
SYK	TT2HUPM	Strong	Biomarker	[551]
TACSTD2	TTP2HE5	Strong	Altered Expression	[552]
TCF3	TTULOD8	Strong	Biomarker	[378]
TEP1	TTQGAVX	Strong	Altered Expression	[553]
TFAP2A	TTDY4BS	Strong	Altered Expression	[554]
TFRC	TT8MG4S	Strong	Biomarker	[492]
TGFA	TTTLQFR	Strong	Altered Expression	[555]
TGFBR1	TTP4520	Strong	Biomarker	[556]
TGM1	TT7A949	Strong	Biomarker	[557]
TGM2	TT2F4OL	Strong	Altered Expression	[558]
THBS1	TTKI0H1	Strong	Altered Expression	[559]
TIAM1	TTNU6I5	Strong	Altered Expression	[560]
TKTL1	TTNQ1J3	Strong	Biomarker	[561]
TLR3	TTD24Y0	Strong	Biomarker	[562]
TLR7	TTRJ1K4	Strong	Biomarker	[563]
TLR9	TTSHG0T	Strong	Biomarker	[564]
TNC	TTUCPMY	Strong	Altered Expression	[565]
TNFRSF13B	TTL9OD4	Strong	Altered Expression	[566]
TNFRSF17	TTZ3P4W	Strong	Altered Expression	[566]
TNFRSF1B	TT63WSF	Strong	Biomarker	[378]
TNFSF13	TTOI1RM	Strong	Altered Expression	[566]
TPX2	TT0PHL4	Strong	Biomarker	[567]
TRIM59	TT613U4	Strong	Altered Expression	[568]
TRIP10	TTKHTGE	Strong	Altered Expression	[569]
TSPO	TTPTXIN	Strong	Altered Expression	[570]
TXNRD1	TTR7UJ3	Strong	Altered Expression	[571]
TYMP	TTO0IB8	Strong	Posttranslational Modification	[572]
TYR	TTULVH8	Strong	Genetic Variation	[19]
UBA1	TTXHWA7	Strong	Biomarker	[573]
UCP1	TTI12YJ	Strong	Biomarker	[574]
UCP3	TT12RJK	Strong	Biomarker	[575]
VANGL1	TT18WJB	Strong	Biomarker	[576]
VDAC2	TTM1I7L	Strong	Biomarker	[364]
VEGFC	TT0QUFV	Strong	Altered Expression	[163]
VEGFD	TTOM5H4	Strong	Altered Expression	[577]
VHL	TTEMWSD	Strong	Genetic Variation	[578]
VSIR	TT51SK8	Strong	Altered Expression	[579]
VTCN1	TTCK85E	Strong	Biomarker	[580]
WNT5A	TTKG7F8	Strong	Altered Expression	[581]
XPA	TTGT87E	Strong	Genetic Variation	[582]
ZEB2	TTT2WK4	Strong	Altered Expression	[583]
BMP7	TTKOBRA	Definitive	Biomarker	[584]
CNTN1	TTPR8FK	Definitive	Altered Expression	[585]
CRTC2	TTFWETR	Definitive	Genetic Variation	[586]
CXCR5	TTIW59R	Definitive	Genetic Variation	[587]
CYP3A5	TTHS0OK	Definitive	Biomarker	[588]
HOXA5	TTXSVQP	Definitive	Altered Expression	[589]
HSPB1	TT9AZWY	Definitive	Altered Expression	[590]
ITGA5	TTHIZP9	Definitive	Biomarker	[591]
ITGB6	TTKQSXZ	Definitive	Altered Expression	[592]
L1CAM	TTC9D3K	Definitive	Altered Expression	[593]
LAMC2	TTNS7H3	Definitive	Biomarker	[594]
NACC1	TT4AQ5F	Definitive	Altered Expression	[595]
NCL	TTK1V5Q	Definitive	Altered Expression	[596]
PTK2	TTON5IT	Definitive	Biomarker	[597]
RUNX3	TTKCVO7	Definitive	Altered Expression	[598]
SCN1A	TTANOZH	Definitive	Altered Expression	[595]
SOCS3	TTI0ME6	Definitive	Biomarker	[336]
TNKS2	TTFQI4H	Definitive	Genetic Variation	[599]
TUSC2	TTJ8O14	Definitive	Altered Expression	[600]
USP7	TTXU3EQ	Definitive	Altered Expression	[601]
XRCC5	TTCB9KW	Definitive	Altered Expression	[602]

This Disease Is Related to 12 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC17A8	DTAGDH7	moderate	Genetic Variation	[603]
SLC43A2	DTK02I1	moderate	Biomarker	[604]
SLC4A3	DT4X2AH	moderate	Biomarker	[605]
SLC12A2	DTHKL3Q	Strong	Altered Expression	[606]
SLC2A13	DT0NSKB	Strong	Biomarker	[607]
SLC2A2	DTUJPOL	Strong	Altered Expression	[531]
SLC45A2	DTNCJAT	Strong	Genetic Variation	[19]
SLC52A1	DT7NOKR	Strong	Biomarker	[608]
SLC52A3	DTBVQIO	Strong	Biomarker	[609]
SLC5A8	DTE3TAW	Strong	Posttranslational Modification	[610]
SLC9A9	DT8LP62	Strong	Biomarker	[611]
SLCO6A1	DTIFXNS	Strong	Biomarker	[358]

This Disease Is Related to 42 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
CYP1A1	DE6OQ3W	Limited	Genetic Variation	[612]
MT1A	DE5ME8A	Limited	Biomarker	[613]
SAT1	DEMWO83	Limited	Altered Expression	[614]
ASNS	DEXISVQ	moderate	Biomarker	[615]
CHKB	DEHWR6V	moderate	Biomarker	[616]
CYP26B1	DEZT8FM	moderate	Biomarker	[617]
CYP2R1	DEBIHM3	moderate	Altered Expression	[618]
HIF1AN	DEY1CBW	moderate	Altered Expression	[619]
HK1	DEDMAGE	moderate	Biomarker	[620]
PER1	DE9HF0I	moderate	Altered Expression	[621]
ABO	DESIA7R	Strong	Biomarker	[622]
ADH1B	DEEN9RD	Strong	Genetic Variation	[13]
ADH1C	DEM1HNL	Strong	Genetic Variation	[623]
ADH4	DEOCWU3	Strong	Altered Expression	[624]
ADH5	DEIOH6A	Strong	Altered Expression	[624]
AKR1A1	DED2FW3	Strong	Biomarker	[625]
AKR1B10	DEP6GT1	Strong	Altered Expression	[626]
AKR1C1	DE7P2FB	Strong	Biomarker	[627]
AKR1C2	DEOY5ZM	Strong	Altered Expression	[628]
CMPK1	DEMPH4I	Strong	Altered Expression	[629]
CYP2C8	DES5XRU	Strong	Biomarker	[588]
CYP4F3	DEFCMPI	Strong	Biomarker	[630]
DHRS9	DEGTU5I	Strong	Altered Expression	[631]
GCLC	DESYL1F	Strong	Altered Expression	[632]
GGCT	DEKW6PB	Strong	Genetic Variation	[633]
GLS	DE3E0VT	Strong	Biomarker	[634]
GSTA4	DEH7XYP	Strong	Posttranslational Modification	[635]
HPGD	DEHKSC6	Strong	Biomarker	[481]
MGST1	DEAPJSO	Strong	Biomarker	[338]
NAT2	DER7TA0	Strong	Genetic Variation	[636]
NNMT	DECVGJ3	Strong	Biomarker	[637]
NT5C2	DE1DOKJ	Strong	Biomarker	[476]
PCYT1A	DEQYXD4	Strong	Biomarker	[638]
SULT1A1	DEYWLRK	Strong	Genetic Variation	[639]
TGM3	DEOEB3Q	Strong	Altered Expression	[640]
UBASH3B	DE10BJ5	Strong	Biomarker	[641]
UGT1A10	DEL5N6Y	Strong	Altered Expression	[642]
UGT1A7	DEZO4N3	Strong	Altered Expression	[642]
UGT1A9	DE85D2P	Strong	Altered Expression	[642]
UPP2	DEBQ2WU	Strong	Biomarker	[643]
CYP2A13	DEXZA9U	Definitive	Altered Expression	[644]
PTGDS	DER3H9C	Definitive	Altered Expression	[645]

This Disease Is Related to 952 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACKR2	OTWYY14H	Limited	Altered Expression	[646]
ACKR4	OTZPWT2N	Limited	Altered Expression	[646]
AKIRIN2	OTQ6WSKW	Limited	Altered Expression	[647]
ALDH7A1	OTV57BZD	Limited	Biomarker	[648]
ALPK1	OTBW6SGD	Limited	Biomarker	[649]
AMBP	OTLU8GU8	Limited	Biomarker	[650]
ANKRD11	OTV0V70M	Limited	Genetic Variation	[19]
ANTXR1	OT5W1GPC	Limited	Altered Expression	[14]
ANXA9	OTKNYMU2	Limited	Biomarker	[651]
APOBEC3A	OTYO6F5P	Limited	Altered Expression	[652]
ARHGEF5	OTUVGFT9	Limited	Altered Expression	[653]
ASCL1	OTI4X44G	Limited	Biomarker	[654]
ATG4B	OTQ4RNRM	Limited	Altered Expression	[655]
ATP2A3	OTFYDEES	Limited	Biomarker	[656]
AUNIP	OTXBB7R3	Limited	Altered Expression	[657]
BACH2	OT17GS18	Limited	Genetic Variation	[19]
BCL10	OT47MCLI	Limited	Altered Expression	[658]
BFSP1	OTXZ3YIU	Limited	Biomarker	[659]
CABIN1	OT4G5CIK	Limited	Genetic Variation	[660]
CARD18	OTBMLB80	Limited	Biomarker	[661]
CARD9	OTJ81AWD	Limited	Altered Expression	[662]
CCL1	OT23NON8	Limited	Genetic Variation	[663]
CCNY	OTK1KG5W	Limited	Altered Expression	[664]
CCT4	OT5D452X	Limited	Biomarker	[665]
CDKN2B	OTAG24N1	Limited	Genetic Variation	[666]
CDSN	OTQW4HV6	Limited	Biomarker	[667]
CERS6	OTOP4GV1	Limited	Biomarker	[668]
CIP2A	OTVS2GXA	Limited	Altered Expression	[669]
CLDN2	OTRF3D6Y	Limited	Altered Expression	[670]
CREB3L1	OT2JHIHM	Limited	Genetic Variation	[43]
CRIP3	OT7H1YOY	Limited	Posttranslational Modification	[648]
CUL1	OTXPE1UZ	Limited	Altered Expression	[274]
CUL2	OTPF83PG	Limited	Altered Expression	[671]
DCTN4	OTM7C943	Limited	Altered Expression	[52]
DLX1	OT7BH057	Limited	Altered Expression	[672]
DSG2	OTJPB2TO	Limited	Altered Expression	[673]
DST	OTHZBM4X	Limited	Altered Expression	[674]
DTNBP1	OT9UQT2S	Limited	Genetic Variation	[19]
DVL1	OTD67RF1	Limited	Altered Expression	[675]
EIF4A1	OTMTBX6N	Limited	Biomarker	[676]
EIF4A3	OTYYFE7K	Limited	Biomarker	[677]
ELMO1	OTY2ORXK	Limited	Biomarker	[678]
ERCC4	OTFIOPG1	Limited	Biomarker	[679]
ETFA	OTXX61VZ	Limited	Biomarker	[452]
ETV1	OT6PMJIK	Limited	Altered Expression	[680]
EVX2	OTH01KN1	Limited	Biomarker	[681]
FBLIM1	OTFHXMON	Limited	Biomarker	[682]
FEV	OTYEC4IR	Limited	Biomarker	[683]
FGF9	OT2SKDGM	Limited	Altered Expression	[684]
FHOD1	OTROM7N3	Limited	Biomarker	[685]
FLACC1	OTZN9TZV	Limited	Genetic Variation	[19]
FOXE1	OT5IR5IT	Limited	Biomarker	[686]
FOXP4	OTHCGIEZ	Limited	Biomarker	[687]
GAB1	OTQKE6V4	Limited	Biomarker	[688]
GAB2	OTBFN705	Limited	Biomarker	[689]
GOLM1	OTOZSV6O	Limited	Altered Expression	[690]
GOPC	OTRBGH71	Limited	Biomarker	[682]
GTF2H1	OTCRXC6B	Limited	Altered Expression	[52]
GTSE1	OTPP742Z	Limited	Altered Expression	[691]
H4C1	OTB71W46	Limited	Biomarker	[692]
HAND2	OTCXYW4Y	Limited	Altered Expression	[693]
HCP5	OTV0YRI8	Limited	Altered Expression	[694]
HEATR3	OTB52FZ4	Limited	Genetic Variation	[69]
HHLA2	OTYBTVQS	Limited	Biomarker	[695]
HMGN2	OTN20MEF	Limited	Altered Expression	[696]
IFNA17	OTHXRYG3	Limited	Biomarker	[697]
IRF9	OTK4MYQJ	Limited	Biomarker	[698]
IVL	OT4VPNGY	Limited	Altered Expression	[699]
KAT5	OTL7257A	Limited	Biomarker	[700]
KDM8	OTCN5ST8	Limited	Altered Expression	[701]
KIF3B	OT0HJREB	Limited	Biomarker	[702]
KLF7	OTS3YVA0	Limited	Altered Expression	[703]
KLK9	OTGJWBIF	Limited	Biomarker	[704]
KRT15	OTS6WLF7	Limited	Biomarker	[705]
KRT5	OTVGI9HT	Limited	Biomarker	[404]
KRT81	OTMKIK2S	Limited	Biomarker	[706]
LEMD1	OTII3FTO	Limited	Biomarker	[707]
LIG4	OT40DNXU	Limited	Altered Expression	[708]
LRIG2	OTDUBLIH	Limited	Biomarker	[709]
LTBP4	OTC8WL2V	Limited	Altered Expression	[710]
LUM	OTSRC874	Limited	Altered Expression	[711]
LZTS1	OTXXL864	Limited	Altered Expression	[712]
MAGEA12	OT8ULELL	Limited	Biomarker	[58]
MCC	OTQVI1EM	Limited	Genetic Variation	[713]
MCM3	OTOOHQPM	Limited	Biomarker	[714]
MCM4	OT19PNNG	Limited	Biomarker	[28]
MINDY4	OTBZ2SZB	Limited	Biomarker	[715]
MMP19	OTLSTT2B	Limited	Biomarker	[716]
MT1M	OTVT8PLU	Limited	Posttranslational Modification	[648]
MTFP1	OT3L6F7U	Limited	Altered Expression	[717]
MYCBP2	OTHODA1F	Limited	Biomarker	[718]
N4BP2L1	OTEGV3GO	Limited	Biomarker	[719]
NANOG	OTUEY1FM	Limited	Biomarker	[720]
NCR3LG1	OT15YWU7	Limited	Biomarker	[721]
NGB	OTW0SIUY	Limited	Altered Expression	[722]
NID1	OTKLBLS6	Limited	Altered Expression	[723]
NOC2L	OTNT7R33	Limited	Genetic Variation	[323]
NR2C2	OTDZWVOJ	Limited	Altered Expression	[419]
NSUN2	OTZCNM33	Limited	Biomarker	[724]
NUPR1	OT4FU8C0	Limited	Biomarker	[725]
NUTM1	OTONYC08	Limited	Genetic Variation	[726]
OPA3	OT6NDC1M	Limited	Altered Expression	[727]
PCBP1	OTHN0TD7	Limited	Biomarker	[728]
PCDHGB6	OT1Y20JS	Limited	Biomarker	[648]
PCGF2	OTIY1J5L	Limited	Altered Expression	[729]
PCLAF	OTMVIOUU	Limited	Biomarker	[730]
PFN1	OTHTGA1H	Limited	Biomarker	[731]
PIGR	OT6GLSUL	Limited	Altered Expression	[732]
PLAGL1	OTZAO900	Limited	Altered Expression	[733]
PLEC	OTU4XDEG	Limited	Altered Expression	[727]
POM121	OTIA7ZOQ	Limited	Biomarker	[734]
PPFIA1	OTYYFA9C	Limited	Altered Expression	[735]
PRDM1	OTQLSVBS	Limited	Altered Expression	[736]
PRKRA	OTUTVZZU	Limited	Altered Expression	[737]
PRM3	OT6574BF	Limited	Biomarker	[738]
PRPF31	OTSJ0Z1Y	Limited	Biomarker	[739]
PSME3	OTSTC4YY	Limited	Biomarker	[740]
PSTPIP1	OT4PGEAB	Limited	Altered Expression	[741]
RAB14	OTF1J0TB	Limited	Biomarker	[742]
RAB23	OTBAKFBR	Limited	Biomarker	[743]
RBBP6	OTTVG4HU	Limited	Altered Expression	[737]
RBL2	OTBQSOE6	Limited	Biomarker	[744]
RHBDF1	OTCQ7UDS	Limited	Biomarker	[745]
RHOH	OT1J9SEB	Limited	Biomarker	[746]
RPS6KA4	OTTK8MUO	Limited	Biomarker	[747]
RRM2B	OTE8GBUR	Limited	Genetic Variation	[748]
RTL1	OTOT33IM	Limited	Biomarker	[59]
SCARA5	OTOVA96E	Limited	Biomarker	[749]
SEC16A	OTFNQ1ZU	Limited	Genetic Variation	[19]
SERPINB4	OT88LHZ8	Limited	Biomarker	[523]
SET	OTGYYQJO	Limited	Biomarker	[750]
SFTPA1	OT87XL1U	Limited	Altered Expression	[751]
SFXN1	OTL66767	Limited	Biomarker	[752]
SIAH1	OT29A838	Limited	Altered Expression	[753]
SIRT4	OT5S0J23	Limited	Altered Expression	[80]
SKP1	OT5BPAZ4	Limited	Genetic Variation	[316]
SLU7	OTZUUICN	Limited	Biomarker	[754]
SMG6	OTRCEJQL	Limited	Genetic Variation	[69]
SMIM10L2B	OT04IG2N	Limited	Biomarker	[755]
SOX17	OT9H4WWE	Limited	Biomarker	[756]
SOX7	OTOZOFAG	Limited	Altered Expression	[757]
SPAAR	OTWXG2R8	Limited	Biomarker	[758]
SPAM1	OTMPOB4E	Limited	Altered Expression	[759]
SPINK7	OTK3VOI3	Limited	Genetic Variation	[663]
SPINT1	OT1CLR5L	Limited	Biomarker	[760]
SPRN	OTVKSA48	Limited	Biomarker	[761]
SPRY2	OTH0CRCZ	Limited	Altered Expression	[762]
ST3GAL4	OTNENJZQ	Limited	Altered Expression	[763]
STMN3	OT20F289	Limited	Altered Expression	[764]
STPG4	OT5K4UFL	Limited	Altered Expression	[436]
TBXT	OTHCO2F0	Limited	Altered Expression	[765]
TCHP	OTVDMHSY	Limited	Biomarker	[766]
TCIM	OTARUXQF	Limited	Altered Expression	[767]
TCP1	OT1MGUX9	Limited	Biomarker	[638]
THBS2	OTXET551	Limited	Altered Expression	[559]
TLK1	OTICTXI8	Limited	Altered Expression	[768]
TMC6	OTKH50J4	Limited	Genetic Variation	[769]
TMC8	OTUAD95X	Limited	Genetic Variation	[770]
TMEM182	OTVDIS2V	Limited	Altered Expression	[771]
TMIGD2	OTWWAHTV	Limited	Biomarker	[695]
TNFSF9	OTV9L89D	Limited	Altered Expression	[772]
TPM1	OTD73X6R	Limited	Altered Expression	[773]
TPM4	OTN4YLYR	Limited	Altered Expression	[774]
TRIM14	OTLQKUG0	Limited	Biomarker	[775]
TSC2	OT47LWI9	Limited	Biomarker	[528]
TSPAN15	OTNQXXIG	Limited	Biomarker	[776]
TTF1	OT4K90WD	Limited	Altered Expression	[777]
CADM1	OTRWG9QS	Disputed	Biomarker	[778]
KLF5	OT1ABI9N	Disputed	Biomarker	[99]
SPINK1	OTSUVAL2	Disputed	Biomarker	[584]
TMC5	OTO5D86M	Disputed	Biomarker	[779]
ACTL6A	OT0EC5BQ	moderate	Biomarker	[780]
ALYREF	OTOF2ADD	moderate	Biomarker	[781]
ANAPC10	OTM03SME	moderate	Altered Expression	[782]
ANKS1B	OT26DGM9	moderate	Altered Expression	[783]
AP2A1	OTEFZB21	moderate	Altered Expression	[732]
ARHGDIA	OTEXWJDO	moderate	Altered Expression	[784]
ARPC1B	OTYE3DN2	moderate	Altered Expression	[785]
ATG16L1	OTEOYC5D	moderate	Biomarker	[786]
ATRN	OTTCLOPV	moderate	Biomarker	[787]
BDP1	OTJ408I9	moderate	Altered Expression	[788]
BEX1	OTBQIF0H	moderate	Biomarker	[789]
BRINP1	OTEUVSCP	moderate	Altered Expression	[790]
BUB3	OTU91HAU	moderate	Altered Expression	[791]
C15orf48	OT85J32K	moderate	Altered Expression	[792]
CCL7	OTDIS99H	moderate	Biomarker	[793]
CCNH	OTKDU3SR	moderate	Genetic Variation	[794]
CDC42EP3	OTUZ3U9Z	moderate	Biomarker	[795]
CDC73	OT6JASZ1	moderate	Altered Expression	[796]
CELSR3	OT8P6QNJ	moderate	Biomarker	[797]
CETN3	OTG4PL7H	moderate	Biomarker	[798]
CGGBP1	OTLEGQIH	moderate	Biomarker	[799]
CHAD	OT7PF813	moderate	Biomarker	[135]
CHRNA3	OTCZQY1U	moderate	Genetic Variation	[800]
CLDN5	OTUX60YO	moderate	Altered Expression	[801]
CLDN7	OTNE0XHQ	moderate	Biomarker	[310]
CLPTM1L	OTDJWQXI	moderate	Genetic Variation	[802]
CMTM3	OTS75IGC	moderate	Biomarker	[803]
CMTM5	OTMS7NDP	moderate	Posttranslational Modification	[804]
CORO1A	OTVAZOHC	moderate	Altered Expression	[805]
COX7A2L	OTY21FKV	moderate	Altered Expression	[783]
CPQ	OTTNZNLD	moderate	Biomarker	[806]
CSNK2B	OT2WW7R1	moderate	Biomarker	[117]
CT83	OTQEGHAB	moderate	Altered Expression	[807]
CYP2W1	OTXSB1AE	moderate	Altered Expression	[808]
DAB2	OTRMQTMZ	moderate	Biomarker	[809]
DACT1	OT19Z704	moderate	Altered Expression	[810]
DACT2	OTNLCC0K	moderate	Altered Expression	[810]
DENND2D	OTXEFJWM	moderate	Altered Expression	[811]
DLX3	OTARP5SQ	moderate	Altered Expression	[812]
DLX4	OTLWVCN4	moderate	Biomarker	[135]
DSC2	OTODVH8K	moderate	Biomarker	[813]
DYNLL1	OTR69LHT	moderate	Biomarker	[814]
EEF1D	OTM5ZD8Y	moderate	Biomarker	[815]
EFNA1	OTU2NUA2	moderate	Biomarker	[816]
EIF4B	OTE8TXA8	moderate	Altered Expression	[183]
EMP1	OTSZHUHQ	moderate	Altered Expression	[817]
EMP3	OTODMJ1D	moderate	Altered Expression	[818]
EMX2	OT0V8OYK	moderate	Altered Expression	[819]
ENO1	OTB1KWJS	moderate	Altered Expression	[820]
ERCC2	OT1C8HQ4	moderate	Genetic Variation	[821]
ERCC5	OTQAKFJM	moderate	Genetic Variation	[821]
EXO1	OTI87RS5	moderate	Genetic Variation	[435]
EXOC4	OT5EWXAN	moderate	Biomarker	[822]
FGF12	OTBM9QIO	moderate	Biomarker	[125]
FGF13	OTHNNVSG	moderate	Biomarker	[823]
FILIP1L	OTPY8IMS	moderate	Altered Expression	[782]
FLG	OTE9QDV6	moderate	Altered Expression	[824]
FLII	OT7G9JG6	moderate	Altered Expression	[825]
GBP2	OTVU4G07	moderate	Altered Expression	[826]
GORASP1	OTQS91S7	moderate	Biomarker	[827]
GPR151	OT7EACU6	moderate	Biomarker	[134]
HHIP	OT77RQYS	moderate	Biomarker	[828]
HOXA10	OTB6GQ09	moderate	Posttranslational Modification	[829]
HOXB7	OTC7WYU8	moderate	Biomarker	[830]
IGF2BP3	OTB97VIK	moderate	Altered Expression	[831]
ING1	OTEZBRKW	moderate	Biomarker	[832]
IRF7	OTC1A2PQ	moderate	Altered Expression	[833]
ITGAX	OTOGIMHE	moderate	Biomarker	[110]
KCNG3	OTSQKEMV	moderate	Biomarker	[135]
KCNMB3	OT2SRKQE	moderate	Biomarker	[125]
KCP	OTIS86DZ	moderate	Biomarker	[834]
KDM2B	OTDMCVW7	moderate	Altered Expression	[835]
KRT1	OTIOJWA4	moderate	Altered Expression	[836]
KRT10	OTSVRD3Q	moderate	Biomarker	[837]
KRT14	OTUVZ1DW	moderate	Altered Expression	[838]
KRT18	OTVLQFIP	moderate	Altered Expression	[839]
KRT9	OTA10UCH	moderate	Altered Expression	[792]
LAT	OTZC1XZ1	moderate	Biomarker	[604]
LATS1	OTOOCG4R	moderate	Posttranslational Modification	[840]
LMLN	OTQF0JPY	moderate	Biomarker	[841]
LTBP3	OTME98V7	moderate	Altered Expression	[842]
MAD2L1	OTXNGZCG	moderate	Biomarker	[843]
MAL	OTBM30SW	moderate	Biomarker	[659]
MAML2	OT1TSVAR	moderate	Genetic Variation	[844]
MAPRE1	OTCVQD60	moderate	Altered Expression	[783]
MASP1	OTWWCNZP	moderate	Biomarker	[125]
MCPH1	OTYT3TT5	moderate	Biomarker	[845]
MIA2	OTOGTUTU	moderate	Biomarker	[846]
MLLT11	OTG5RVHC	moderate	Altered Expression	[847]
MMP23B	OT2OR6TS	moderate	Altered Expression	[163]
MRGPRX3	OTRKCCDS	moderate	Biomarker	[134]
MRGPRX4	OTOBHZVA	moderate	Biomarker	[134]
MT1X	OT9AKFVS	moderate	Biomarker	[848]
MUC5B	OTPW6K5C	moderate	Altered Expression	[849]
MXI1	OTUQ9E0D	moderate	Biomarker	[843]
MYCL	OT1MFQ5U	moderate	Genetic Variation	[850]
MZF1	OTMVZCPW	moderate	Altered Expression	[851]
NAPSA	OT6F8IAL	moderate	Biomarker	[122]
NCOA7	OT2CNBOG	moderate	Biomarker	[852]
NIPBL	OTF6OOLU	moderate	Biomarker	[853]
NKRF	OTUVY0P6	moderate	Altered Expression	[854]
NLK	OT2LETFS	moderate	Altered Expression	[855]
NNAT	OTNRLO7G	moderate	Altered Expression	[856]
NOB1	OTW0YNSL	moderate	Altered Expression	[857]
NOP53	OTA2YKO6	moderate	Altered Expression	[858]
NOX1	OTZPJQCC	moderate	Biomarker	[859]
NR2E1	OTW47GKM	moderate	Biomarker	[135]
NUSAP1	OT85HIJ5	moderate	Altered Expression	[860]
OLFM3	OTBHPDTL	moderate	Altered Expression	[861]
ONECUT1	OTK1QUQT	moderate	Posttranslational Modification	[862]
OSR1	OTB19LEQ	moderate	Biomarker	[135]
OTX1	OTRGSGH9	moderate	Biomarker	[135]
OTX2	OTTV05B1	moderate	Biomarker	[135]
PADI2	OTT40K94	moderate	Altered Expression	[863]
PAK6	OTAHPZTT	moderate	Biomarker	[186]
PEG10	OTWD2278	moderate	Altered Expression	[864]
PERP	OTP0YL53	moderate	Altered Expression	[865]
PFN2	OT5SSSA7	moderate	Biomarker	[866]
PGAM1	OTZ5DB06	moderate	Biomarker	[867]
PHEX	OTG7N3J7	moderate	Biomarker	[868]
PLAG1	OTT9AJQY	moderate	Biomarker	[869]
PLIN2	OTRXJ9UN	moderate	Biomarker	[870]
POT1	OTNBXJCQ	moderate	Genetic Variation	[802]
POTEF	OTV3WXYE	moderate	Altered Expression	[871]
PRDX3	OTLB2WEU	moderate	Altered Expression	[872]
PVR	OT3N91T7	moderate	Altered Expression	[159]
PYCARD	OT67RON3	moderate	Biomarker	[873]
RAB2A	OT6SK83U	moderate	Biomarker	[874]
RAB6A	OTLS86J5	moderate	Biomarker	[875]
RAB8A	OTPB54Y3	moderate	Biomarker	[876]
RABEP2	OTO61X27	moderate	Biomarker	[129]
RAD17	OT1I93DT	moderate	Biomarker	[877]
RALA	OT734R7X	moderate	Altered Expression	[878]
RBMX	OTFZN66E	moderate	Altered Expression	[879]
RBP2	OTR8QG5V	moderate	Altered Expression	[880]
REST	OTLL92LQ	moderate	Biomarker	[881]
RFC2	OTJ9N6BD	moderate	Altered Expression	[882]
RMDN1	OTE1NB6U	moderate	Altered Expression	[567]
RMDN2	OTK5WSFI	moderate	Altered Expression	[567]
RND3	OTXMXPIH	moderate	Biomarker	[883]
ROBO3	OTPVG40S	moderate	Biomarker	[884]
S100A16	OT3ERKQI	moderate	Biomarker	[885]
S100A7A	OTNM8DCP	moderate	Biomarker	[886]
SEC62	OTCWEL5F	moderate	Biomarker	[887]
SENP3	OTFQDOMC	moderate	Altered Expression	[888]
SEPTIN9	OT1VMRFQ	moderate	Genetic Variation	[179]
SESN2	OT889IXY	moderate	Biomarker	[889]
SHMT1	OTIINA3J	moderate	Genetic Variation	[890]
SLC25A40	OTYMJ69D	moderate	Biomarker	[891]
SLIT3	OTU8MKEU	moderate	Biomarker	[884]
SMG1	OTTS3SXE	moderate	Altered Expression	[123]
SNX3	OTXL5W8F	moderate	Biomarker	[892]
SOX14	OTPEKVOM	moderate	Biomarker	[799]
SP2	OT1YI07B	moderate	Biomarker	[893]
STIL	OT9799VN	moderate	Biomarker	[176]
SUZ12	OT655XF8	moderate	Biomarker	[894]
SYBU	OT3FQV7N	moderate	Altered Expression	[567]
SYT1	OTVTPOI6	moderate	Biomarker	[827]
TBPL1	OT4I143E	moderate	Altered Expression	[196]
TCHHL1	OTAMOJGN	moderate	Altered Expression	[895]
TEAD4	OTJS0T2B	moderate	Altered Expression	[896]
TENT5C	OTOWVQ4O	moderate	Biomarker	[897]
TIMP2	OT8S1RRP	moderate	Biomarker	[442]
TMPRSS11A	OTB35677	moderate	Biomarker	[898]
TMPRSS13	OTMAOAP3	moderate	Biomarker	[841]
TOM1L1	OT37NXR0	moderate	Altered Expression	[899]
TPD52L2	OTTOG0NK	moderate	Biomarker	[900]
TREX2	OT5QAGJ4	moderate	Genetic Variation	[901]
TSC1	OTFF4YZ7	moderate	Altered Expression	[528]
ABCG8	OTIJ76XW	Strong	Genetic Variation	[356]
ACCS	OTHIHI9D	Strong	Biomarker	[902]
ACTN4	OTCNZAJ5	Strong	Biomarker	[903]
ADAM12	OTZKOTDB	Strong	Altered Expression	[904]
ADAM15	OTZ7VLTP	Strong	Genetic Variation	[905]
ADAR	OTQNOHR8	Strong	Altered Expression	[906]
ADGRG1	OTQBB8NT	Strong	Altered Expression	[907]
AFAP1L2	OTJBI0VN	Strong	Biomarker	[908]
AIM2	OT86QUI8	Strong	Altered Expression	[909]
AKAP12	OTCVRDDX	Strong	Posttranslational Modification	[910]
AMTN	OTXAMT4V	Strong	Altered Expression	[211]
ANKRD36B	OT3MW415	Strong	Genetic Variation	[911]
ANOS1	OTZJT4KN	Strong	Altered Expression	[912]
ANP32A	OTRHPFO2	Strong	Biomarker	[913]
ANP32B	OT3SQMLU	Strong	Altered Expression	[566]
ANXA6	OT9KIQ0Y	Strong	Biomarker	[641]
AP2M1	OTQCOSFN	Strong	Altered Expression	[298]
AP4B1	OTGJUIRA	Strong	Biomarker	[914]
API5	OTYX9YCZ	Strong	Altered Expression	[915]
APOBEC3B	OTHLNI51	Strong	Biomarker	[248]
AQP5	OT77GBY8	Strong	Biomarker	[223]
ARHGEF12	OTM2D3LT	Strong	Altered Expression	[916]
ARHGEF28	OT3F32IU	Strong	Biomarker	[71]
ARID1A	OTRWDV3P	Strong	Biomarker	[917]
ARL6IP5	OTYZ6BEQ	Strong	Genetic Variation	[918]
ARSF	OTC0L12N	Strong	Altered Expression	[919]
ART1	OT7FBG5W	Strong	Genetic Variation	[920]
ASPRV1	OT8WVIBW	Strong	Altered Expression	[921]
ATF2	OTNIZPEA	Strong	Altered Expression	[922]
AXIN1	OTRGZGZ5	Strong	Altered Expression	[923]
B3GAT1	OTXFP98E	Strong	Biomarker	[924]
BAD	OT63ERYM	Strong	Altered Expression	[847]
BAG1	OTRQNIA4	Strong	Altered Expression	[925]
BCAM	OTHZOPSD	Strong	Altered Expression	[926]
BCAR1	OTKT2C2N	Strong	Altered Expression	[927]
BEX4	OT3LXD15	Strong	Altered Expression	[928]
BHLHE22	OTZUQY5L	Strong	Altered Expression	[184]
BHLHE23	OTLSVD17	Strong	Biomarker	[914]
BHLHE40	OTITX14U	Strong	Altered Expression	[929]
BMP5	OTC0Y6E0	Strong	Biomarker	[930]
BMPR1A	OTQOA4ZH	Strong	Genetic Variation	[931]
BNC1	OTGJ5WUF	Strong	Altered Expression	[932]
BRD8	OTIKS3PC	Strong	Biomarker	[462]
BRF2	OT2C6TH2	Strong	Biomarker	[933]
BUB1B	OT8KME51	Strong	Altered Expression	[934]
CAGE1	OTF3HI3N	Strong	Posttranslational Modification	[935]
CAMK2A	OTJGX19T	Strong	Altered Expression	[916]
CAP1	OTYM8A2N	Strong	Altered Expression	[238]
CAV2	OT1FGRQX	Strong	Altered Expression	[936]
CCAR2	OTLUDG5T	Strong	Biomarker	[937]
CCDC6	OTXRQDYG	Strong	Biomarker	[938]
CCHCR1	OT22C116	Strong	Altered Expression	[939]
CCL27	OTUZYC61	Strong	Altered Expression	[940]
CCL8	OTCTWYN8	Strong	Genetic Variation	[941]
CCN4	OT69BER9	Strong	Biomarker	[942]
CCNG2	OTII38K2	Strong	Biomarker	[943]
CCNL1	OTAJSS3D	Strong	Biomarker	[944]
CCT6A	OTCYWL5F	Strong	Biomarker	[945]
CD109	OTDADBM4	Strong	Altered Expression	[946]
CD151	OTF3UZS7	Strong	Altered Expression	[947]
CD1C	OT4XINUJ	Strong	Altered Expression	[948]
CD68	OTOYEY3J	Strong	Biomarker	[949]
CD82	OTH8MC64	Strong	Biomarker	[950]
CDC6	OTX93FE7	Strong	Altered Expression	[951]
CDCA2	OTX8UF9J	Strong	Altered Expression	[952]
CDH13	OTD2CYM5	Strong	Altered Expression	[953]
CDK2AP1	OTNFOHDJ	Strong	Biomarker	[954]
CDK2AP2	OTR99SJ8	Strong	Biomarker	[955]
CDO1	OTLG1P77	Strong	Posttranslational Modification	[956]
CDX2	OTCG4TSY	Strong	Biomarker	[957]
CEACAM7	OTKFDTZY	Strong	Altered Expression	[256]
CEBPD	OTNBIPMY	Strong	Biomarker	[123]
CELF1	OT6JQ5RS	Strong	Altered Expression	[958]
CENPF	OT7AG0SW	Strong	Altered Expression	[959]
CENPH	OTPOO9LK	Strong	Altered Expression	[960]
CFDP1	OTXY7J96	Strong	Posttranslational Modification	[961]
CHAF1A	OTXSSY4H	Strong	Biomarker	[962]
CHAF1B	OTOMK4KH	Strong	Biomarker	[962]
CHD1L	OT7CZK7C	Strong	Altered Expression	[963]
CHFR	OTRAD2TT	Strong	Genetic Variation	[964]
CHGA	OTXYX5JH	Strong	Altered Expression	[965]
CHL1	OT6E6E8P	Strong	Altered Expression	[966]
CIB1	OT4BVCRU	Strong	Altered Expression	[967]
CIB2	OT9ZJX1I	Strong	Altered Expression	[968]
CIITA	OTRJNZFO	Strong	Altered Expression	[969]
CISH	OT8T5NYL	Strong	Biomarker	[970]
CKMT1A	OTCINHH5	Strong	Altered Expression	[971]
CKS1B	OTNUPLUJ	Strong	Altered Expression	[972]
CLDN1	OT27KV99	Strong	Altered Expression	[973]
CLDN22	OTA4Y7EF	Strong	Biomarker	[211]
CLEC10A	OTD8HQT6	Strong	Altered Expression	[432]
CLIC4	OT6KTPKD	Strong	Altered Expression	[974]
CLOCK	OTNEOJY7	Strong	Biomarker	[975]
CMPK2	OTOG90R0	Strong	Altered Expression	[629]
CNOT7	OTJBKCPI	Strong	Biomarker	[962]
CNOT8	OT6CMCS0	Strong	Biomarker	[962]
CNPY2	OTGY8ESX	Strong	Biomarker	[976]
COL11A1	OTB0DRMS	Strong	Biomarker	[977]
COL17A1	OTID5AH2	Strong	Posttranslational Modification	[978]
COL4A3	OT6SB8X5	Strong	Biomarker	[979]
COL4A6	OTUREU5Z	Strong	Altered Expression	[980]
COX5A	OTP0961M	Strong	Biomarker	[981]
CPOX	OTIAY121	Strong	Biomarker	[981]
CRABP1	OTISDG5X	Strong	Biomarker	[982]
CRABP2	OTY01V9G	Strong	Altered Expression	[880]
CRISP2	OT8HLTV5	Strong	Posttranslational Modification	[983]
CRNN	OTAORBR4	Strong	Altered Expression	[984]
CSHL1	OTQKU2F5	Strong	Biomarker	[51]
CSMD1	OTIVDSC4	Strong	Biomarker	[985]
CSN2	OT22C0PD	Strong	Biomarker	[986]
CSTA	OT1K68KE	Strong	Biomarker	[987]
CTAG1B	OTIQGW6U	Strong	Altered Expression	[271]
CTAG2	OT8HISP4	Strong	Altered Expression	[988]
CTC1	OTRJY7QD	Strong	Biomarker	[989]
CTDSPL	OTZJ0CZK	Strong	Biomarker	[799]
CTNNA1	OTFC725Z	Strong	Biomarker	[990]
CTNNAL1	OTESJ6JD	Strong	Altered Expression	[991]
CTNND1	OTUMPSHR	Strong	Genetic Variation	[992]
CUX1	OTU1LCNJ	Strong	Biomarker	[378]
CXCL14	OTM189TA	Strong	Altered Expression	[993]
CXCL5	OTZOUPCA	Strong	Biomarker	[994]
CYB5D2	OTX10KKR	Strong	Altered Expression	[995]
CYBA	OT16N9ZO	Strong	Biomarker	[996]
CYLD	OT37FKH0	Strong	Altered Expression	[997]
DAP	OT5YLL7E	Strong	Altered Expression	[998]
DCAF4	OTQU0EUO	Strong	Altered Expression	[999]
DCC	OT2C1SHW	Strong	Posttranslational Modification	[1000]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[1001]
DDX3X	OTDO4TRX	Strong	Biomarker	[1002]
DDX56	OTGURA53	Strong	Biomarker	[1003]
DDX60	OTVPHA0C	Strong	Biomarker	[1003]
DEF8	OTS93PPZ	Strong	Genetic Variation	[325]
DEFB1	OT5SV0E4	Strong	Altered Expression	[1004]
DEFB103B	OT8RWY64	Strong	Biomarker	[110]
DHRS4	OTTPOIOP	Strong	Genetic Variation	[1005]
DLEC1	OTMKKBUW	Strong	Posttranslational Modification	[648]
DMBT1	OTVNU9D9	Strong	Biomarker	[1006]
DMKN	OTRIGZMK	Strong	Altered Expression	[1007]
DMP1	OTBWBWW7	Strong	Altered Expression	[1008]
DNAH11	OT6IYFVV	Strong	Genetic Variation	[356]
DNAJB7	OT4BOECZ	Strong	Biomarker	[1009]
DNAJC2	OT3JDA0R	Strong	Biomarker	[1010]
DPAGT1	OTYEJAGZ	Strong	Biomarker	[1011]
DROSHA	OTCE68KZ	Strong	Genetic Variation	[1002]
DSC3	OTYG47F8	Strong	Biomarker	[813]
DSG1	OT11HC3A	Strong	Biomarker	[1012]
DSP	OTB2MOP8	Strong	Altered Expression	[1013]
DSPP	OT1TYNDN	Strong	Biomarker	[1014]
DVL3	OTPRROHJ	Strong	Biomarker	[1015]
E2F4	OTB3JFH4	Strong	Biomarker	[1016]
E2F7	OTWW358N	Strong	Biomarker	[1017]
EBAG9	OTTQLQCP	Strong	Biomarker	[1018]
EBF3	OTB0IWLW	Strong	Posttranslational Modification	[610]
ECM1	OT1K65VW	Strong	Altered Expression	[1019]
ECRG4	OTHZYUXX	Strong	Altered Expression	[1020]
EFNB2	OT0DCUOM	Strong	Altered Expression	[1021]
EIF3A	OTFABY9G	Strong	Biomarker	[1022]
EIF4G1	OT2CF1E6	Strong	Altered Expression	[298]
EIF4G2	OTEO98CR	Strong	Posttranslational Modification	[961]
EIF6	OTEXMUED	Strong	Biomarker	[1023]
EMD	OTR8ZANE	Strong	Biomarker	[1024]
ENO2	OTRODL0T	Strong	Altered Expression	[1025]
EPS8	OTZ6ES6V	Strong	Altered Expression	[1026]
ESM1	OT331Y8V	Strong	Altered Expression	[1027]
ETV4	OT8C98UZ	Strong	Altered Expression	[1028]
FADD	OTV7GFHH	Strong	Biomarker	[1029]
FAM168A	OTDXQCS5	Strong	Biomarker	[848]
FAM3C	OTBR6U9G	Strong	Altered Expression	[1030]
FANCD2	OTVEB5LF	Strong	Altered Expression	[1031]
FBP1	OTQBANEP	Strong	Altered Expression	[1032]
FERMT1	OT626PBA	Strong	Biomarker	[422]
FETUB	OT7V07NI	Strong	Altered Expression	[1033]
FEZ1	OTWCXPRE	Strong	Posttranslational Modification	[712]
FGF3	OT9PK2SI	Strong	Genetic Variation	[1034]
FGFRL1	OT8HZ3ZL	Strong	Biomarker	[1035]
FOXA1	OTEBY0TD	Strong	Altered Expression	[1036]
FOXN1	OTE80D6I	Strong	Biomarker	[1037]
FOXO3	OTHXQG4P	Strong	Biomarker	[1038]
FRZB	OTTO3DPY	Strong	Biomarker	[1039]
FSD1	OT8P6PT3	Strong	Biomarker	[1040]
FSD1L	OTBQ48RF	Strong	Biomarker	[1040]
FSTL1	OT6KEZUD	Strong	Biomarker	[1041]
FUCA1	OTW71IK4	Strong	Biomarker	[1042]
FUT1	OTODG57A	Strong	Biomarker	[1043]
FXR1	OTEMQ1SR	Strong	Biomarker	[1044]
FXYD5	OT81DIOD	Strong	Altered Expression	[1045]
GADD45A	OTDRV63V	Strong	Altered Expression	[1046]
GALNT2	OTZZ5386	Strong	Biomarker	[1047]
GALNT3	OT7M67WT	Strong	Biomarker	[1048]
GBP6	OTL8PQW0	Strong	Altered Expression	[1049]
GCFC2	OTC7FRXL	Strong	Biomarker	[1050]
GDE1	OTU6FSBF	Strong	Altered Expression	[768]
GDF10	OTEVXGJ7	Strong	Altered Expression	[1051]
GEMIN2	OT4L6TLL	Strong	Biomarker	[1052]
GEMIN4	OTX7402E	Strong	Posttranslational Modification	[961]
GINS2	OT974IYI	Strong	Altered Expression	[1053]
GLIS1	OTBDNB26	Strong	Biomarker	[1054]
GNA12	OT3IRZH3	Strong	Altered Expression	[1055]
GPAA1	OTWVRR35	Strong	Altered Expression	[1056]
GPC1	OTQKRSSV	Strong	Altered Expression	[1057]
GPRC5A	OTPOCWR7	Strong	Biomarker	[1058]
GPX4	OTRAFFX2	Strong	Altered Expression	[1059]
GRB10	OTCKXGRC	Strong	Altered Expression	[1060]
GRP	OT8JDFNI	Strong	Altered Expression	[1061]
GSDMB	OTWA7P10	Strong	Genetic Variation	[1062]
GSDME	OT1ZWY32	Strong	Biomarker	[460]
GSTK1	OTDNGWAF	Strong	Biomarker	[358]
GSTM3	OTLA2WJT	Strong	Altered Expression	[1063]
H2AX	OT18UX57	Strong	Biomarker	[1064]
HABP2	OTAUIPW0	Strong	Altered Expression	[1065]
HAS2	OTTD3PAL	Strong	Altered Expression	[1066]
HCLS1	OTX7WGYN	Strong	Biomarker	[378]
HERC2	OTNQYKOB	Strong	Genetic Variation	[325]
HGD	OTTKLQOO	Strong	Biomarker	[1067]
HIC1	OTI9TWY4	Strong	Biomarker	[1068]
HLA-C	OTV38BUJ	Strong	Altered Expression	[1069]
HLA-DQA2	OT1DH0N9	Strong	Genetic Variation	[325]
HLTF	OTRX2OSF	Strong	Altered Expression	[1070]
HMGN5	OTUUAHVQ	Strong	Altered Expression	[1071]
HMMR	OT4M0JTZ	Strong	Altered Expression	[567]
HNRNPD	OT5UO1FA	Strong	Biomarker	[1072]
HNRNPK	OTNPRM8U	Strong	Altered Expression	[1073]
HNRNPL	OT0DJX74	Strong	Genetic Variation	[1074]
HNRNPU	OTLQN1E2	Strong	Biomarker	[462]
HOPX	OTBSR6C9	Strong	Altered Expression	[1075]
HOXA1	OTMSOJ7D	Strong	Biomarker	[1076]
HOXA2	OT6G6ZIK	Strong	Genetic Variation	[648]
HOXA9	OTKNK5H0	Strong	Posttranslational Modification	[1077]
HOXB5	OTU74TB8	Strong	Altered Expression	[1078]
HOXC10	OT5WF17M	Strong	Altered Expression	[1079]
HOXC6	OTBCRAZV	Strong	Altered Expression	[1080]
HOXD9	OTZ4GVR1	Strong	Altered Expression	[1081]
HPSE2	OTGEPP8V	Strong	Altered Expression	[1082]
HS3ST2	OTWFA0GJ	Strong	Biomarker	[1083]
HSPB2	OTS01646	Strong	Altered Expression	[1084]
HYAL1	OT2SJN0X	Strong	Altered Expression	[759]
HYAL2	OTTVINXW	Strong	Altered Expression	[1085]
IBSP	OT29944Y	Strong	Biomarker	[1086]
ICAM3	OTTZ5A5D	Strong	Biomarker	[1087]
ICAM5	OTDGGAFH	Strong	Altered Expression	[1088]
ID4	OTPMJ39I	Strong	Posttranslational Modification	[1089]
IFI16	OT4SPU0U	Strong	Altered Expression	[1090]
IFIT1	OTXOQDSG	Strong	Altered Expression	[1091]
IFIT2	OTI4EOAR	Strong	Altered Expression	[1092]
IFIT3	OTPGHZB9	Strong	Altered Expression	[1091]
IFITM1	OTECO1G8	Strong	Altered Expression	[1093]
IFITM2	OTAT6TI6	Strong	Altered Expression	[1094]
IFNA8	OTW0PCKU	Strong	Biomarker	[1095]
IGSF1	OT3XD6U2	Strong	Biomarker	[462]
IHH	OT1DWGXC	Strong	Altered Expression	[1096]
IKBKE	OT5VYOSM	Strong	Altered Expression	[1097]
IL17RA	OTVVI8ER	Strong	Biomarker	[1098]
ING4	OT0VVG4V	Strong	Altered Expression	[1099]
INPP5A	OT9CMGMS	Strong	Biomarker	[1100]
INSM1	OTG8RV8E	Strong	Biomarker	[965]
INTS2	OT2N5TCK	Strong	Genetic Variation	[1034]
IRF4	OT1DHQ1P	Strong	Genetic Variation	[19]
IRF6	OTKJ44EV	Strong	Genetic Variation	[1101]
IRS4	OTTOL40K	Strong	Biomarker	[1102]
IRX1	OT0ZN9EJ	Strong	Posttranslational Modification	[610]
IST1	OTSFEZ2O	Strong	Altered Expression	[1103]
ITGA3	OTBCH21D	Strong	Biomarker	[1104]
ITGA9	OTHN1IKA	Strong	Altered Expression	[1105]
ITGB4	OT28UK84	Strong	Biomarker	[1106]
ITPKA	OTX5ERUD	Strong	Altered Expression	[1107]
KHSRP	OTDHZARB	Strong	Biomarker	[378]
KIF5B	OTT34MT8	Strong	Altered Expression	[1108]
KIR3DL1	OTPOSXFX	Strong	Genetic Variation	[336]
KLK10	OTD573EL	Strong	Altered Expression	[1109]
KMT2B	OTMMAZQX	Strong	Biomarker	[1110]
KMT2D	OTTVHCLY	Strong	Biomarker	[1110]
KNSTRN	OTYA7UXS	Strong	Biomarker	[1111]
KRT13	OTTYSKGX	Strong	Genetic Variation	[1112]
KRT16	OTGA0EQN	Strong	Biomarker	[1113]
KRT20	OT4RB40L	Strong	Biomarker	[1114]
KRT40	OT2ODDUR	Strong	Biomarker	[404]
KRT6B	OTBXJYHY	Strong	Biomarker	[779]
KRT7	OTLT3JFN	Strong	Biomarker	[452]
KRT8	OTTM4X11	Strong	Posttranslational Modification	[1115]
LAMTOR2	OTHEDISB	Strong	Biomarker	[955]
LBR	OT1HG3HG	Strong	Biomarker	[1116]
LCORL	OTJNQRC5	Strong	Genetic Variation	[1095]
LDB1	OT20EAPR	Strong	Altered Expression	[1117]
LDOC1	OTWZH4O9	Strong	Biomarker	[789]
LGALS3BP	OT9AGQKH	Strong	Altered Expression	[1118]
LGALS8	OT71LJ8T	Strong	Altered Expression	[1119]
LGR6	OTPZ1PWR	Strong	Biomarker	[55]
LIMS1	OT729S0T	Strong	Biomarker	[1120]
LIN28B	OTVWP0FN	Strong	Altered Expression	[1121]
LIN7C	OTB3015O	Strong	Biomarker	[1122]
LMO4	OT5NDCT9	Strong	Altered Expression	[1117]
LORICRIN	OTFRPVEO	Strong	Biomarker	[117]
LOXL4	OT6XY2JL	Strong	Altered Expression	[1123]
LPP	OT6TU8SE	Strong	Genetic Variation	[19]
LRFN2	OTI2QPM2	Strong	Genetic Variation	[356]
LRIG1	OTY5HZN5	Strong	Biomarker	[1124]
LRP1B	OT4YZG2N	Strong	Altered Expression	[1125]
LTO1	OTQ17ZDT	Strong	Biomarker	[1126]
LYNX1	OTK4103B	Strong	Biomarker	[1127]
LYPD3	OTLR2PYX	Strong	Altered Expression	[1128]
LYPD5	OTGP7UKA	Strong	Biomarker	[1129]
MACC1	OTV3DLX0	Strong	Biomarker	[1130]
MAGEB6	OTOTV1FU	Strong	Biomarker	[1131]
MAK16	OTD546E5	Strong	Biomarker	[494]
MAP2	OT6UYT3X	Strong	Altered Expression	[1132]
MAPK6	OTDDNF3Q	Strong	Altered Expression	[1133]
MAPRE2	OTAE3MX4	Strong	Altered Expression	[783]
MAU2	OTALDF8Q	Strong	Biomarker	[1134]
MBD2	OTUQPP0R	Strong	Biomarker	[33]
MCAT	OTH07FIW	Strong	Altered Expression	[267]
MCM2	OTGGORIQ	Strong	Biomarker	[429]
MCTS1	OT7SAOJP	Strong	Altered Expression	[267]
MDC1	OTEUQH4J	Strong	Biomarker	[1135]
MEPE	OTXJRUW0	Strong	Biomarker	[1136]
MICA	OTPEIEAR	Strong	Altered Expression	[1137]
MICB	OTS2DVDW	Strong	Altered Expression	[1137]
MLKL	OTDSLC81	Strong	Biomarker	[997]
MMP26	OT9O89KU	Strong	Altered Expression	[1138]
MOK	OTQK7M9V	Strong	Altered Expression	[1139]
MRE11	OTGU8TZM	Strong	Biomarker	[1140]
MRPL13	OT6D8Y9G	Strong	Biomarker	[364]
MRPL28	OT4LUTZU	Strong	Genetic Variation	[1141]
MSH3	OTD3YPVL	Strong	Genetic Variation	[205]
MSH6	OT46FP09	Strong	Biomarker	[1142]
MSN	OTZJ4J6G	Strong	Altered Expression	[1143]
MST1	OTOC4UNG	Strong	Biomarker	[47]
MT3	OTVCZ7HI	Strong	Altered Expression	[1144]
MUC21	OTQ8GP5L	Strong	Biomarker	[1145]
MUC4	OTLT11V1	Strong	Biomarker	[1146]
MUC7	OTSTMP0X	Strong	Altered Expression	[1147]
MYEOV	OTDC7UHL	Strong	Altered Expression	[1148]
MYO5A	OTMWLP3E	Strong	Altered Expression	[1149]
NAA10	OTYB9R6I	Strong	Altered Expression	[1150]
NAA25	OTS3QVF1	Strong	Biomarker	[462]
NAB2	OTG4BDF3	Strong	Biomarker	[375]
NANS	OTMQ2FUH	Strong	Biomarker	[1151]
NBN	OT73B5MD	Strong	Altered Expression	[1152]
NCOA1	OTLIUJQD	Strong	Altered Expression	[1153]
ND2	OTG9OHOX	Strong	Genetic Variation	[1154]
NDN	OTYBYJ82	Strong	Posttranslational Modification	[243]
NDRG2	OT5L6KD7	Strong	Altered Expression	[1155]
NDUFC2	OT9M119L	Strong	Biomarker	[1156]
NECTIN1	OTTE5ZR6	Strong	Altered Expression	[1157]
NEIL1	OTHBU5DJ	Strong	Genetic Variation	[1158]
NEIL2	OTV6JEON	Strong	Genetic Variation	[1158]
NFATC3	OTYOORME	Strong	Biomarker	[1159]
NFIB	OTX94PD0	Strong	Altered Expression	[1160]
NINL	OTWIK6HT	Strong	Altered Expression	[1161]
NIPAL1	OTRYI60X	Strong	Biomarker	[1162]
NLRP2	OTJA81JU	Strong	Altered Expression	[1152]
NME2	OTCYGLHV	Strong	Biomarker	[1163]
NMT1	OT42GQ3D	Strong	Altered Expression	[1164]
NOLC1	OTKDZU0D	Strong	Altered Expression	[1165]
NSG1	OTRIMA50	Strong	Altered Expression	[1166]
NSUN5	OTBN7RS8	Strong	Biomarker	[462]
NTS	OTPGDNQS	Strong	Genetic Variation	[1167]
NUDT1	OTZSES3W	Strong	Altered Expression	[1168]
NUP62	OTMN63DH	Strong	Altered Expression	[52]
NXT1	OT0VO6AY	Strong	Genetic Variation	[1141]
OAS2	OT64CCTM	Strong	Posttranslational Modification	[1169]
OCA2	OTDWIGBF	Strong	Genetic Variation	[19]
OPN1LW	OTFNUZ7O	Strong	Biomarker	[1170]
ORM1	OTZKSBRE	Strong	Altered Expression	[1171]
OTUD4	OT7U62SW	Strong	Biomarker	[1068]
OTUD7B	OTMVM8R7	Strong	Altered Expression	[1172]
OVOL1	OTFJ62UI	Strong	Altered Expression	[1173]
OVOL2	OTFM1GKF	Strong	Biomarker	[1174]
PAG1	OTFOJUIQ	Strong	Biomarker	[1170]
PARD3	OTH5BPLO	Strong	Altered Expression	[1175]
PAX1	OT0Y3MIM	Strong	Biomarker	[1176]
PBX1	OTORABGO	Strong	Altered Expression	[1177]
PCBP2	OTXCN9CG	Strong	Altered Expression	[1178]
PCBP4	OTDLL4NB	Strong	Biomarker	[1170]
PDCD4	OTZ6NXUX	Strong	Biomarker	[676]
PDCD7	OTK5YO7J	Strong	Biomarker	[1179]
PDE4DIP	OTS15WNF	Strong	Altered Expression	[1180]
PDGFRL	OTJPRECT	Strong	Biomarker	[1181]
PDIA3	OTHPQ0Q3	Strong	Biomarker	[1182]
PDLIM5	OTLQVV22	Strong	Altered Expression	[1117]
PDLIM7	OTAZVODU	Strong	Altered Expression	[1183]
PDPN	OTBUV19I	Strong	Altered Expression	[1184]
PDYN	OTEJ6430	Strong	Biomarker	[1185]
PER2	OTU2B1DJ	Strong	Altered Expression	[1186]
PGP	OT6QQ7OR	Strong	Biomarker	[1187]
PHB2	OTCAX3AW	Strong	Biomarker	[1188]
PHF21B	OTU5GLCQ	Strong	Biomarker	[1189]
PHLDA3	OTXFUDO2	Strong	Altered Expression	[1190]
PHLPP1	OTIFXW8D	Strong	Biomarker	[1191]
PHLPP2	OTXB1OUI	Strong	Altered Expression	[1192]
PIAS3	OT3TWH9R	Strong	Biomarker	[503]
PIDD1	OTWFM930	Strong	Altered Expression	[1193]
PINK1	OT50NR57	Strong	Altered Expression	[1194]
PIP	OTH719AH	Strong	Genetic Variation	[1195]
PITX1	OTA0UN4C	Strong	Biomarker	[1196]
PKP1	OT9HSQ8F	Strong	Biomarker	[122]
PKP2	OTJOVF68	Strong	Biomarker	[1197]
PLCD1	OT6WFVXZ	Strong	Altered Expression	[1198]
PLCE1	OTJISZOX	Strong	Biomarker	[609]
PLPP2	OT0BQAXX	Strong	Biomarker	[525]
PMPCB	OTRMBHNM	Strong	Biomarker	[1010]
PMS2	OTNLWTMI	Strong	Biomarker	[443]
PNO1	OT010GIS	Strong	Biomarker	[494]
POLH	OTN07WXU	Strong	Altered Expression	[1199]
POLI	OTBA4DCE	Strong	Genetic Variation	[1200]
POU2F1	OTK7ELJ0	Strong	Altered Expression	[530]
POU5F1	OTDHHN7O	Strong	Biomarker	[1201]
PPL	OTTM4WDO	Strong	Altered Expression	[1202]
PPP1R1B	OTSIJMQ9	Strong	Altered Expression	[1203]
PRB2	OTAD4JZ0	Strong	Altered Expression	[1204]
PRDM2	OT8L7CGX	Strong	Genetic Variation	[1141]
PRDX1	OTZ3BEC4	Strong	Biomarker	[874]
PROX1	OT68R6IO	Strong	Biomarker	[187]
PRRT2	OTCJUBDO	Strong	Biomarker	[1205]
PRRX1	OTTZK5G8	Strong	Biomarker	[1206]
PRSS2	OTOMVUWL	Strong	Biomarker	[1207]
PRSS55	OTXXWI5Y	Strong	Posttranslational Modification	[983]
PRTFDC1	OTKJ44KY	Strong	Posttranslational Modification	[1208]
PSG2	OT2EIXAI	Strong	Altered Expression	[256]
PSMD2	OT6HZHN7	Strong	Posttranslational Modification	[961]
PSMD4	OTH1VZTM	Strong	Altered Expression	[919]
PTCH1	OTMG07H5	Strong	Genetic Variation	[1209]
PTHLH	OTI1JF13	Strong	Biomarker	[1210]
PTMA	OT2W4T1M	Strong	Biomarker	[1211]
PTMS	OT9PS4Q0	Strong	Biomarker	[1212]
PTPRD	OTZPJ3GX	Strong	Biomarker	[1213]
PTRH2	OTBU39Q1	Strong	Biomarker	[1214]
PTTG1	OTIMYS4W	Strong	Biomarker	[837]
PUDP	OTEPEJLX	Strong	Altered Expression	[1149]
RAB11A	OTC4FW0J	Strong	Altered Expression	[628]
RAB27B	OTPF9D0K	Strong	Altered Expression	[1215]
RAB3GAP1	OT4DQ8F2	Strong	Altered Expression	[1165]
RAB40B	OTCA9ZF5	Strong	Altered Expression	[1216]
RABGEF1	OTWC3Z3R	Strong	Altered Expression	[1217]
RACGAP1	OTQE8IEH	Strong	Biomarker	[1017]
RAD18	OTQ9PLNT	Strong	Altered Expression	[1031]
RAD21	OTQS84ZF	Strong	Altered Expression	[504]
RAD52	OT0OTDHI	Strong	Biomarker	[1095]
RALGDS	OTG36NI7	Strong	Biomarker	[1218]
RALY	OT78NNWY	Strong	Genetic Variation	[325]
RAP1A	OT5RH6TI	Strong	Altered Expression	[1217]
RAP1B	OTHEIIMM	Strong	Altered Expression	[1219]
RAP1GAP	OTC31ONQ	Strong	Altered Expression	[1220]
RAPGEF1	OTZ0TBN1	Strong	Altered Expression	[1221]
RAPH1	OTMQXW7S	Strong	Biomarker	[1222]
RARRES1	OTETUPP5	Strong	Altered Expression	[1223]
RARRES2	OT1BJE8K	Strong	Biomarker	[1224]
RASSF7	OT0V4EIZ	Strong	Genetic Variation	[1225]
RB1	OT9VMY7B	Strong	Altered Expression	[1226]
RBL1	OTDEBFYC	Strong	Biomarker	[1204]
RBMS3	OTFSC9MR	Strong	Biomarker	[494]
RBP1	OTRP1MFC	Strong	Biomarker	[1227]
RCHY1	OTAE7504	Strong	Altered Expression	[1228]
REEP5	OTZU4TJI	Strong	Genetic Variation	[1229]
REG1B	OTSC2133	Strong	Altered Expression	[1156]
RETREG1	OTYOSLZX	Strong	Altered Expression	[1230]
RGL1	OTY6ZHVA	Strong	Biomarker	[35]
RHOBTB1	OTGE8K45	Strong	Genetic Variation	[1231]
RIOX2	OT2YFPI2	Strong	Biomarker	[1232]
RMDN3	OTKO7AUM	Strong	Altered Expression	[567]
RNASE1	OTKZ7CO9	Strong	Altered Expression	[1233]
RNASE3	OTVE2XD1	Strong	Genetic Variation	[1234]
RNF2	OTFPLOIN	Strong	Biomarker	[1235]
ROMO1	OTIEYVBW	Strong	Altered Expression	[1236]
RPL14	OTZZW7TK	Strong	Biomarker	[1237]
RPP14	OT4OYFSK	Strong	Biomarker	[955]
RPS6	OTT4D1LN	Strong	Altered Expression	[1238]
RRAS	OTBBF28C	Strong	Biomarker	[1239]
RRAS2	OT83NCEB	Strong	Altered Expression	[1240]
S100A1	OT1F2G4J	Strong	Biomarker	[59]
S100A11	OTI57KDN	Strong	Biomarker	[1241]
S100A14	OTVFJJ91	Strong	Biomarker	[886]
SAFB	OTGRV2LW	Strong	Altered Expression	[1242]
SAGE1	OT4H6FFA	Strong	Biomarker	[1243]
SART1	OTHMOGO1	Strong	Biomarker	[1244]
SATB2	OT2W80XC	Strong	Biomarker	[1245]
SBNO1	OTNX3RL0	Strong	Biomarker	[1246]
SBNO2	OT1C6J3K	Strong	Biomarker	[1246]
SCAF11	OTX59D0X	Strong	Biomarker	[1052]
SCGB3A1	OTIR98RB	Strong	Biomarker	[1068]
SCNN1G	OTSJYQVQ	Strong	Biomarker	[1247]
SCO2	OTJQQDRS	Strong	Posttranslational Modification	[572]
SCYL1	OTQ0IN7P	Strong	Biomarker	[1248]
SEC14L2	OTJST64D	Strong	Genetic Variation	[1249]
SEM1	OTASLBM1	Strong	Altered Expression	[1250]
SEMA3C	OTEGUY7F	Strong	Altered Expression	[1251]
SEMA3F	OTQFMS8S	Strong	Biomarker	[1252]
SEMA4A	OT8901H3	Strong	Biomarker	[1253]
SENP5	OTN9Q07Y	Strong	Altered Expression	[1254]
SERPINB13	OTILBHCE	Strong	Altered Expression	[1255]
SERPINB2	OT72QLZB	Strong	Altered Expression	[1256]
SERPINE2	OTYF5340	Strong	Altered Expression	[1257]
SERPINF2	OTZGAF8B	Strong	Altered Expression	[1258]
SERTAD1	OTBHKZQP	Strong	Biomarker	[1259]
SETD1A	OTVVWRIC	Strong	Biomarker	[524]
SF3B6	OTPRKS6S	Strong	Biomarker	[955]
SFRP1	OT0U9G41	Strong	Biomarker	[1260]
SFRP2	OT8GZ0CA	Strong	Posttranslational Modification	[189]
SFRP5	OTLCVVSH	Strong	Posttranslational Modification	[189]
SFTA2	OTVRIUIV	Strong	Biomarker	[404]
SFTPA2	OT6SFOMU	Strong	Posttranslational Modification	[1261]
SH3KBP1	OTIUA60B	Strong	Biomarker	[1262]
SHANK2	OTSQTPFQ	Strong	Biomarker	[1263]
SIGLEC7	OTNDLURR	Strong	Biomarker	[378]
SIPA1	OTXY5RXC	Strong	Biomarker	[1264]
SIRT7	OT5M4OT4	Strong	Altered Expression	[80]
SKI	OT4KJ8F6	Strong	Altered Expression	[1265]
SLC16A4	OT1YXBKC	Strong	Biomarker	[529]
SLC22A18	OT9C3KR4	Strong	Genetic Variation	[1266]
SLC35F2	OTSAD4EQ	Strong	Biomarker	[1267]
SLPI	OTUNFUU8	Strong	Altered Expression	[1268]
SMAD2	OTC6VB4K	Strong	Posttranslational Modification	[1269]
SMARCA1	OT0Y6PTU	Strong	Altered Expression	[1270]
SMARCA2	OTSGJ8SV	Strong	Biomarker	[1270]
SMARCB1	OT2LP7LJ	Strong	Biomarker	[1271]
SMPX	OTLSHGBF	Strong	Biomarker	[51]
SMR3B	OTL5HNM8	Strong	Altered Expression	[502]
SMUG1	OT2YIOCQ	Strong	Biomarker	[1272]
SMURF2	OT3TRVL7	Strong	Altered Expression	[292]
SNAI1	OTDPYAMC	Strong	Biomarker	[1273]
SNAI2	OT7Y8EJ2	Strong	Altered Expression	[1274]
SNED1	OTBQVXY5	Strong	Altered Expression	[1275]
SOAT1	OTB4Y5RJ	Strong	Biomarker	[1276]
SOCS2	OTBPNKJQ	Strong	Altered Expression	[1277]
SOS2	OTV3XRE5	Strong	Altered Expression	[1221]
SOX1	OTVI1RAR	Strong	Biomarker	[1176]
SOX30	OTGT38E3	Strong	Altered Expression	[1278]
SOX4	OTSS40SS	Strong	Altered Expression	[1279]
SOX9	OTVDJFGN	Strong	Altered Expression	[1280]
SPAG9	OT45AHMB	Strong	Altered Expression	[1281]
SPATA33	OTU5TYJA	Strong	Genetic Variation	[325]
SPIN1	OT69VAOX	Strong	Biomarker	[1282]
SPINK5	OT61IIAO	Strong	Biomarker	[1283]
SPRR1A	OTJMI34A	Strong	Biomarker	[1284]
SPRR3	OTN9QJKG	Strong	Altered Expression	[1285]
SPZ1	OTQH8HJ5	Strong	Posttranslational Modification	[983]
SRRM2	OTSIMMC9	Strong	Biomarker	[494]
SRSF1	OTF61HOV	Strong	Altered Expression	[919]
SRSF3	OTOFT707	Strong	Biomarker	[1286]
SRSF5	OTC5WP98	Strong	Altered Expression	[1287]
SSR1	OTQ6GDL2	Strong	Biomarker	[1288]
ST13	OTNML6UP	Strong	Altered Expression	[1289]
ST6GAL1	OT7US3NO	Strong	Genetic Variation	[69]
STAG1	OT564IX4	Strong	Biomarker	[1290]
STAT2	OTO9G2RZ	Strong	Biomarker	[665]
STAT5A	OTBSJGN3	Strong	Altered Expression	[1291]
STING1	OTDAP4G0	Strong	Biomarker	[1292]
STIP1	OT7TXLOX	Strong	Genetic Variation	[43]
STK11	OT1YZSP3	Strong	Biomarker	[1293]
SUB1	OTK71JYU	Strong	Biomarker	[955]
SYNE1	OTSBSLUH	Strong	Biomarker	[35]
SYP	OTFJKMO4	Strong	Genetic Variation	[965]
SYTL2	OTUIOWKL	Strong	Altered Expression	[549]
TALDO1	OTDKV2S2	Strong	Genetic Variation	[1294]
TAS2R38	OTX5MM36	Strong	Biomarker	[938]
TBC1D9	OTSSCTB5	Strong	Altered Expression	[1295]
TBX20	OTMPU2XQ	Strong	Biomarker	[1296]
TCEAL1	OTAPG2L5	Strong	Altered Expression	[1166]
TCF19	OT7NKLF9	Strong	Biomarker	[1297]
TCF21	OT393IMA	Strong	Biomarker	[942]
TERF2IP	OT3M5P3G	Strong	Altered Expression	[1217]
TESC	OTI8C76M	Strong	Altered Expression	[528]
TET1	OTZDHT1D	Strong	Altered Expression	[1298]
TFAM	OTXXV5V7	Strong	Biomarker	[1299]
TFDP1	OT6RZ7VT	Strong	Altered Expression	[1072]
TGFBI	OTR443C5	Strong	Altered Expression	[1300]
TGFBR3	OTQOOUC4	Strong	Biomarker	[1051]
TGFBRAP1	OT80QNR5	Strong	Biomarker	[1301]
THY1	OTVONVTB	Strong	Genetic Variation	[1302]
TIMP3	OTDGQAD1	Strong	Posttranslational Modification	[1303]
TLE1	OT50MRZ1	Strong	Biomarker	[1304]
TMPRSS11E	OTO5U2TK	Strong	Altered Expression	[1305]
TOMM40	OTZDQ29F	Strong	Genetic Variation	[356]
TP53BP2	OTOWJ2Y4	Strong	Altered Expression	[1306]
TPI1	OT14KP4B	Strong	Biomarker	[364]
TRAF1	OTTLM5RU	Strong	Altered Expression	[1307]
TRAF3	OT5TQBGV	Strong	Biomarker	[1308]
TRIM21	OTA4UJCF	Strong	Altered Expression	[1309]
TRIM29	OT2DNESG	Strong	Altered Expression	[1310]
TRIM32	OTJOV0PG	Strong	Altered Expression	[1311]
TRIT1	OTCU9FS5	Strong	Biomarker	[1312]
TSPAN1	OTZQPIYK	Strong	Altered Expression	[1313]
TSPAN31	OT8WQ83R	Strong	Biomarker	[1151]
AKAP4	OTL4Z99V	Definitive	Biomarker	[1314]
ATP6V0D1	OT9GU2NW	Definitive	Biomarker	[1315]
BRMS1	OTV5A6LL	Definitive	Posttranslational Modification	[1316]
CDK5R2	OTNUTLPU	Definitive	Biomarker	[1315]
CLCA2	OTF191LZ	Definitive	Biomarker	[1317]
COX1	OTG3O9BN	Definitive	Altered Expression	[180]
ELF3	OTUTLEQO	Definitive	Biomarker	[1318]
EPB41L3	OTS6CHG2	Definitive	Biomarker	[983]
EVPL	OTZIAFEK	Definitive	Genetic Variation	[1319]
GATA5	OTO81B63	Definitive	Posttranslational Modification	[1320]
ING2	OT6H0EWF	Definitive	Biomarker	[1321]
ING5	OTRNNSFM	Definitive	Altered Expression	[1322]
KIF14	OTXHT4JM	Definitive	Altered Expression	[1323]
KIF2A	OT2WQ6QD	Definitive	Biomarker	[1324]
KRT4	OT24PHPM	Definitive	Altered Expression	[1325]
LDHB	OT9B1CT3	Definitive	Altered Expression	[1326]
MARCKSL1	OT13J2FM	Definitive	Altered Expression	[1327]
NPRL2	OTOB10MO	Definitive	Biomarker	[600]
PELP1	OTVXQNOT	Definitive	Altered Expression	[1328]
PLCH1	OT6Z1L2E	Definitive	Genetic Variation	[1329]
RASSF2	OT2JHDO4	Definitive	Biomarker	[983]
RHOC	OTOLE1FT	Definitive	Altered Expression	[1330]
SEMA3B	OTCZCPMS	Definitive	Posttranslational Modification	[1331]
SFN	OTLJCZ1U	Definitive	Altered Expression	[1332]
SKIL	OTNBXH32	Definitive	Altered Expression	[1333]
SUMO1	OTJFD4P5	Definitive	Biomarker	[1334]
SZRD1	OTJMEJWT	Definitive	Altered Expression	[1335]
TIMP1	OTOXC51H	Definitive	Altered Expression	[1336]
TPM2	OTA1L0P8	Definitive	Altered Expression	[1337]
TRIB1	OTPEO17G	Definitive	Altered Expression	[1338]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] ClinicalTrials.gov (NCT04398524) A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC. U.S. National Institutes of Health.
• [5] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [6] ClinicalTrials.gov (NCT04180215) A Study of TheraT Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers. U.S. National Institutes of Health.
• [7] ClinicalTrials.gov (NCT01251562) Safety Study of Sterile Compound c31510 for Injection to Subjects With Solid Tumors. U.S. National Institutes of Health.
• [8] ClinicalTrials.gov (NCT03291002) Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC. U.S. National Institutes of Health.
• [9] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035080)
• [10] Clinical pipeline report, company report or official report of Inovio Pharmaceuticals.
• [11] ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.Cancers (Basel). 2019 Dec 7;11(12):1971. doi: 10.3390/cancers11121971.
• [12] EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib.Cancer Chemother Pharmacol. 2018 May;81(5):965-968. doi: 10.1007/s00280-018-3571-2. Epub 2018 Apr 2.
• [13] Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.Esophagus. 2019 Apr;16(2):141-146. doi: 10.1007/s10388-018-0643-7. Epub 2018 Sep 1.
• [14] Bacillus anthracis Protective Antigen Shows High Specificity for a UV Induced Mouse Model of Cutaneous Squamous Cell Carcinoma.Front Med (Lausanne). 2019 Feb 12;6:22. doi: 10.3389/fmed.2019.00022. eCollection 2019.
• [15] Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.Medicine (Baltimore). 2017 Feb;96(6):e5903. doi: 10.1097/MD.0000000000005903.
• [16] circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.Mol Carcinog. 2019 Oct;58(10):1783-1794. doi: 10.1002/mc.23065. Epub 2019 Jun 17.
• [17] Apolipoprotein E Promotes Invasion in Oral Squamous Cell Carcinoma.Am J Pathol. 2017 Oct;187(10):2259-2272. doi: 10.1016/j.ajpath.2017.06.016. Epub 2017 Jul 24.
• [18] Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.J Proteomics. 2018 Feb 20;173:52-61. doi: 10.1016/j.jprot.2017.11.022. Epub 2017 Dec 1.
• [19] Combined analysis of keratinocyte cancers identifies novel genome-wide loci.Hum Mol Genet. 2019 Sep 15;28(18):3148-3160. doi: 10.1093/hmg/ddz121.
• [20] Complement C5a-Mediated TAM-ing of Antitumor Immunity Drives Squamous Carcinogenesis.Cancer Cell. 2018 Oct 8;34(4):531-533. doi: 10.1016/j.ccell.2018.09.005.
• [21] Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma.Clin Cancer Res. 2005 Jan 1;11(1):242-8.
• [22] CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death.Mol Carcinog. 2019 Sep;58(9):1691-1700. doi: 10.1002/mc.23075. Epub 2019 Jun 24.
• [23] Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.Oncogene. 2018 Jan 4;37(1):116-127. doi: 10.1038/onc.2017.303. Epub 2017 Sep 11.
• [24] Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma.J Clin Med. 2019 Sep 12;8(9):1454. doi: 10.3390/jcm8091454.
• [25] Outcomes of Patients With Sinonasal Squamous Cell Carcinoma Treated With Particle Therapy Using Protons or Carbon Ions.Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1096-1103. doi: 10.1016/j.ijrobp.2018.04.041. Epub 2018 Apr 22.
• [26] Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma.PLoS One. 2016 Mar 31;11(3):e0152165. doi: 10.1371/journal.pone.0152165. eCollection 2016.
• [27] Preclinical Prevention Trial of Calcitriol: Impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis.Neoplasia. 2019 Apr;21(4):376-388. doi: 10.1016/j.neo.2019.02.002. Epub 2019 Mar 13.
• [28] Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.Tumour Biol. 2017 Apr;39(4):1010428317697547. doi: 10.1177/1010428317697547.
• [29] High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.Int J Med Sci. 2017 Apr 8;14(5):419-424. doi: 10.7150/ijms.18555. eCollection 2017.
• [30] EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.Oncogenesis. 2019 Sep 4;8(9):49. doi: 10.1038/s41389-019-0159-6.
• [31] EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.Med Sci Monit. 2018 Oct 9;24:7213-7222. doi: 10.12659/MSM.910909.
• [32] Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.Sci Rep. 2016 Dec 12;6:38792. doi: 10.1038/srep38792.
• [33] Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep. 2018 Apr 3;23(1):194-212.e6. doi: 10.1016/j.celrep.2018.03.063.
• [34] p16 expression in follicular dendritic cell sarcoma: a potential mimicker of human papillomavirus-related oropharyngeal squamous cell carcinoma.Hum Pathol. 2017 Aug;66:40-47. doi: 10.1016/j.humpath.2017.05.019. Epub 2017 May 26.
• [35] Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.Oncotarget. 2019 Mar 5;10(19):1760-1774. doi: 10.18632/oncotarget.26678. eCollection 2019 Mar 5.
• [36] FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?.Int J Mol Sci. 2017 Feb 18;18(2):443. doi: 10.3390/ijms18020443.
• [37] Expression and function of FRA1 protein in tumors.Mol Biol Rep. 2020 Jan;47(1):737-752. doi: 10.1007/s11033-019-05123-9. Epub 2019 Oct 14.
• [38] FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.PLoS One. 2012;7(6):e39937. doi: 10.1371/journal.pone.0039937. Epub 2012 Jun 28.
• [39] Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity.ChemMedChem. 2019 Mar 5;14(5):594-602. doi: 10.1002/cmdc.201800805. Epub 2019 Feb 11.
• [40] Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels.Cancer Sci. 2009 Dec;100(12):2325-30. doi: 10.1111/j.1349-7006.2009.01321.x. Epub 2009 Aug 25.
• [41] Activity of glutathione-metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs.Bull Exp Biol Med. 2002 Jun;133(6):606-8. doi: 10.1023/a:1020206514239.
• [42] Metastatic squamous cell carcinoma of the oropharynx in a child with a mutation in the Connexin 26 gene.J Pediatr Hematol Oncol. 2011 Jul;33(5):387-9. doi: 10.1097/MPH.0b013e3181e65c1c.
• [43] Recurrent fusion transcripts in squamous cell carcinomas of the vulva.Oncotarget. 2017 Mar 7;8(10):16843-16850. doi: 10.18632/oncotarget.15167.
• [44] Human Papillomavirus 16 E6 Induces FoxM1B in Oral Keratinocytes through GRHL2.J Dent Res. 2018 Jul;97(7):795-802. doi: 10.1177/0022034518756071. Epub 2018 Feb 14.
• [45] Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma.Oncol Rep. 2017 Jan;37(1):540-546. doi: 10.3892/or.2016.5280. Epub 2016 Nov 29.
• [46] Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma.Cancer Manag Res. 2019 Sep 6;11:8219-8227. doi: 10.2147/CMAR.S218427. eCollection 2019.
• [47] Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.Clin Proteomics. 2017 Aug 15;14:31. doi: 10.1186/s12014-017-9166-9. eCollection 2017.
• [48] Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.J Cutan Pathol. 2020 Jan;47(1):17-21. doi: 10.1111/cup.13573. Epub 2019 Sep 1.
• [49] Interleukin-7 promotes lung-resident CD14(+) monocytes activity in patients with lung squamous carcinoma.Int Immunopharmacol. 2019 Feb;67:202-210. doi: 10.1016/j.intimp.2018.12.022. Epub 2018 Dec 14.
• [50] Aberrant expression of interferon regulatory factor 3 in human lung cancer.Biochem Biophys Res Commun. 2010 Jun 25;397(2):202-7. doi: 10.1016/j.bbrc.2010.05.085. Epub 2010 May 23.
• [51] Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.J Clin Invest. 2018 Jun 1;128(6):2581-2599. doi: 10.1172/JCI96915. Epub 2018 May 14.
• [52] Investigation of cancer-associated fibroblasts and p62 expression in oral cancer before and after chemotherapy.J Craniomaxillofac Surg. 2018 Apr;46(4):605-610. doi: 10.1016/j.jcms.2017.12.016. Epub 2018 Jan 12.
• [53] Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Scand J Immunol. 2007 Aug-Sep;66(2-3):320-8. doi: 10.1111/j.1365-3083.2007.01963.x.
• [54] MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.Oncol Lett. 2019 Jan;17(1):688-696. doi: 10.3892/ol.2018.9637. Epub 2018 Oct 29.
• [55] Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma.Nat Genet. 2017 Nov;49(11):1624-1632. doi: 10.1038/ng.3957. Epub 2017 Sep 25.
• [56] LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.Cell Death Dis. 2017 Sep 7;8(9):e3035. doi: 10.1038/cddis.2017.433.
• [57] A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model.PLoS One. 2017 Mar 30;12(3):e0174707. doi: 10.1371/journal.pone.0174707. eCollection 2017.
• [58] Expression of melanoma-associated antigens in oral squamous cell carcinoma.J Oral Pathol Med. 2008 Feb;37(2):88-93. doi: 10.1111/j.1600-0714.2007.00600.x.
• [59] Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature.J Cutan Pathol. 2020 Jan;47(1):36-46. doi: 10.1111/cup.13551. Epub 2019 Aug 11.
• [60] Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis.Cancer J. 2004 Jan-Feb;10(1):27-32. doi: 10.1097/00130404-200401000-00007.
• [61] The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.Urol Oncol. 2019 Jun;37(6):353.e17-353.e24. doi: 10.1016/j.urolonc.2019.01.020. Epub 2019 Jan 28.
• [62] GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.Eur J Cancer Prev. 1999 Aug;8(4):315-23. doi: 10.1097/00008469-199908000-00008.
• [63] Overexpression of p21-activated kinase 2 is correlated with high-grade oral squamous cell carcinomas.Future Oncol. 2018 May;14(11):1091-1100. doi: 10.2217/fon-2017-0643. Epub 2018 May 1.
• [64] Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.Curr Med Sci. 2019 Jun;39(3):410-414. doi: 10.1007/s11596-019-2051-1. Epub 2019 Jun 17.
• [65] Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.Carcinogenesis. 2017 Aug 1;38(8):827-836. doi: 10.1093/carcin/bgx044.
• [66] Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma.Oncol Lett. 2018 Jun;15(6):9151-9161. doi: 10.3892/ol.2018.8468. Epub 2018 Apr 11.
• [67] Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.Int J Cancer. 2008 Jan 15;122(2):325-32. doi: 10.1002/ijc.23106.
• [68] Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death.Front Oncol. 2018 Feb 5;8:10. doi: 10.3389/fonc.2018.00010. eCollection 2018.
• [69] Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.Nat Genet. 2012 Oct;44(10):1090-7. doi: 10.1038/ng.2411. Epub 2012 Sep 9.
• [70] Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers.Oncotarget. 2017 Jul 4;8(40):67878-67890. doi: 10.18632/oncotarget.18948. eCollection 2017 Sep 15.
• [71] NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1677-86. eCollection 2014.
• [72] Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.J Oral Pathol Med. 2018 Feb;47(2):121-127. doi: 10.1111/jop.12651. Epub 2017 Nov 7.
• [73] MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma.Oncogenesis. 2018 Oct 8;7(10):79. doi: 10.1038/s41389-018-0089-8.
• [74] Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer.Histopathology. 2010 Dec;57(6):885-92. doi: 10.1111/j.1365-2559.2010.03725.x.
• [75] SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.Anticancer Res. 2018 Feb;38(2):723-736. doi: 10.21873/anticanres.12278.
• [76] Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.J Oral Pathol Med. 2013 May;42(5):389-95. doi: 10.1111/jop.12025. Epub 2012 Dec 21.
• [77] DNA methylation markers of surfactant proteins in lung cancer.Int J Oncol. 2007 Jul;31(1):181-91.
• [78] Signal regulatory protein associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.Oncotarget. 2016 Dec 6;7(49):81305-81321. doi: 10.18632/oncotarget.12874.
• [79] MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma.Cancer Lett. 2019 Aug 1;456:40-48. doi: 10.1016/j.canlet.2019.04.028. Epub 2019 May 2.
• [80] Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer.Cancer Manag Res. 2018 Sep 10;10:3341-3356. doi: 10.2147/CMAR.S166946. eCollection 2018.
• [81] The sirtuin 6: An overture in skin cancer.Exp Dermatol. 2020 Feb;29(2):124-135. doi: 10.1111/exd.14057. Epub 2019 Dec 29.
• [82] High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.J Thorac Oncol. 2012 May;7(5):833-40. doi: 10.1097/JTO.0b013e31824de09c.
• [83] SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.Clin Cancer Res. 2013 Feb 1;19(3):560-70. doi: 10.1158/1078-0432.CCR-12-2334. Epub 2012 Dec 4.
• [84] Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.Cancer Res. 2001 Mar 1;61(5):2183-8.
• [85] STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4806-E4814. doi: 10.1073/pnas.1718546115. Epub 2018 May 7.
• [86] Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.Anticancer Res. 2017 Nov;37(11):6119-6123. doi: 10.21873/anticanres.12060.
• [87] Expressions and significances of TTF-1 and PTEN in early endometrial cancer.Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):20-26.
• [88] Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):481-488. doi: 10.1097/PAI.0000000000000324.
• [89] The effect of marrow stromal cells on TRAF6 expression levels in myeloma cells.Oncol Lett. 2017 Aug;14(2):1464-1470. doi: 10.3892/ol.2017.6322. Epub 2017 Jun 6.
• [90] Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.Sci Rep. 2018 Dec 3;8(1):17529. doi: 10.1038/s41598-018-35723-7.
• [91] Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma.Int J Oncol. 2013 Aug;43(2):539-47. doi: 10.3892/ijo.2013.1961. Epub 2013 May 27.
• [92] Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.J Oral Pathol Med. 2018 May;47(5):502-510. doi: 10.1111/jop.12708. Epub 2018 Apr 6.
• [93] Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.Br J Cancer. 2018 Aug;119(5):580-590. doi: 10.1038/s41416-018-0200-0. Epub 2018 Aug 6.
• [94] The pivotal role of IKK in the development of spontaneous lung squamous cell carcinomas.Cancer Cell. 2013 Apr 15;23(4):527-40. doi: 10.1016/j.ccr.2013.03.009.
• [95] Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.PLoS One. 2009 May 21;4(5):e5652. doi: 10.1371/journal.pone.0005652.
• [96] HOXA11 hypermethylation is associated with progression of non-small cell lung cancer.Oncotarget. 2013 Dec;4(12):2317-25. doi: 10.18632/oncotarget.1464.
• [97] Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.Int J Cancer. 2019 Feb 15;144(4):788-801. doi: 10.1002/ijc.31975. Epub 2018 Dec 4.
• [98] Immunohistochemical expression of cytosolic phospholipase A2 in non-small cell lung carcinoma.Asian Pac J Cancer Prev. 2010;11(5):1367-72.
• [99] Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Nat Genet. 2016 Jun;48(6):607-16. doi: 10.1038/ng.3564. Epub 2016 May 9.
• [100] Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.Exp Dermatol. 2014 Aug;23(8):573-8. doi: 10.1111/exd.12468. Epub 2014 Jul 16.
• [101] MiR-495/IGF-1/AKT Signaling as a Novel Axis Is Involved in the Epithelial-to-Mesenchymal Transition of Oral Squamous Cell Carcinoma.J Oral Maxillofac Surg. 2019 May;77(5):1009-1021. doi: 10.1016/j.joms.2018.12.021. Epub 2018 Dec 31.
• [102] Phospho-Np63 regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.FEBS Lett. 2013 Nov 1;587(21):3581-6. doi: 10.1016/j.febslet.2013.09.023. Epub 2013 Sep 23.
• [103] Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma.Int J Oncol. 2019 Oct;55(4):949-959. doi: 10.3892/ijo.2019.4866. Epub 2019 Aug 30.
• [104] Microvesicles Contribute to the Bystander Effect of DNA Damage.Int J Mol Sci. 2017 Apr 7;18(4):788. doi: 10.3390/ijms18040788.
• [105] BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.Asian Pac J Cancer Prev. 2015;16(4):1615-9. doi: 10.7314/apjcp.2015.16.4.1615.
• [106] The role of the globular heads of the C1q receptor in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.J Transl Med. 2014 Oct 5;12:286. doi: 10.1186/s12967-014-0286-y.
• [107] Lack of RING finger domain (RFD) mutations of the c-cbl gene in oral squamous cell carcinomas in Chennai, India.Asian Pac J Cancer Prev. 2013;14(2):1073-5. doi: 10.7314/apjcp.2013.14.2.1073.
• [108] CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma.J Oral Pathol Med. 2019 Jul;48(6):477-482. doi: 10.1111/jop.12869. Epub 2019 May 23.
• [109] The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.Tumour Biol. 2013 Feb;34(1):65-70. doi: 10.1007/s13277-012-0511-3. Epub 2012 Sep 14.
• [110] Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas.J Invest Dermatol. 2012 Nov;132(11):2642-51. doi: 10.1038/jid.2012.190. Epub 2012 Jun 21.
• [111] Assessment of CAR- or CD46-dependent adenoviral vector-mediated TRAIL gene therapy in clinical adenocarcinoma lung cancer cells.Oncology. 2009;77(6):366-77. doi: 10.1159/000275831. Epub 2010 Jan 11.
• [112] Cytogenetic findings in benign and malignant oral tumors - the role of autologous human plasma.Br J Oral Maxillofac Surg. 2012 Oct;50(7):606-10. doi: 10.1016/j.bjoms.2011.12.007. Epub 2012 Jan 9.
• [113] Involvement of CD74 in head and neck squamous cell carcinomas.J Cancer Res Clin Oncol. 2014 Jun;140(6):937-47. doi: 10.1007/s00432-014-1648-9. Epub 2014 Mar 25.
• [114] Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.BMC Cancer. 2018 Jul 24;18(1):758. doi: 10.1186/s12885-018-4481-8.
• [115] Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.Oral Oncol. 2012 Sep;48(9):836-41. doi: 10.1016/j.oraloncology.2012.03.017. Epub 2012 Apr 16.
• [116] The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma.Pathology. 2008 Aug;40(5):500-4. doi: 10.1080/00313020802198010.
• [117] Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.Free Radic Biol Med. 2008 Sep 1;45(5):651-8. doi: 10.1016/j.freeradbiomed.2008.05.020. Epub 2008 Jun 3.
• [118] Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.Pathol Oncol Res. 2014 Jul;20(3):687-95. doi: 10.1007/s12253-014-9749-y. Epub 2014 Feb 23.
• [119] Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.Int J Cancer. 2010 May 15;126(10):2319-29. doi: 10.1002/ijc.24920.
• [120] Expression profiling of CYP1B1 in oral squamous cell carcinoma: counterintuitive downregulation in tumors.PLoS One. 2011;6(11):e27914. doi: 10.1371/journal.pone.0027914. Epub 2011 Nov 16.
• [121] Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2. PLoS One. 2012;7(6):e39197.
• [122] The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung.Ups J Med Sci. 2020 Feb;125(1):19-29. doi: 10.1080/03009734.2019.1692101. Epub 2019 Dec 6.
• [123] C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.PLoS One. 2014 Nov 17;9(11):e112073. doi: 10.1371/journal.pone.0112073. eCollection 2014.
• [124] Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.Mol Cell Proteomics. 2017 Oct;16(10):1864-1888. doi: 10.1074/mcp.M116.064451. Epub 2017 Aug 9.
• [125] Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.BMC Cancer. 2009 Jul 16;9:237. doi: 10.1186/1471-2407-9-237.
• [126] Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivo.Sci Rep. 2015 Dec 7;5:17621. doi: 10.1038/srep17621.
• [127] Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinoma.Oncol Rep. 2014 Mar;31(3):1116-20. doi: 10.3892/or.2014.2975. Epub 2014 Jan 13.
• [128] Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture.Oncogene. 2009 Feb 5;28(5):674-85. doi: 10.1038/onc.2008.416. Epub 2008 Nov 17.
• [129] Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.Oncotarget. 2012 Apr;3(4):414-425. doi: 10.18632/oncotarget.519.
• [130] Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma.PLoS One. 2014 Mar 19;9(3):e92534. doi: 10.1371/journal.pone.0092534. eCollection 2014.
• [131] Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.Horm Cancer. 2012 Aug;3(4):172-80. doi: 10.1007/s12672-012-0108-8. Epub 2012 Mar 23.
• [132] Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance.Genet Mol Res. 2015 Aug 28;14(3):10185-92. doi: 10.4238/2015.August.28.2.
• [133] Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.J Cell Physiol. 2016 Aug;231(8):1761-70. doi: 10.1002/jcp.25279. Epub 2016 Feb 8.
• [134] Identification and characterization of a novel CXC chemokine in xenograft tumor induced by mas-overexpressing cells.Int J Cancer. 2009 Sep 15;125(6):1316-27. doi: 10.1002/ijc.24440.
• [135] DNA methylation biomarkers for lung cancer.Tumour Biol. 2012 Apr;33(2):287-96. doi: 10.1007/s13277-011-0282-2. Epub 2011 Dec 6.
• [136] G-protein-coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas.Int J Cancer. 2020 Jul 1;147(1):218-229. doi: 10.1002/ijc.32838. Epub 2020 Jan 7.
• [137] Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.Mol Cancer. 2015 Feb 3;14:20. doi: 10.1186/s12943-015-0300-x.
• [138] Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.PLoS One. 2011;6(5):e20487. doi: 10.1371/journal.pone.0020487. Epub 2011 May 31.
• [139] Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.Clin Oral Investig. 2013 Apr;17(3):949-55. doi: 10.1007/s00784-012-0784-3. Epub 2012 Jul 11.
• [140] Extracellular heat shock protein A9 is a novel interaction partner of podoplanin in oral squamous cell carcinoma cells.Biochem Biophys Res Commun. 2013 Apr 26;434(1):124-30. doi: 10.1016/j.bbrc.2013.03.057. Epub 2013 Mar 26.
• [141] Co-targeting EGFR and IKK/NF-B signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.Br J Cancer. 2019 Feb;120(3):306-316. doi: 10.1038/s41416-018-0351-z. Epub 2018 Dec 26.
• [142] Immunosuppressive effect on T cell activation by interleukin-16- and interleukin-10-cDNA-double-transfected human squamous cell line.Burns. 2009 May;35(3):383-9. doi: 10.1016/j.burns.2008.06.017. Epub 2008 Oct 23.
• [143] Interleukin 17A and interleukin 17F polymorphisms are associated with oral squamous cell carcinoma susceptibility in a Chinese population.J Oral Maxillofac Surg. 2015 Feb;73(2):267-73. doi: 10.1016/j.joms.2014.09.009. Epub 2014 Sep 30.
• [144] Salivary IL-6 mRNA is a Robust Biomarker in Oral Squamous Cell Carcinoma.J Clin Med. 2019 Nov 13;8(11):1958. doi: 10.3390/jcm8111958.
• [145] Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.J Am Soc Nephrol. 2010 Apr;21(4):713-22. doi: 10.1681/ASN.2009060669. Epub 2010 Jan 28.
• [146] Polymorphisms of microRNA-binding sites in integrin genes are associated with oral squamous cell carcinoma susceptibility and progression.Tohoku J Exp Med. 2014 May;233(1):33-41. doi: 10.1620/tjem.233.33.
• [147] Sonic hedgehog acts as a negative regulator of {beta}-catenin signaling in the adult tongue epithelium.Am J Pathol. 2010 Jul;177(1):404-14. doi: 10.2353/ajpath.2010.091079. Epub 2010 May 27.
• [148] DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.Lung Cancer. 2010 Aug;69(2):172-9. doi: 10.1016/j.lungcan.2009.11.002. Epub 2009 Nov 28.
• [149] Phospho-Np63/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.Cell Cycle. 2014;13(5):749-61. doi: 10.4161/cc.27676. Epub 2014 Jan 6.
• [150] Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.Cancer Lett. 2015 Nov 1;368(1):36-45. doi: 10.1016/j.canlet.2015.07.003. Epub 2015 Jul 13.
• [151] Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.Immunogenetics. 2014 Aug;66(7-8):439-48. doi: 10.1007/s00251-014-0778-1. Epub 2014 May 13.
• [152] Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ -arrestin-1 dependent manner in NSCLC.Oncotarget. 2014 Nov 15;5(21):10486-502. doi: 10.18632/oncotarget.2395.
• [153] The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.Pathobiology. 2015;82(2):58-67. doi: 10.1159/000381904. Epub 2015 May 28.
• [154] Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.Oncotarget. 2016 Dec 6;7(49):81341-81356. doi: 10.18632/oncotarget.13228.
• [155] LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.J Oral Pathol Med. 2015 Jul;44(6):475-81. doi: 10.1111/jop.12317. Epub 2015 Mar 17.
• [156] Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.Br J Dermatol. 2016 Dec;175(6):1204-1209. doi: 10.1111/bjd.14679. Epub 2016 Aug 31.
• [157] Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China.Oncol Rep. 2009 Jun;21(6):1627-32. doi: 10.3892/or_00000397.
• [158] Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB.Oncogenesis. 2019 May 13;8(5):34. doi: 10.1038/s41389-019-0144-0.
• [159] Aberrant DNA Methylation in Keratoacanthoma.PLoS One. 2016 Oct 27;11(10):e0165370. doi: 10.1371/journal.pone.0165370. eCollection 2016.
• [160] Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).Neoplasia. 2008 May;10(5):462-70. doi: 10.1593/neo.08164.
• [161] p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.Oncogene. 2008 Jan 10;27(3):308-17. doi: 10.1038/sj.onc.1210646. Epub 2007 Jul 16.
• [162] Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.PLoS One. 2013;8(2):e54705. doi: 10.1371/journal.pone.0054705. Epub 2013 Feb 6.
• [163] High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.Oncol Rep. 2014 Jun;31(6):2644-50. doi: 10.3892/or.2014.3124. Epub 2014 Apr 2.
• [164] Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.Transplantation. 2017 Sep;101(9):2102-2110. doi: 10.1097/TP.0000000000001759.
• [165] Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.Cancer Sci. 2008 Jul;99(7):1390-400. doi: 10.1111/j.1349-7006.2008.00838.x. Epub 2008 Apr 29.
• [166] MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population.J Exp Clin Cancer Res. 2009 Jan 22;28(1):10. doi: 10.1186/1756-9966-28-10.
• [167] Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes.Br J Cancer. 2019 Jul;121(1):51-64. doi: 10.1038/s41416-019-0464-z. Epub 2019 May 22.
• [168] Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.Oncol Rep. 2014 Nov;32(5):2183-90. doi: 10.3892/or.2014.3423. Epub 2014 Aug 20.
• [169] Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.Cancer Res. 2009 Aug 15;69(16):6694-703. doi: 10.1158/0008-5472.CAN-09-0016.
• [170] A Novel Mutation in the DNA Binding Domain of NFKB is Associated with Speckled Leukoplakia.Asian Pac J Cancer Prev. 2016;17(7):3627-9.
• [171] Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.Int J Oncol. 2012 Jun;40(6):1907-14. doi: 10.3892/ijo.2012.1373. Epub 2012 Feb 14.
• [172] NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma.Sci Rep. 2017 Dec 6;7(1):17064. doi: 10.1038/s41598-017-17298-x.
• [173] Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.Cancer Sci. 2009 Oct;100(10):1908-16. doi: 10.1111/j.1349-7006.2009.01252.x. Epub 2009 Jun 23.
• [174] PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells.Oncogene. 2012 Dec 6;31(49):5090-8. doi: 10.1038/onc.2012.10. Epub 2012 Feb 20.
• [175] AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma.Mol Med Rep. 2017 Aug;16(2):1964-1972. doi: 10.3892/mmr.2017.6847. Epub 2017 Jun 23.
• [176] Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.Diagn Cytopathol. 2015 Jun;43(6):462-70. doi: 10.1002/dc.23256. Epub 2015 Jan 22.
• [177] The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma.Gene. 2013 Jul 15;524(1):28-34. doi: 10.1016/j.gene.2013.04.030. Epub 2013 Apr 20.
• [178] Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs.Cancer Res. 2015 Oct 1;75(19):4211-23. doi: 10.1158/0008-5472.CAN-15-1107. Epub 2015 Aug 21.
• [179] The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC.Sci Rep. 2016 Jun 1;6:26526. doi: 10.1038/srep26526.
• [180] 4,5-Diaryl 3(2H)Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth.Molecules. 2019 May 6;24(9):1751. doi: 10.3390/molecules24091751.
• [181] Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.Oncogene. 2009 Nov 12;28(45):3960-70. doi: 10.1038/onc.2009.251. Epub 2009 Sep 7.
• [182] RNASEL and MIR146A SNP-SNP interaction as a susceptibility factor for non-melanoma skin cancer.PLoS One. 2014 Apr 3;9(4):e93602. doi: 10.1371/journal.pone.0093602. eCollection 2014.
• [183] RSK activation of translation factor eIF4B drives abnormal increases of laminin 2 and MYC protein during neoplastic progression to squamous cell carcinoma.PLoS One. 2013 Oct 28;8(10):e78979. doi: 10.1371/journal.pone.0078979. eCollection 2013.
• [184] Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma.Histopathology. 2015 Jun;66(7):939-48. doi: 10.1111/his.12556. Epub 2015 Feb 5.
• [185] Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma.Int J Cancer. 2006 Oct 1;119(7):1648-53. doi: 10.1002/ijc.22011.
• [186] Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.Oncol Res. 2010;18(9):401-8. doi: 10.3727/096504010x12644422320744.
• [187] Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.Int J Mol Sci. 2019 Nov 10;20(22):5619. doi: 10.3390/ijms20225619.
• [188] MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.Acta Otolaryngol. 2009 May;129(5):476-80. doi: 10.1080/00016480802256079.
• [189] Promoter methylation of SFRPs gene family in cervical cancer.Gynecol Oncol. 2009 Feb;112(2):301-6. doi: 10.1016/j.ygyno.2008.10.004. Epub 2008 Nov 26.
• [190] Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.Odontology. 2012 Jul;100(2):156-63. doi: 10.1007/s10266-011-0033-2. Epub 2011 May 24.
• [191] Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.Mol Cancer. 2010 May 12;9:106. doi: 10.1186/1476-4598-9-106.
• [192] CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.Cell Oncol (Dordr). 2019 Aug;42(4):449-458. doi: 10.1007/s13402-019-00434-2. Epub 2019 Mar 5.
• [193] Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.
• [194] The unfolded protein response is activated in differentiating epidermal keratinocytes.J Invest Dermatol. 2009 Sep;129(9):2126-35. doi: 10.1038/jid.2009.51. Epub 2009 Mar 12.
• [195] Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).Med Sci Monit. 2015 Aug 5;21:2275-81. doi: 10.12659/MSM.893925.
• [196] Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.Oncotarget. 2017 Sep 16;8(46):80139-80155. doi: 10.18632/oncotarget.20960. eCollection 2017 Oct 6.
• [197] Np63 Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.Cell Rep. 2018 Sep 18;24(12):3224-3236. doi: 10.1016/j.celrep.2018.08.058.
• [198] Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.Oncol Rep. 2005 May;13(5):837-46.
• [199] Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis.J Pathol. 2011 Jul;224(3):367-76. doi: 10.1002/path.2867. Epub 2011 May 5.
• [200] Prognostic Value of MAC30 Expression in Human Pure Squamous Cell Carcinomas of the Lung.Asian Pac J Cancer Prev. 2016;17(5):2705-10.
• [201] Tripeptidyl peptidase II in human oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2013 Jan;139(1):123-30. doi: 10.1007/s00432-012-1307-y. Epub 2012 Sep 18.
• [202] The overexpressed functional transient receptor potential channel TRPM2 in oral squamous cell carcinoma.Sci Rep. 2016 Dec 23;6:38471. doi: 10.1038/srep38471.
• [203] Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.Int J Oncol. 2012 May;40(5):1431-40. doi: 10.3892/ijo.2012.1340. Epub 2012 Jan 20.
• [204] Expression of thymidylate synthase predicts clinical outcomes of S-1-based chemotherapy in squamous cell lung cancer.Oncol Lett. 2017 Sep;14(3):3319-3326. doi: 10.3892/ol.2017.6610. Epub 2017 Jul 19.
• [205] Clinical relevance of the multidrug resistanceassociated protein1 gene in nonsmall cell lung cancer: A systematic review and metaanalysis.Oncol Rep. 2018 Nov;40(5):3078-3091. doi: 10.3892/or.2018.6652. Epub 2018 Aug 17.
• [206] A study of natural IgG antibodies against ATP-binding cassette subfamily C member 3 in oral squamous cell carcinoma.J Cancer Res Ther. 2019;15(4):921-926. doi: 10.4103/jcrt.JCRT_150_18.
• [207] Recurrent copy number gains of ACVR1 and corresponding transcript overexpression are associated with survival in head and neck squamous cell carcinomas.Histopathology. 2011 Jul;59(1):81-9. doi: 10.1111/j.1365-2559.2011.03885.x. Epub 2011 Jun 13.
• [208] Upregulation of ADAM10 in oral squamous cell carcinoma and its correlation with EGFR, neoangiogenesis and clinicopathologic factors.J Craniomaxillofac Surg. 2019 Oct;47(10):1583-1588. doi: 10.1016/j.jcms.2019.07.008. Epub 2019 Jul 19.
• [209] MicroRNA-224, negatively regulated by c-jun, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma.J Cell Mol Med. 2019 Aug;23(8):4913-4920. doi: 10.1111/jcmm.14107. Epub 2019 Jun 17.
• [210] MiR-126 inhibits cell migration and invasion by targeting ADAM9 in oral squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10324-10331. doi: 10.26355/eurrev_201912_19670.
• [211] Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma.Oncol Lett. 2019 Dec;18(6):6572-6582. doi: 10.3892/ol.2019.11013. Epub 2019 Oct 21.
• [212] Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.Mol Med Rep. 2015 Aug;12(2):2225-30. doi: 10.3892/mmr.2015.3602. Epub 2015 Apr 8.
• [213] Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.Int J Cancer. 2005 Mar 20;114(2):242-8. doi: 10.1002/ijc.20711.
• [214] Activated leukocyte cell adhesion molecule: a new paradox in cancer.Transl Res. 2008 Mar;151(3):122-8. doi: 10.1016/j.trsl.2007.09.006. Epub 2007 Oct 23.
• [215] Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.Pharmacogenet Genomics. 2007 Mar;17(3):197-205. doi: 10.1097/FPC.0b013e328010bda1.
• [216] AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.Int J Med Sci. 2018 Apr 3;15(6):638-644. doi: 10.7150/ijms.23291. eCollection 2018.
• [217] Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.Sci Rep. 2015 Oct 26;5:15698. doi: 10.1038/srep15698.
• [218] ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma.Exp Ther Med. 2017 Nov;14(5):5214-5218. doi: 10.3892/etm.2017.5148. Epub 2017 Sep 20.
• [219] Expression of P53, BAX, and BCL-2 in human malignant melanoma and squamous cell carcinoma cells after tea tree oil treatment in vitro.Cytotechnology. 2019 Feb;71(1):461-473. doi: 10.1007/s10616-018-0287-4. Epub 2019 Jan 1.
• [220] Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.Oncotarget. 2016 Jan 26;7(4):4882-9. doi: 10.18632/oncotarget.6639.
• [221] Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.J Oral Maxillofac Surg. 2019 Apr;77(4):859-866. doi: 10.1016/j.joms.2018.11.034. Epub 2018 Dec 11.
• [222] Amyloid precursor protein and its phosphorylated form in non-small cell lung carcinoma.Pathol Res Pract. 2019 Aug;215(8):152463. doi: 10.1016/j.prp.2019.152463. Epub 2019 May 23.
• [223] AQP1, AQP5, Bcl-2 and p16 in pharyngeal squamous cell carcinoma.J Laryngol Otol. 2015 Jun;129(6):580-6. doi: 10.1017/S002221511500119X.
• [224] Assessing the Expression of Aquaporin 3 Antigen-Recognition Sites in Oral Squamous Cell Carcinoma.Appl Immunohistochem Mol Morphol. 2020 Sep;28(8):611-620. doi: 10.1097/PAI.0000000000000802.
• [225] The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2 and ATF4 in Lung Cancer.Dis Markers. 2018 Sep 16;2018:5068701. doi: 10.1155/2018/5068701. eCollection 2018.
• [226] Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.Cancer Genet Cytogenet. 2008 Mar;181(2):112-8. doi: 10.1016/j.cancergencyto.2007.12.003.
• [227] Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas.Anticancer Res. 2003 Mar-Apr;23(2C):1913-5.
• [228] Aurora B expression modulates paclitaxel response in non-small cell lung cancer.Br J Cancer. 2017 Feb 28;116(5):592-599. doi: 10.1038/bjc.2016.453. Epub 2017 Jan 17.
• [229] Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.Oncotarget. 2017 Feb 21;8(8):13986-14002. doi: 10.18632/oncotarget.14753.
• [230] The role of Bak expression in apoptosis of the oral squamous cell carcinoma (OSCC) and metastases to lymph nodes (LNMs).Rocz Akad Med Bialymst. 2004;49 Suppl 1:14-5.
• [231] The clinical relationship between the slug-mediated Puma/p53 signaling pathway and radiotherapy resistance in nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):953-958.
• [232] Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?.Urology. 2008 Aug;72(2):374-8. doi: 10.1016/j.urology.2007.12.063. Epub 2008 Mar 17.
• [233] TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.Br J Cancer. 2015 Sep 15;113(6):878-85. doi: 10.1038/bjc.2015.283. Epub 2015 Aug 20.
• [234] miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.Cell Death Dis. 2018 Feb 7;9(2):193. doi: 10.1038/s41419-017-0219-9.
• [235] The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.Cancer Med. 2018 Apr;7(4):1056-1069. doi: 10.1002/cam4.1348. Epub 2018 Feb 26.
• [236] Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.Int J Mol Sci. 2019 Jan 16;20(2):375. doi: 10.3390/ijms20020375.
• [237] A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors.Exp Dermatol. 2019 Sep;28(9):1029-1035. doi: 10.1111/exd.13997. Epub 2019 Aug 12.
• [238] Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin.J Pathol. 2003 Apr;199(4):509-16. doi: 10.1002/path.1308.
• [239] All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.Int J Cancer. 1997 Jan 17;70(2):194-200. doi: 10.1002/(sici)1097-0215(19970117)70:2<194::aid-ijc10>3.0.co;2-j.
• [240] Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.PLoS One. 2015 Apr 7;10(4):e0121398. doi: 10.1371/journal.pone.0121398. eCollection 2015.
• [241] Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway.Int J Cancer. 2004 Aug 10;111(1):17-22. doi: 10.1002/ijc.20234.
• [242] Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.Oncol Rep. 2007 Nov;18(5):1107-13.
• [243] NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.BMC Cancer. 2015 Oct 30;15:825. doi: 10.1186/s12885-015-1806-8.
• [244] CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.Stem Cell Res. 2016 Mar;16(2):405-17. doi: 10.1016/j.scr.2016.02.028. Epub 2016 Feb 13.
• [245] Expression of stromal cell markers in distinct compartments of human skin cancers.J Cutan Pathol. 2006 Feb;33(2):145-55. doi: 10.1111/j.0303-6987.2006.00446.x.
• [246] Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.Head Neck. 2007 Jun;29(6):550-8. doi: 10.1002/hed.20544.
• [247] Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.Clin Epigenetics. 2019 Dec 3;11(1):178. doi: 10.1186/s13148-019-0782-2.
• [248] Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22730-22736. doi: 10.1073/pnas.1911385116. Epub 2019 Oct 17.
• [249] Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth.Cancer Lett. 2017 Dec 1;410:41-49. doi: 10.1016/j.canlet.2017.09.023. Epub 2017 Sep 23.
• [250] Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.J Mol Med (Berl). 2018 Jun;96(6):513-525. doi: 10.1007/s00109-018-1636-7. Epub 2018 Apr 30.
• [251] Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.Mol Cancer. 2019 Mar 4;18(1):34. doi: 10.1186/s12943-019-0987-1.
• [252] Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation.Biomed Res Int. 2014;2014:634945. doi: 10.1155/2014/634945. Epub 2014 Jun 12.
• [253] p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?.Cancer Lett. 2011 Jul 28;306(2):134-41. doi: 10.1016/j.canlet.2011.02.039. Epub 2011 Mar 15.
• [254] Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):548-558. doi: 10.1016/j.ijrobp.2019.06.2531. Epub 2019 Jul 2.
• [255] Correlation between immunohistochemical staining of CEACAM1 and clinicopathological findings in oral pre-neoplastic lesions and squamous cell carcinoma.Med Mol Morphol. 2018 Mar;51(1):41-47. doi: 10.1007/s00795-017-0169-4. Epub 2017 Sep 8.
• [256] CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology.Clin Radiol. 2018 Dec;73(12):1033-1040. doi: 10.1016/j.crad.2018.07.104. Epub 2018 Aug 14.
• [257] C/EBP expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBP confers susceptibility to UVB-induced skin squamous cell carcinomas.J Invest Dermatol. 2011 Jun;131(6):1339-46. doi: 10.1038/jid.2011.31. Epub 2011 Feb 24.
• [258] Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations.J Cancer Res Clin Oncol. 2008 May;134(5):609-15. doi: 10.1007/s00432-007-0325-7. Epub 2007 Oct 9.
• [259] hCG beta expression by cervical squamous carcinoma--in vivo histological association with tumour invasion and apoptosis.Histopathology. 2008 Aug;53(2):147-55. doi: 10.1111/j.1365-2559.2008.03082.x.
• [260] Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.Clin Cancer Res. 2018 Jul 15;24(14):3263-3272. doi: 10.1158/1078-0432.CCR-17-3347. Epub 2018 Apr 11.
• [261] Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.Nat Genet. 2014 Jul;46(7):736-41. doi: 10.1038/ng.3002. Epub 2014 Jun 1.
• [262] Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.J Pharm Biomed Anal. 2018 Jun 5;155:148-156. doi: 10.1016/j.jpba.2018.03.062. Epub 2018 Mar 31.
• [263] Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.Med Oncol. 2014 May;31(5):932. doi: 10.1007/s12032-014-0932-5. Epub 2014 Mar 28.
• [264] Differential expression of claudin?, occludin, SOX2 and proliferating cell nuclear antigen between basaloid squamous cell carcinoma and squamous cell carcinoma.Mol Med Rep. 2019 Aug;20(2):1977-1985. doi: 10.3892/mmr.2019.10417. Epub 2019 Jun 24.
• [265] CLIC1 promotes the progression of oral squamous cell carcinoma via integrins/ERK pathways.Am J Transl Res. 2019 Feb 15;11(2):557-571. eCollection 2019.
• [266] Expression of the antiapoptotic proteins clusterin and bcl-2 in laryngeal squamous cell carcinomas.Tumour Biol. 2006;27(4):195-200. doi: 10.1159/000093055. Epub 2006 May 2.
• [267] STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.Tumour Biol. 2016 Apr;37(4):5385-95. doi: 10.1007/s13277-015-4385-z. Epub 2015 Nov 12.
• [268] Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.Sci Transl Med. 2014 Nov 26;6(264):264ra163. doi: 10.1126/scitranslmed.3009540.
• [269] Significance of Jab1 expression in human esophageal squamous cell carcinoma.J Clin Gastroenterol. 2009 Jul;43(6):520-6. doi: 10.1097/MCG.0b013e3181919245.
• [270] Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.Clin Cancer Res. 2008 Aug 1;14(15):4794-9. doi: 10.1158/1078-0432.CCR-08-0576.
• [271] NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.Oncotarget. 2018 Nov 13;9(89):35997-36011. doi: 10.18632/oncotarget.26323. eCollection 2018 Nov 13.
• [272] Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response.Cancers (Basel). 2019 Apr 21;11(4):567. doi: 10.3390/cancers11040567.
• [273] Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.BMC Cancer. 2018 Apr 5;18(1):385. doi: 10.1186/s12885-018-4315-8.
• [274] Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.J Med Chem. 2018 Apr 12;61(7):2680-2693. doi: 10.1021/acs.jmedchem.7b01277. Epub 2018 Mar 26.
• [275] CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma.PLoS One. 2018 Jan 23;13(1):e0188847. doi: 10.1371/journal.pone.0188847. eCollection 2018.
• [276] miRNA-101 Targets TGF-R1 to Retard the Progression of Oral Squamous Cell Carcinoma.Oncol Res. 2020 Mar 27;28(2):203-212. doi: 10.3727/096504019X15761480623959. Epub 2019 Dec 12.
• [277] PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.Oncogene. 2019 Jun;38(25):5021-5037. doi: 10.1038/s41388-019-0773-y. Epub 2019 Mar 15.
• [278] Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men.Cancer Biomark. 2010-2011;8(6):351-9. doi: 10.3233/CBM-2011-0224.
• [279] Retinoic acid-metabolizing enzyme cytochrome P450 26A1 promotes skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene.Oncol Lett. 2018 Jun;15(6):9987-9993. doi: 10.3892/ol.2018.8599. Epub 2018 Apr 27.
• [280] Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma.Cancer Cell Int. 2018 May 1;18:67. doi: 10.1186/s12935-018-0561-8. eCollection 2018.
• [281] Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.Oral Oncol. 2008 Dec;44(12):1139-46. doi: 10.1016/j.oraloncology.2008.02.016. Epub 2008 May 19.
• [282] Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.J Biol Chem. 2006 Sep 8;281(36):26408-18. doi: 10.1074/jbc.M602853200. Epub 2006 Jul 11.
• [283] L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.BMC Cancer. 2012 Oct 20;12:484. doi: 10.1186/1471-2407-12-484.
• [284] DNA damage-inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti-carcinoma effect of 1,25(OH)(2) D(3).Exp Dermatol. 2019 Jan;28(1):45-52. doi: 10.1111/exd.13815. Epub 2018 Dec 5.
• [285] Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.PLoS One. 2018 Jul 26;13(7):e0200633. doi: 10.1371/journal.pone.0200633. eCollection 2018.
• [286] DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.Oncotarget. 2017 Apr 4;8(14):23414-23426. doi: 10.18632/oncotarget.15582.
• [287] The diacylglycerol kinase (DGK)/Akt/NF-B feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.Oncogene. 2019 Apr;38(14):2533-2550. doi: 10.1038/s41388-018-0604-6. Epub 2018 Dec 7.
• [288] High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.BMC Cancer. 2006 Oct 26;6:256. doi: 10.1186/1471-2407-6-256.
• [289] DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.Oncol Res. 2018 Jan 19;26(1):45-58. doi: 10.3727/096504017X14926874596386. Epub 2017 May 4.
• [290] Immunohistochemical evaluation of Klotho and DNA methyltransferase 3a in oral squamous cell carcinomas.Med Mol Morphol. 2017 Sep;50(3):155-160. doi: 10.1007/s00795-017-0156-9. Epub 2017 Mar 16.
• [291] DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.Int J Med Sci. 2013 Oct 12;10(12):1727-39. doi: 10.7150/ijms.6884. eCollection 2013.
• [292] Susceptible genes and molecular pathways related to heavy ion irradiation in oral squamous cell carcinoma cells.Radiother Oncol. 2008 Nov;89(2):237-44. doi: 10.1016/j.radonc.2008.04.015. Epub 2008 May 29.
• [293] Endothelin system in oral squamous carcinoma cells: specific siRNA targeting of ECE-1 blocks cell proliferation.Int J Cancer. 2006 Apr 1;118(7):1645-52. doi: 10.1002/ijc.21525.
• [294] Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.Pain. 2011 Oct;152(10):2323-2332. doi: 10.1016/j.pain.2011.06.025. Epub 2011 Jul 22.
• [295] Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.Nat Commun. 2017 Apr 7;8:14922. doi: 10.1038/ncomms14922.
• [296] Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.Clin Cancer Res. 2006 Feb 15;12(4):1080-7. doi: 10.1158/1078-0432.CCR-05-2022.
• [297] Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin.PLoS One. 2012;7(9):e46040. doi: 10.1371/journal.pone.0046040. Epub 2012 Sep 24.
• [298] Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.Int J Cancer. 2007 Jun 15;120(12):2538-44. doi: 10.1002/ijc.22585.
• [299] Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.Pathology. 2007 Dec;39(6):545-50. doi: 10.1080/00313020701684391.
• [300] Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor.Lab Invest. 2004 May;84(5):639-48. doi: 10.1038/labinvest.3700072.
• [301] EpCAM associates with integrin and regulates cell adhesion in cancer cells.Biochem Biophys Res Commun. 2020 Feb 19;522(4):903-909. doi: 10.1016/j.bbrc.2019.11.152. Epub 2019 Dec 2.
• [302] Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.Mod Pathol. 2006 Oct;19(10):1369-77. doi: 10.1038/modpathol.3800660. Epub 2006 Jul 7.
• [303] Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma.BMC Cancer. 2012 May 28;12:194. doi: 10.1186/1471-2407-12-194.
• [304] Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras-Mutant Lung Cancers.Mol Cancer Ther. 2019 Oct;18(10):1863-1874. doi: 10.1158/1535-7163.MCT-18-0573. Epub 2019 Jul 18.
• [305] Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.Clin Exp Metastasis. 2014 Mar;31(3):307-16. doi: 10.1007/s10585-013-9629-y. Epub 2013 Dec 15.
• [306] Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.J Exp Clin Cancer Res. 2019 Jun 24;38(1):274. doi: 10.1186/s13046-019-1277-x.
• [307] Overexpression of ETS2 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2003 Feb;9(2):205-8. doi: 10.3748/wjg.v9.i2.205.
• [308] EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.J Cell Mol Med. 2019 Oct;23(10):6942-6954. doi: 10.1111/jcmm.14579. Epub 2019 Jul 31.
• [309] ERK phosphorylation functions in invadopodia formation in tongue cancer cells in a novel silicate fibre-based 3D cell culture system.Int J Oral Sci. 2018 Oct 22;10(4):30. doi: 10.1038/s41368-018-0033-y.
• [310] Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.J Cell Biochem. 2019 Oct;120(10):18117-18127. doi: 10.1002/jcb.29115. Epub 2019 Jun 3.
• [311] Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.Int J Cancer. 2017 Jan 1;140(1):130-141. doi: 10.1002/ijc.30426. Epub 2016 Sep 23.
• [312] The decreased expression of protease-activated receptor 4 in esophageal squamous carcinoma.Neoplasma. 2014;61(5):546-52. doi: 10.4149/neo_2014_067.
• [313] EGF domain of coagulation factor IX is conducive to exposure of phosphatidylserine.Cell Biol Int. 2017 Apr;41(4):374-383. doi: 10.1002/cbin.10733. Epub 2017 Feb 27.
• [314] Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.J Oral Pathol Med. 2010 Apr;39(4):342-8. doi: 10.1111/j.1600-0714.2009.00836.x. Epub 2009 Dec 15.
• [315] Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation.Exp Cell Res. 2018 Sep 15;370(2):343-352. doi: 10.1016/j.yexcr.2018.06.036. Epub 2018 Jun 30.
• [316] FBXW7 Mutations Promote Cell Proliferation, Migration, and Invasion in Cervical Cancer.Genet Test Mol Biomarkers. 2019 Jun;23(6):409-417. doi: 10.1089/gtmb.2018.0278.
• [317] FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.Thorac Cancer. 2017 Nov;8(6):655-665. doi: 10.1111/1759-7714.12504. Epub 2017 Sep 14.
• [318] Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro.Radiat Environ Biophys. 2010 May;49(2):261-70. doi: 10.1007/s00411-010-0271-7. Epub 2010 Mar 7.
• [319] Fibroblast growth factor-binding protein expression changes with disease progression in clinical and experimental human squamous epithelium.Int J Cancer. 2001 May 1;92(3):374-81. doi: 10.1002/ijc.1207.
• [320] FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.Virchows Arch. 2018 May;472(5):759-769. doi: 10.1007/s00428-017-2282-0. Epub 2017 Dec 21.
• [321] Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.Oncotarget. 2017 Oct 23;8(56):96225-96238. doi: 10.18632/oncotarget.21958. eCollection 2017 Nov 10.
• [322] Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.Clin Nucl Med. 2017 Apr;42(4):e218-e220. doi: 10.1097/RLU.0000000000001569.
• [323] An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.Oncotarget. 2018 Feb 5;9(17):13517-13529. doi: 10.18632/oncotarget.24399. eCollection 2018 Mar 2.
• [324] The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.J Pathol. 2020 Jan;250(1):107-119. doi: 10.1002/path.5342. Epub 2019 Dec 3.
• [325] Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.J Invest Dermatol. 2016 May;136(5):930-937. doi: 10.1016/j.jid.2016.01.013. Epub 2016 Jan 29.
• [326] Immunohistochemical evaluation of HLA-G and FoxP3+ T regulatory cells in oral cavity and lower lip squamous cell carcinomas.Braz Oral Res. 2019;33:e020. doi: 10.1590/1807-3107bor-2019.vol33.0020. Epub 2019 Apr 11.
• [327] Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.Ann Diagn Pathol. 2017 Oct;30:36-41. doi: 10.1016/j.anndiagpath.2017.05.013. Epub 2017 May 26.
• [328] Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression.Clin Cancer Res. 2004 Jul 1;10(13):4480-8. doi: 10.1158/1078-0432.CCR-03-0670.
• [329] Role of sialyl 6-sulfo Lewis X in antitumor immunity against oral squamous cell carcinoma.J Oral Pathol Med. 2017 Oct;46(9):759-765. doi: 10.1111/jop.12585. Epub 2017 May 14.
• [330] Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis.World J Gastroenterol. 2007 Aug 14;13(30):4126-30. doi: 10.3748/wjg.v13.i30.4126.
• [331] Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas.Expert Rev Mol Diagn. 2019 Feb;19(2):137-148. doi: 10.1080/14737159.2019.1567334. Epub 2019 Jan 21.
• [332] Transcriptional repression of the human galactocerebrosidase gene in squamous cell carcinomas of the larynx.Int J Cancer. 1999 Dec 10;83(6):750-4. doi: 10.1002/(sici)1097-0215(19991210)83:6<750::aid-ijc9>3.0.co;2-v.
• [333] The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma.Genes Chromosomes Cancer. 2009 Feb;48(2):132-42. doi: 10.1002/gcc.20626.
• [334] Elevated GAPDH expression is associated with the proliferation and invasion of lung and esophageal squamous cell carcinomas.Proteomics. 2015 Sep;15(17):3087-100. doi: 10.1002/pmic.201400577. Epub 2015 Jun 25.
• [335] Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15.J Surg Oncol. 2018 Dec;118(8):1326-1334. doi: 10.1002/jso.25278. Epub 2018 Oct 17.
• [336] SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.Oncotarget. 2017 Apr 11;8(15):24652-24667. doi: 10.18632/oncotarget.15629.
• [337] Reduced expression of connexin 31.1 in larynx cancer is not caused by GJB5 mutations.Cancer Lett. 2004 Oct 28;214(2):225-9. doi: 10.1016/j.canlet.2004.04.004.
• [338] Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array.Int J Cancer. 2003 Mar 10;104(1):66-72. doi: 10.1002/ijc.10912.
• [339] DNA replication licensing factor MCM2, geminin, and Ki67 define proliferative state and are linked with survival in oral squamous cell carcinoma.Eur J Oral Sci. 2018 Jun;126(3):186-196. doi: 10.1111/eos.12420.
• [340] Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.Cancer Res. 2006 Dec 15;66(24):11831-9. doi: 10.1158/0008-5472.CAN-06-2876.
• [341] The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.Oncogene. 2013 May 16;32(20):2534-42. doi: 10.1038/onc.2012.278. Epub 2012 Jul 2.
• [342] hGPR87 contributes to viability of human tumor cells.Int J Cancer. 2008 May 1;122(9):2008-16. doi: 10.1002/ijc.23349.
• [343] Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2017 Nov;143(11):2257-2265. doi: 10.1007/s00432-017-2466-7. Epub 2017 Jun 26.
• [344] Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.BMC Cancer. 2011 Jun 5;11:220. doi: 10.1186/1471-2407-11-220.
• [345] GRK5 functions as an oncogenic factor in non-small-cell lung cancer.Cell Death Dis. 2018 Feb 20;9(3):295. doi: 10.1038/s41419-018-0299-1.
• [346] Gelsolin rs1078305 and rs10818524 polymorphisms were associated with risk of oral squamous cell carcinoma in a Chinese Han population.Biomarkers. 2016;21(3):267-71. doi: 10.3109/1354750X.2015.1134664. Epub 2016 Feb 5.
• [347] A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions.Carcinogenesis. 2008 Oct;29(10):1950-4. doi: 10.1093/carcin/bgn160. Epub 2008 Jul 18.
• [348] Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.J Surg Res. 1998 Jun;77(1):50-4. doi: 10.1006/jsre.1998.5337.
• [349] Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.Oncol Rep. 2012 Apr;27(4):954-8. doi: 10.3892/or.2011.1616. Epub 2011 Dec 30.
• [350] Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res. 2011 Jul 1;71(13):4373-9. doi: 10.1158/0008-5472.CAN-11-0046. Epub 2011 Apr 28.
• [351] Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma.Int J Cancer. 2014 Jan 1;134(1):244-8. doi: 10.1002/ijc.28339. Epub 2013 Jul 16.
• [352] Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas.APMIS. 2008 Dec;116(12):1034-42. doi: 10.1111/j.1600-0463.2008.01048.x.
• [353] HIPK2 expression in progression of cutaneous epithelial neoplasm.Int J Dermatol. 2015 Mar;54(3):347-54. doi: 10.1111/ijd.12664.
• [354] Human leucocyte antigen-G 14-bp InDel polymorphism and oral squamous cell carcinoma risk in Chinese Han population: A case-control study.Int J Immunogenet. 2018 Jul 21. doi: 10.1111/iji.12390. Online ahead of print.
• [355] HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.Int J Mol Sci. 2019 May 19;20(10):2473. doi: 10.3390/ijms20102473.
• [356] Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.Am J Hum Genet. 2012 Nov 2;91(5):928-34. doi: 10.1016/j.ajhg.2012.09.009. Epub 2012 Oct 25.
• [357] The expression and significance of the HOXA7 gene in oral squamous cell carcinoma.J Oral Sci. 2017 Sep 14;59(3):329-335. doi: 10.2334/josnusd.16-0634. Epub 2017 May 19.
• [358] Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians.Carcinogenesis. 2019 Sep 18;40(9):1061-1069. doi: 10.1093/carcin/bgz051.
• [359] Expression of heparanase in basal cell carcinoma and squamous cell carcinoma.An Bras Dermatol. 2016 Sep-Oct;91(5):595-600. doi: 10.1590/abd1806-4841.20164957.
• [360] A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.Int J Cancer. 2016 Sep 1;139(5):1106-16. doi: 10.1002/ijc.30139. Epub 2016 May 5.
• [361] Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.Lung Cancer. 2015 Feb;87(2):107-16. doi: 10.1016/j.lungcan.2014.12.012. Epub 2014 Dec 25.
• [362] Proteomics analysis of proteins interacting with heat shock factor 1 in squamous cell carcinoma of the cervix.Oncol Lett. 2019 Sep;18(3):2568-2575. doi: 10.3892/ol.2019.10539. Epub 2019 Jun 27.
• [363] Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer.Exp Ther Med. 2019 Apr;17(4):2657-2665. doi: 10.3892/etm.2019.7228. Epub 2019 Jan 31.
• [364] Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis.Proteomics. 2004 Aug;4(8):2465-75. doi: 10.1002/pmic.200300762.
• [365] Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.Arch Oral Biol. 2016 Sep;69:25-32. doi: 10.1016/j.archoralbio.2016.05.008. Epub 2016 May 12.
• [366] Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.PLoS One. 2014 Dec 15;9(12):e115004. doi: 10.1371/journal.pone.0115004. eCollection 2014.
• [367] Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol. 2009 May;174(5):1931-9.
• [368] Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.Clin Cancer Res. 2011 Jun 15;17(12):4155-66. doi: 10.1158/1078-0432.CCR-10-3381. Epub 2011 May 3.
• [369] Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma.Br J Cancer. 2007 Nov 19;97(10):1409-15. doi: 10.1038/sj.bjc.6604035. Epub 2007 Nov 13.
• [370] Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.Am J Surg Pathol. 2018 Sep;42(9):1216-1223. doi: 10.1097/PAS.0000000000001099.
• [371] Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells. Mol Cancer Ther. 2006 Dec;5(12):3032-41. doi: 10.1158/1535-7163.MCT-05-0474.
• [372] Multiple cutaneous squamous cell carcinomas in a patient with interferon gamma receptor 2 (IFN gamma R2) deficiency.J Med Genet. 2010 Sep;47(9):631-4. doi: 10.1136/jmg.2009.072108. Epub 2010 Jun 28.
• [373] The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells.Biochem J. 2013 Apr 1;451(1):91-9. doi: 10.1042/BJ20121422.
• [374] Gene expression and prognosis of insulinlike growth factorbinding protein family members in nonsmall cell lung cancer.Oncol Rep. 2019 Nov;42(5):1981-1995. doi: 10.3892/or.2019.7314. Epub 2019 Sep 16.
• [375] Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.Int J Cancer. 2007 May 15;120(10):2068-77. doi: 10.1002/ijc.22264.
• [376] The distribution of interleukin-19 in healthy and neoplastic tissue.Cytokine. 2008 Nov;44(2):221-8. doi: 10.1016/j.cyto.2008.06.007. Epub 2008 Sep 21.
• [377] eIF2 Phosphorylation Mediates IL24-Induced Apoptosis through Inhibition of Translation.Mol Cancer Res. 2017 Aug;15(8):1117-1124. doi: 10.1158/1541-7786.MCR-16-0454. Epub 2017 May 1.
• [378] p75 Nerve Growth Factor Receptor as a Specific Nerve Marker in the Diagnosis of Perineural Invasion of Squamous Cell Carcinoma.Am J Clin Pathol. 2019 May 3;151(6):574-583. doi: 10.1093/ajcp/aqz011.
• [379] NK4 gene therapy combined with cisplatin inhibits tumour growth and metastasis of squamous cell carcinoma.Anticancer Res. 2011 Jan;31(1):105-11.
• [380] ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate.Oncotarget. 2018 Jul 20;9(56):30894-30904. doi: 10.18632/oncotarget.25768. eCollection 2018 Jul 20.
• [381] Association between integrin-linked kinase and hyperthermia in oral squamous cell carcinoma.Oncol Lett. 2017 Dec;14(6):7705-7714. doi: 10.3892/ol.2017.7222. Epub 2017 Oct 19.
• [382] IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.Oncol Rep. 2018 Jan;39(1):3-12. doi: 10.3892/or.2017.6072. Epub 2017 Nov 2.
• [383] Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.Ann Surg Oncol. 2008 Jan;15(1):96-103. doi: 10.1245/s10434-007-9631-1. Epub 2007 Oct 2.
• [384] Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).PLoS One. 2019 Aug 8;14(8):e0220567. doi: 10.1371/journal.pone.0220567. eCollection 2019.
• [385] Roles of miR-138 and ISG15 in oral squamous cell carcinoma.Exp Ther Med. 2017 Sep;14(3):2329-2334. doi: 10.3892/etm.2017.4720. Epub 2017 Jul 9.
• [386] Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study.J Oral Pathol Med. 1995 Sep;24(8):343-8. doi: 10.1111/j.1600-0714.1995.tb01197.x.
• [387] CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598.
• [388] Osteopontin-integrin (v)(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.FEBS Lett. 2015 Jan 16;589(2):231-9. doi: 10.1016/j.febslet.2014.12.004. Epub 2014 Dec 10.
• [389] Junction plakoglobin, a potential prognostic marker of oral squamous cell carcinoma, promotes proliferation, migration and invasion.J Oral Pathol Med. 2020 Jan;49(1):30-38. doi: 10.1111/jop.12952. Epub 2019 Sep 19.
• [390] Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas.Dig Dis Sci. 2008 Aug;53(8):2039-44. doi: 10.1007/s10620-007-0116-7. Epub 2007 Dec 13.
• [391] Changes in the expression of the potassium channels TASK1, TASK3 and TRESK in a rat model of oral squamous cell carcinoma and their relation to malignancy.Arch Oral Biol. 2019 Apr;100:75-85. doi: 10.1016/j.archoralbio.2019.02.007. Epub 2019 Feb 16.
• [392] KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort.Oncotarget. 2017 May 30;8(46):80348-80357. doi: 10.18632/oncotarget.18302. eCollection 2017 Oct 6.
• [393] Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed.Oncotarget. 2017 Jul 28;8(34):57898-57904. doi: 10.18632/oncotarget.19649. eCollection 2017 Aug 22.
• [394] Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation.Mol Med Rep. 2019 Mar;19(3):2202-2210. doi: 10.3892/mmr.2019.9851. Epub 2019 Jan 11.
• [395] KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.APMIS. 2016 Apr;124(4):291-8. doi: 10.1111/apm.12507. Epub 2016 Jan 25.
• [396] Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma.Clin Cancer Res. 2004 Feb 15;10(4):1379-83. doi: 10.1158/1078-0432.ccr-1519-02.
• [397] Utility of Immunohistochemistry in Distinguishing Primary Adnexal Carcinoma From Metastatic Breast Carcinoma to Skin and Squamous Cell Carcinoma.Am J Dermatopathol. 2018 Jun;40(6):389-396. doi: 10.1097/DAD.0000000000001025.
• [398] Kruppel-like factor 4 regulates keratinocyte senescence.Biochem Biophys Res Commun. 2018 May 5;499(2):389-395. doi: 10.1016/j.bbrc.2018.03.172. Epub 2018 Mar 26.
• [399] KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/-catenin signaling pathway.Cell Biol Int. 2017 Apr;41(4):392-404. doi: 10.1002/cbin.10736. Epub 2017 Feb 16.
• [400] KLK6 protease accelerates skin tumor formation and progression.Carcinogenesis. 2018 Dec 31;39(12):1529-1536. doi: 10.1093/carcin/bgy110.
• [401] Targeting PKC-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.Cell Commun Signal. 2019 Oct 28;17(1):137. doi: 10.1186/s12964-019-0446-z.
• [402] Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.J Low Genit Tract Dis. 2019 Jan;23(1):77-81. doi: 10.1097/LGT.0000000000000428.
• [403] Cytokeratin expression in epidermal stem cells in skin adnexal tumors.Oncol Lett. 2019 Jan;17(1):927-932. doi: 10.3892/ol.2018.9679. Epub 2018 Nov 8.
• [404] A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.Sci Rep. 2019 Mar 26;9(1):5207. doi: 10.1038/s41598-019-41585-4.
• [405] Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.Pathol Int. 2004 Sep;54(9):688-92. doi: 10.1111/j.1440-1827.2004.01681.x.
• [406] Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-B pathway activation through RPS3.Cell Death Dis. 2019 Dec 9;10(12):936. doi: 10.1038/s41419-019-2177-x.
• [407] Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.Clin Chim Acta. 2015 Mar 10;442:13-21. doi: 10.1016/j.cca.2014.12.038. Epub 2015 Jan 9.
• [408] Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.BMC Cancer. 2019 Feb 15;19(1):155. doi: 10.1186/s12885-019-5327-8.
• [409] Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.Cancer Chemother Pharmacol. 2012 Apr;69(4):983-9. doi: 10.1007/s00280-011-1790-x. Epub 2011 Dec 4.
• [410] Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis.J Cell Mol Med. 2019 Jan;23(1):680-688. doi: 10.1111/jcmm.13987. Epub 2018 Nov 5.
• [411] Overexpression of Pim-1 in head and neck squamous cell carcinomas.Int J Oncol. 2007 Jun;30(6):1381-7.
• [412] Upregulated LOX and increased collagen content associated with aggressive clinicopathological features and unfavorable outcome in oral squamous cell carcinoma.J Cell Biochem. 2019 Sep;120(9):14348-14359. doi: 10.1002/jcb.28669. Epub 2019 May 29.
• [413] Characterization of two newly established cell lines derived from squamous cell carcinomas of the oesophagus.Anticancer Res. 1997 May-Jun;17(3C):2185-92.
• [414] Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.Int J Cancer. 2008 Mar 1;122(5):978-89. doi: 10.1002/ijc.23221.
• [415] Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.Cancer Res. 2007 Dec 15;67(24):11601-11. doi: 10.1158/0008-5472.CAN-07-3243.
• [416] A decision analysis model for elective neck dissection in patients with cT1-2 cN0 oral squamous cell carcinoma.Acta Otorhinolaryngol Ital. 2019 Dec;39(6):374-380. doi: 10.14639/0392-100X-2101. Epub 2019 Mar 25.
• [417] Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.Cancer Immunol Res. 2014 May;2(5):480-6. doi: 10.1158/2326-6066.CIR-13-0124. Epub 2013 Nov 11.
• [418] Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.Target Oncol. 2019 Apr;14(2):223-235. doi: 10.1007/s11523-019-00626-8.
• [419] Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress.Cell Death Dis. 2017 Jan 19;8(1):e2562. doi: 10.1038/cddis.2016.492.
• [420] Induction of squamous cell carcinoma after MAP3K8 overexpression in murine salivry gland epithelial cells.Head Neck. 2019 Apr;41(4):924-929. doi: 10.1002/hed.25411. Epub 2019 Feb 5.
• [421] Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.Mol Biol Rep. 2020 Feb;47(2):1223-1232. doi: 10.1007/s11033-019-05223-6. Epub 2019 Dec 11.
• [422] KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage.J Invest Dermatol. 2017 Feb;137(2):475-483. doi: 10.1016/j.jid.2016.09.023. Epub 2016 Oct 7.
• [423] Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.Clin Cancer Res. 2007 Oct 1;13(19):5910-7. doi: 10.1158/1078-0432.CCR-07-0352.
• [424] Nitric oxide up-regulates the expression of intercellular adhesion molecule-1 on cancer cells.Biochem Biophys Res Commun. 1999 Apr 13;257(2):395-9. doi: 10.1006/bbrc.1999.0476.
• [425] Overexpression of MARCKS indicates a poor prognosis of oral squamous cell carcinoma.Oncol Lett. 2018 Oct;16(4):5498-5504. doi: 10.3892/ol.2018.9311. Epub 2018 Aug 16.
• [426] Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.BMC Cancer. 2017 Feb 7;17(1):113. doi: 10.1186/s12885-017-3081-3.
• [427] Keratinocytes express the CD146 (Muc18/S-endo) antigen in tissue culture and during inflammatory skin diseases.J Invest Dermatol. 2000 Aug;115(2):219-24. doi: 10.1046/j.1523-1747.2000.00039.x.
• [428] STAT3- and GSK3-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.Carcinogenesis. 2019 Mar 12;40(1):173-183. doi: 10.1093/carcin/bgy135.
• [429] Assessment of Proliferative Index Between the Tumor Margin, Center of Tumor, and the Invasive Tumor Front of Oral Squamous Cell Carcinoma With the Help of Mcm-2: An Immunohistochemical Study.Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):30-35. doi: 10.1097/PAI.0000000000000709.
• [430] Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.Int J Mol Sci. 2017 Nov 6;18(11):2339. doi: 10.3390/ijms18112339.
• [431] Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.Adv Clin Exp Med. 2016 Jan-Feb;25(1):117-28. doi: 10.17219/acem/60715.
• [432] MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma.Front Oncol. 2019 Jan 29;9:29. doi: 10.3389/fonc.2019.00029. eCollection 2019.
• [433] Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.J Cell Biochem. 2018 Jan;119(1):723-735. doi: 10.1002/jcb.26236. Epub 2017 Jul 31.
• [434] A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.Oncotarget. 2016 May 24;7(21):31137-52. doi: 10.18632/oncotarget.9082.
• [435] Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.Int J Cancer. 2015 Aug 15;137(4):810-8. doi: 10.1002/ijc.29435. Epub 2015 Feb 26.
• [436] Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.G Ital Dermatol Venereol. 2019 Jun;154(3):327-337. doi: 10.23736/S0392-0488.17.05770-4. Epub 2017 Dec 15.
• [437] Differential expression of degradome components in cutaneous squamous cell carcinomas.Mod Pathol. 2014 Jul;27(7):945-57. doi: 10.1038/modpathol.2013.217. Epub 2013 Dec 20.
• [438] MMP-11 promoted the oral cancer migration and Fak/Src activation.Oncotarget. 2017 May 16;8(20):32783-32793. doi: 10.18632/oncotarget.15824.
• [439] Association of polymorphisms in IL-8, MMP-1 and MMP-13 with the risk and prognosis of oral and oropharyngeal squamous cell carcinoma.Arch Oral Biol. 2019 Dec;108:104547. doi: 10.1016/j.archoralbio.2019.104547. Epub 2019 Aug 29.
• [440] Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.Anticancer Res. 2014 Sep;34(9):4929-37.
• [441] Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma.Cancer Med. 2017 Nov;6(11):2541-2551. doi: 10.1002/cam4.1213. Epub 2017 Sep 29.
• [442] Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.Anticancer Agents Med Chem. 2012 Sep;12(7):744-52. doi: 10.2174/187152012802650156.
• [443] No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis.Pathobiology. 2019;86(2-3):145-151. doi: 10.1159/000495251. Epub 2019 Jan 16.
• [444] Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer.J Histochem Cytochem. 2007 Apr;55(4):347-53. doi: 10.1369/jhc.6A7133.2006. Epub 2006 Dec 22.
• [445] A squamous cell carcinoma in a young woman with Lynch syndrome.Fam Cancer. 2019 Apr;18(2):193-196. doi: 10.1007/s10689-018-00113-5.
• [446] Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling.Int J Mol Med. 2019 Jul;44(1):115-124. doi: 10.3892/ijmm.2019.4181. Epub 2019 May 6.
• [447] Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer.BMC Cancer. 2018 Dec 17;18(1):1254. doi: 10.1186/s12885-018-5179-7.
• [448] Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.Am J Respir Cell Mol Biol. 1998 Apr;18(4):489-96. doi: 10.1165/ajrcmb.18.4.2978.
• [449] MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.Exp Cell Res. 2019 Sep 1;382(1):111450. doi: 10.1016/j.yexcr.2019.05.031. Epub 2019 May 29.
• [450] Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):409-15. doi: 10.1001/archotol.132.4.409.
• [451] MicroRNA?55 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway.Mol Med Rep. 2018 Sep;18(3):3106-3114. doi: 10.3892/mmr.2018.9292. Epub 2018 Jul 16.
• [452] Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature.Acta Histochem. 2019 Aug;121(6):765-767. doi: 10.1016/j.acthis.2019.06.002. Epub 2019 Jun 21.
• [453] Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer.Med Sci Monit. 2018 Nov 30;24:8655-8668. doi: 10.12659/MSM.911125.
• [454] Normal respiratory mucosa, precursor lesions and lung carcinomas: differential expression of human mucin genes.Front Biosci. 2001 Oct 1;6:D1264-75. doi: 10.2741/copin.
• [455] NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.Gynecol Oncol. 2019 Feb;152(2):387-395. doi: 10.1016/j.ygyno.2018.11.013. Epub 2018 Nov 13.
• [456] Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study.J Histochem Cytochem. 2010 Dec;58(12):1121-7. doi: 10.1369/jhc.2010.956979. Epub 2010 Sep 17.
• [457] A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma.J Biol Chem. 2005 May 20;280(20):19977-85. doi: 10.1074/jbc.M501231200. Epub 2005 Mar 17.
• [458] Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma.Mol Cell Biochem. 2007 Dec;306(1-2):163-9. doi: 10.1007/s11010-007-9566-7. Epub 2007 Jul 28.
• [459] NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma.Oncotarget. 2018 May 22;9(39):25503-25516. doi: 10.18632/oncotarget.25347. eCollection 2018 May 22.
• [460] Association of DFNA5, SYK, and NELL1 variants along with HPV infection in oral cancer among the prolonged tobacco-chewers.Tumour Biol. 2018 Aug;40(8):1010428318793023. doi: 10.1177/1010428318793023.
• [461] Expression of MMR system genes is correlated to NF-kB in patients with oral squamous cell carcinoma.J Clin Pathol. 2020 May;73(5):273-277. doi: 10.1136/jclinpath-2019-206161. Epub 2019 Oct 29.
• [462] Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.Clin Cancer Res. 1997 Oct;3(10):1873-7.
• [463] Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan.Head Neck. 2020 Jan;42(1):5-13. doi: 10.1002/hed.25971. Epub 2019 Oct 1.
• [464] Expression of natriuretic peptide receptor-A in esophageal squamous cell carcinomas and the relationship with tumor invasion and migration.World J Surg Oncol. 2014 May 21;12:154. doi: 10.1186/1477-7819-12-154.
• [465] Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1961-6. doi: 10.1158/1055-9965.EPI-05-0101.
• [466] Immunohistochemical study on neuropilin 1 (NRP1) immunoexpression in oral squamous cell carcinoma.Folia Histochem Cytobiol. 2018;1(2):98-105. doi: 10.5603/FHC.a2018.0010. Epub 2018 Jun 6.
• [467] Usefulness of ENT clinical examinations in hospitalised patients chronically addicted to alcohol and tobacco to detect head and neck squamous cell carcinomas. A retrospective study of 159 patients.Clin Otolaryngol. 2019 Sep;44(5):815-819. doi: 10.1111/coa.13355. Epub 2019 May 29.
• [468] The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.Biochimie. 2011 Sep;93(9):1369-78. doi: 10.1016/j.biochi.2011.04.024. Epub 2011 May 17.
• [469] Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study.Anesth Analg. 2016 Dec;123(6):1429-1436. doi: 10.1213/ANE.0000000000001293.
• [470] Is Human Oxoguanine Glycosylase 1 Genetic Variant Successful Even on Oral Squamous Cell Carcinoma?.Pathobiology. 2017;84(4):223-228. doi: 10.1159/000466702. Epub 2017 Apr 28.
• [471] Breaking the oncostatin M feed-forward loop to suppress metastasis and therapy failure.J Pathol. 2018 May;245(1):6-8. doi: 10.1002/path.5063. Epub 2018 Apr 2.
• [472] Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.Appl Immunohistochem Mol Morphol. 2020 Sep;28(8):602-610. doi: 10.1097/PAI.0000000000000803.
• [473] Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.BMC Oral Health. 2019 Oct 31;19(1):233. doi: 10.1186/s12903-019-0928-9.
• [474] Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.Am J Ophthalmol. 2019 Apr;200:226-241. doi: 10.1016/j.ajo.2018.12.020. Epub 2019 Jan 8.
• [475] PDE3A is hypermethylated in cisplatin resistant non-small cell lung cancer cells and is a modulator of chemotherapy response.Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2635-2641.
• [476] Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.Cancer Med. 2013 Feb;2(1):40-9. doi: 10.1002/cam4.56. Epub 2013 Feb 3.
• [477] A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.Oncol Lett. 2018 May;15(5):6147-6160. doi: 10.3892/ol.2018.8105. Epub 2018 Feb 22.
• [478] Stabilization of G-quadruplex DNA and inhibition of Bcl-2 expression by a pyridostatin analog.Bioorg Med Chem Lett. 2016 Apr 1;26(7):1660-3. doi: 10.1016/j.bmcl.2016.02.065. Epub 2016 Feb 23.
• [479] Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.Neoplasia. 2019 Aug;21(8):810-821. doi: 10.1016/j.neo.2019.06.003. Epub 2019 Jul 2.
• [480] Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3043-3049. doi: 10.31557/APJCP.2019.20.10.3043.
• [481] Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
• [482] Erratum: Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells.Oncol Lett. 2019 Mar;17(3):3615. doi: 10.3892/ol.2019.10014. Epub 2019 Feb 4.
• [483] Autophagy regulated by prolyl isomerase Pin1 and phospho-Ser-GSK3 involved in protection of oral squamous cell carcinoma against cadmium toxicity.Biochem Biophys Res Commun. 2015 Oct 23;466(3):541-6. doi: 10.1016/j.bbrc.2015.09.066. Epub 2015 Sep 14.
• [484] The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.Cancer Lett. 2014 Oct 10;353(1):104-14. doi: 10.1016/j.canlet.2014.07.012. Epub 2014 Jul 18.
• [485] The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells.Int J Mol Sci. 2018 Sep 25;19(10):2907. doi: 10.3390/ijms19102907.
• [486] The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.Prostate. 2017 Nov;77(15):1452-1467. doi: 10.1002/pros.23400. Epub 2017 Sep 6.
• [487] Molecular classification of basal cell carcinoma of skin by gene expression profiling.Mol Carcinog. 2015 Dec;54(12):1605-12. doi: 10.1002/mc.22233. Epub 2014 Oct 18.
• [488] Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.
• [489] Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.Clin Cancer Res. 2019 Jun 1;25(11):3384-3391. doi: 10.1158/1078-0432.CCR-18-2661. Epub 2019 Mar 7.
• [490] Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies.Blood. 2006 Jan 1;107(1):250-6. doi: 10.1182/blood-2005-03-1194. Epub 2005 Sep 13.
• [491] Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.Oncogene. 2006 Sep 7;25(40):5517-26. doi: 10.1038/sj.onc.1209563. Epub 2006 Apr 17.
• [492] PKC- attenuates the cancer stem cell among squamous cell carcinoma cells through down-regulating p63.Pathol Res Pract. 2017 Sep;213(9):1119-1124. doi: 10.1016/j.prp.2017.07.013. Epub 2017 Jul 14.
• [493] Functional kinomics identifies candidate therapeutic targets in head and neck cancer. Clin Cancer Res. 2014 Aug 15;20(16):4274-88. doi: 10.1158/1078-0432.CCR-13-2858.
• [494] Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma.Oncogene. 2017 Jun 1;36(22):3137-3148. doi: 10.1038/onc.2016.451. Epub 2016 Dec 12.
• [495] Association of over-expressed TFDP1 with progression of hepatocellular carcinomas. J Hum Genet. 2003;48(12):609-613.
• [496] The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.Mol Carcinog. 2012 Jul;51(7):553-64. doi: 10.1002/mc.20820. Epub 2011 Jul 7.
• [497] Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis.PLoS One. 2012;7(7):e40576. doi: 10.1371/journal.pone.0040576. Epub 2012 Jul 18.
• [498] Differential Expression of Prostaglandin I2 Synthase Associated with Arachidonic Acid Pathway in the Oral Squamous Cell Carcinoma.J Oncol. 2018 Nov 8;2018:6301980. doi: 10.1155/2018/6301980. eCollection 2018.
• [499] Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin.J Invest Dermatol. 2015 Oct;135(10):2492-2501. doi: 10.1038/jid.2015.166. Epub 2015 Apr 30.
• [500] PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.World J Surg Oncol. 2017 May 25;15(1):105. doi: 10.1186/s12957-017-1172-x.
• [501] Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.Arch Pathol Lab Med. 2008 Aug;132(8):1307-12. doi: 10.5858/2008-132-1307-EOPORL.
• [502] Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues.Asian Pac J Cancer Prev. 2011;12(4):947-51.
• [503] PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.Gynecol Oncol. 2015 Dec;139(3):529-35. doi: 10.1016/j.ygyno.2015.09.087. Epub 2015 Oct 4.
• [504] Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.J Cell Physiol. 2018 Aug;233(8):6125-6134. doi: 10.1002/jcp.26456. Epub 2018 Mar 6.
• [505] Differential expression of retinoic acid receptors in normal and malignant esophageal tissues.J Exp Ther Oncol. 2004 Apr;4(1):1-8.
• [506] Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells.Oncogene. 1996 May 2;12(9):2019-28.
• [507] A role for stromal autophagy in cancer-associated fibroblast activation.Autophagy. 2019 Apr;15(4):738-739. doi: 10.1080/15548627.2019.1569936. Epub 2019 Jan 22.
• [508] RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet. 2012 Feb 10;90(2):340-6. doi: 10.1016/j.ajhg.2011.12.008. Epub 2012 Jan 19.
• [509] Suppression of rho B expression in invasive carcinoma from head and neck cancer patients.Clin Cancer Res. 2002 Jul;8(7):2225-32.
• [510] PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.Carcinogenesis. 2018 Mar 8;39(3):418-428. doi: 10.1093/carcin/bgx120.
• [511] Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.Lung Cancer. 2018 Oct;124:168-178. doi: 10.1016/j.lungcan.2018.08.008. Epub 2018 Aug 11.
• [512] Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer. 2002 Jan 21;86(2):274-81.
• [513] Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes.Oncogene. 2006 Jul 27;25(32):4449-57. doi: 10.1038/sj.onc.1209479. Epub 2006 Mar 13.
• [514] Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.Am J Pathol. 2011 May;178(5):2407-15. doi: 10.1016/j.ajpath.2011.01.043.
• [515] A Novel Homozygous Missense Mutation in the FU-CRD2 Domain of the R-spondin1 Gene Associated with Familial 46,XX DSD.Sex Dev. 2017;11(5-6):269-274. doi: 10.1159/000485393. Epub 2017 Dec 21.
• [516] Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.Cell Growth Differ. 1998 Aug;9(8):619-27.
• [517] BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis.Mol Cancer Res. 2018 Oct;16(10):1568-1578. doi: 10.1158/1541-7786.MCR-18-0120. Epub 2018 Jun 22.
• [518] High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.Med Sci Monit. 2017 Oct 20;23:5011-5017. doi: 10.12659/msm.904279.
• [519] The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.BMC Cancer. 2019 Jun 17;19(1):597. doi: 10.1186/s12885-019-5784-0.
• [520] Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions.Mol Cancer. 2006 Apr 7;5:15. doi: 10.1186/1476-4598-5-15.
• [521] Pathobiology of Notch2 in lung cancer.Pathology. 2017 Aug;49(5):486-493. doi: 10.1016/j.pathol.2017.05.005. Epub 2017 Jun 27.
• [522] Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9017-22. doi: 10.1073/pnas.0508825103. Epub 2006 Jun 5.
• [523] Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases.Int J Mol Sci. 2018 Apr 6;19(4):1102. doi: 10.3390/ijms19041102.
• [524] Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling.Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):327-336. doi: 10.1158/1055-9965.EPI-18-0723. Epub 2018 Oct 30.
• [525] Altered expression of sphingosine-1-phosphate metabolizing enzymes in oral cancer correlate with clinicopathological attributes. Cancer Invest. 2017 Feb 7;35(2):139-141.
• [526] Immunohistochemistry and clinical value of sirtuin 2 in non-metastasized non-small cell lung cancer.J Thorac Dis. 2019 Sep;11(9):3973-3979. doi: 10.21037/jtd.2019.08.102.
• [527] Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.Oncol Lett. 2018 Sep;16(3):2873-2880. doi: 10.3892/ol.2018.9000. Epub 2018 Jun 20.
• [528] Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.
• [529] Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.Front Oncol. 2018 Aug 28;8:324. doi: 10.3389/fonc.2018.00324. eCollection 2018.
• [530] Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells.Mol Cell Biochem. 1999 Sep;199(1-2):209-15. doi: 10.1023/a:1006958217143.
• [531] Expression of glucose transporters in head-and-neck tumors.Int J Cancer. 1994 Mar 1;56(5):622-9. doi: 10.1002/ijc.2910560503.
• [532] Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.Nat Genet. 2013 Jun;45(6):632-8. doi: 10.1038/ng.2638. Epub 2013 May 5.
• [533] Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.Ann Surg. 2017 Mar;265(3):481-491. doi: 10.1097/SLA.0000000000001905.
• [534] Diagnostic usefulness of F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1692-700. doi: 10.1007/s00259-013-2477-9. Epub 2013 Jun 26.
• [535] Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.Lab Invest. 2014 Jul;94(7):766-76. doi: 10.1038/labinvest.2014.70. Epub 2014 May 19.
• [536] Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9990-5. doi: 10.1073/pnas.1510837112. Epub 2015 Jul 27.
• [537] Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma.World J Gastroenterol. 2003 Sep;9(9):1900-3. doi: 10.3748/wjg.v9.i9.1900.
• [538] Specificity protein 1 is a novel target of 2,4-bis (p-hydroxyphenyl)-2-butenal for the suppression of human oral squamous cell carcinoma cell growth.J Biomed Sci. 2014 Jan 15;21(1):4. doi: 10.1186/1423-0127-21-4.
• [539] Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.Anticancer Res. 2018 Mar;38(3):1361-1368. doi: 10.21873/anticanres.12359.
• [540] A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):714-20. doi: 10.1158/1055-9965.EPI-15-1070. Epub 2016 Feb 12.
• [541] The crucial role of SRPK1 in TGF--induced proliferation and apoptosis in the esophageal squamous cell carcinomas.Med Oncol. 2015 Jul;32(7):209. doi: 10.1007/s12032-015-0654-3. Epub 2015 Jun 23.
• [542] Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.Life Sci. 1994;55(23):1797-806. doi: 10.1016/0024-3205(94)90090-6.
• [543] Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.Oncotarget. 2018 Feb 8;9(14):11691-11706. doi: 10.18632/oncotarget.24450. eCollection 2018 Feb 20.
• [544] Silencing of the interferon-inducible gene Ifi204/p204 induces resistance to interferon--mediated cell growth arrest of tumor cells.Cytokine. 2019 Jun;118:80-92. doi: 10.1016/j.cyto.2018.06.029. Epub 2018 Jul 14.
• [545] Activation of the IL-4/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells.Front Immunol. 2019 Nov 13;10:2638. doi: 10.3389/fimmu.2019.02638. eCollection 2019.
• [546] Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.Oncol Rep. 2012 Apr;27(4):940-6. doi: 10.3892/or.2011.1607. Epub 2011 Dec 22.
• [547] Correlation between STK33 and the pathology and prognosis of lung cancer.Oncol Lett. 2017 Oct;14(4):4800-4804. doi: 10.3892/ol.2017.6766. Epub 2017 Aug 17.
• [548] A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.Cancer Med. 2018 May;7(5):1802-1813. doi: 10.1002/cam4.1449. Epub 2018 Mar 25.
• [549] SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma.Biomarkers. 2010 Mar;15(2):104-10. doi: 10.3109/13547500903311910.
• [550] SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.PLoS One. 2016 Feb 16;11(2):e0148911. doi: 10.1371/journal.pone.0148911. eCollection 2016.
• [551] Activated spleen tyrosine kinase promotes malignant progression of oral squamous cell carcinoma via mTOR/S6 signaling pathway in an ERK1/2-independent manner.Oncotarget. 2017 Aug 3;8(48):83900-83912. doi: 10.18632/oncotarget.19911. eCollection 2017 Oct 13.
• [552] TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.Int J Mol Med. 2019 Dec;44(6):2161-2170. doi: 10.3892/ijmm.2019.4378. Epub 2019 Oct 21.
• [553] Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.World J Gastroenterol. 2003 Nov;9(11):2395-9. doi: 10.3748/wjg.v9.i11.2395.
• [554] Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.Int J Cancer. 2009 Mar 15;124(6):1285-92. doi: 10.1002/ijc.24087.
• [555] Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.Appl Immunohistochem Mol Morphol. 2002 Dec;10(4):351-6. doi: 10.1097/00129039-200212000-00011.
• [556] Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.J Pathol. 2018 Mar;244(3):367-379. doi: 10.1002/path.5019. Epub 2018 Feb 1.
• [557] Keratinocyte transglutaminase expression varies in squamous cell carcinomas.J Invest Dermatol. 1994 Apr;102(4):462-9. doi: 10.1111/1523-1747.ep12373021.
• [558] The expression of transglutaminase 2 (TG-2) in oral squamous cell carcinoma and its clinical significance.J Chin Med Assoc. 2017 Aug;80(8):515-520. doi: 10.1016/j.jcma.2017.05.004. Epub 2017 Jul 1.
• [559] Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.PLoS One. 2016 Aug 11;11(8):e0161007. doi: 10.1371/journal.pone.0161007. eCollection 2016.
• [560] The prognostic value of T Lymphoma Invasion and Metastasis 1 (TIAM1) expression in oral squamous cell carcinoma. J Biochem Mol Toxicol. 2017 Apr;31(4).
• [561] EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer.Int J Mol Sci. 2017 Apr 20;18(4):878. doi: 10.3390/ijms18040878.
• [562] The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects.Mol Cancer Ther. 2017 Jun;16(6):1068-1079. doi: 10.1158/1535-7163.MCT-16-0454. Epub 2017 Jan 30.
• [563] Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.Oral Oncol. 2019 Apr;91:21-28. doi: 10.1016/j.oraloncology.2019.02.014. Epub 2019 Feb 20.
• [564] Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.J Oral Pathol Med. 2015 Sep;44(8):571-7. doi: 10.1111/jop.12272. Epub 2014 Oct 23.
• [565] Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma.Hum Pathol. 2012 Nov;43(11):1973-81. doi: 10.1016/j.humpath.2012.02.006. Epub 2012 May 9.
• [566] B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.Endocrinology. 2012 Feb;153(2):739-49. doi: 10.1210/en.2011-1504. Epub 2011 Dec 13.
• [567] Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.Int J Oncol. 2009 Jun;34(6):1565-71. doi: 10.3892/ijo_00000286.
• [568] TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.Oncol Lett. 2017 Aug;14(2):2153-2164. doi: 10.3892/ol.2017.6467. Epub 2017 Jun 22.
• [569] CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.Oncogene. 2015 Jul;34(27):3527-35. doi: 10.1038/onc.2014.280. Epub 2014 Sep 1.
• [570] Expression of peripheral benzodiazepine receptor, PCNA, and caspase-3 in cells of skin melanoma and squamous cell carcinoma.Bull Exp Biol Med. 2007 Jul;144(1):77-9. doi: 10.1007/s10517-007-0259-8.
• [571] The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer.Oncotarget. 2017 Dec 14;8(70):115270-115279. doi: 10.18632/oncotarget.23252. eCollection 2017 Dec 29.
• [572] 5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter.Anticancer Res. 2019 Aug;39(8):4129-4136. doi: 10.21873/anticanres.13571.
• [573] Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients.BMC Med Genomics. 2008 Nov 11;1:55. doi: 10.1186/1755-8794-1-55.
• [574] The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.
• [575] Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism.Cancer Biol Med. 2017 Nov;14(4):396-404. doi: 10.20892/j.issn.2095-3941.2017.0089.
• [576] KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.FEBS Lett. 2009 Feb 18;583(4):711-7. doi: 10.1016/j.febslet.2009.01.014. Epub 2009 Jan 21.
• [577] Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma.Dis Markers. 2008;25(3):141-8. doi: 10.1155/2008/468323.
• [578] A mutation at IVS1 + 5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer?: case report.BMC Med Genet. 2012 Mar 31;13:23. doi: 10.1186/1471-2350-13-23.
• [579] Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.Cancer Immunol Immunother. 2017 May;66(5):627-636. doi: 10.1007/s00262-017-1968-0. Epub 2017 Feb 24.
• [580] Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.J Thorac Oncol. 2018 Jun;13(6):779-791. doi: 10.1016/j.jtho.2018.03.002. Epub 2018 Mar 8.
• [581] ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.Respir Res. 2017 Mar 24;18(1):52. doi: 10.1186/s12931-017-0537-6.
• [582] Increased risk of skin cancer in Japanese heterozygotes of xeroderma pigmentosum group A.J Hum Genet. 2018 Nov;63(11):1181-1184. doi: 10.1038/s10038-018-0495-y. Epub 2018 Aug 8.
• [583] Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.J Cell Mol Med. 2019 Jun;23(6):4269-4280. doi: 10.1111/jcmm.14318. Epub 2019 Apr 4.
• [584] Integrated molecular portrait of non-small cell lung cancers.BMC Med Genomics. 2013 Dec 3;6:53. doi: 10.1186/1755-8794-6-53.
• [585] Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.Jpn J Clin Oncol. 2012 Jul;42(7):612-8. doi: 10.1093/jjco/hys066. Epub 2012 May 11.
• [586] Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients.Mol Cancer. 2014 Jan 31;13:19. doi: 10.1186/1476-4598-13-19.
• [587] Expression and clinical significance of CXCR5/CXCL13 in human nonsmall cell lung carcinoma.Int J Oncol. 2014 Dec;45(6):2232-40. doi: 10.3892/ijo.2014.2688. Epub 2014 Sep 30.
• [588] Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma.World J Gastroenterol. 2007 Feb 21;13(7):997-1002. doi: 10.3748/wjg.v13.i7.997.
• [589] HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.J Cancer. 2017 Apr 9;8(6):1071-1081. doi: 10.7150/jca.17295. eCollection 2017.
• [590] Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):543-53. doi: 10.1016/j.ijrobp.2007.08.061. Epub 2007 Nov 5.
• [591] Integrin-5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.Arch Oral Biol. 2019 May;101:85-91. doi: 10.1016/j.archoralbio.2019.03.007. Epub 2019 Mar 11.
• [592] Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells.Exp Cell Res. 2005 Oct 1;309(2):273-83. doi: 10.1016/j.yexcr.2005.06.008.
• [593] L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.Mol Cancer. 2011 Oct 10;10:127. doi: 10.1186/1476-4598-10-127.
• [594] Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway.Am J Pathol. 2019 Aug;189(8):1637-1653. doi: 10.1016/j.ajpath.2019.03.012.
• [595] Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.Hum Pathol. 2012 Apr;43(4):506-19. doi: 10.1016/j.humpath.2011.05.021. Epub 2011 Sep 1.
• [596] The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas.Med Oncol. 2015 Mar;32(3):45. doi: 10.1007/s12032-015-0484-3. Epub 2015 Jan 29.
• [597] Structure-Based Design, Synthesis, and Characterization of the First Irreversible Inhibitor of Focal Adhesion Kinase.ACS Chem Biol. 2018 Aug 17;13(8):2067-2073. doi: 10.1021/acschembio.8b00250. Epub 2018 Jun 22.
• [598] Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.Mol Med Rep. 2019 Feb;19(2):885-894. doi: 10.3892/mmr.2018.9705. Epub 2018 Nov 29.
• [599] Tankyrase 2 (TNKS2) polymorphism associated with risk in developing non-small cell lung cancer in a Chinese population.Pathol Res Pract. 2015 Oct;211(10):766-71. doi: 10.1016/j.prp.2015.07.003. Epub 2015 Jul 8.
• [600] Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.Respir Res. 2015 Jun 26;16(1):76. doi: 10.1186/s12931-015-0230-6.
• [601] USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.Tumour Biol. 2015 Mar;36(3):1721-9. doi: 10.1007/s13277-014-2773-4. Epub 2014 Dec 18.
• [602] Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.DNA Cell Biol. 2011 Dec;30(12):987-94. doi: 10.1089/dna.2010.1196. Epub 2011 Jun 11.
• [603] Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.PLoS Genet. 2013;9(1):e1003190. doi: 10.1371/journal.pgen.1003190. Epub 2013 Jan 17.
• [604] L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.J Nucl Med. 2007 Dec;48(12):2063-71. doi: 10.2967/jnumed.107.043620.
• [605] In vitro cytokine expression in in situ-like areas of malignant neoplasia.Arch Oral Biol. 2013 May;58(5):552-7. doi: 10.1016/j.archoralbio.2012.06.001. Epub 2012 Jun 29.
• [606] Expression of Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma and EGFR-mutated adenocarcinoma patients.QJM. 2016 Apr;109(4):237-44. doi: 10.1093/qjmed/hcv207. Epub 2015 Nov 11.
• [607] H?myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.Curr Cancer Drug Targets. 2011 Oct;11(8):966-75. doi: 10.2174/156800911797264752.
• [608] Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.Front Pharmacol. 2019 Feb 6;10:79. doi: 10.3389/fphar.2019.00079. eCollection 2019.
• [609] GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology.Eur J Cancer Prev. 2013 Sep;22(5):417-9. doi: 10.1097/CEJ.0b013e32835c7f53.
• [610] Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.Cancer Res. 2008 Jun 15;68(12):4494-9. doi: 10.1158/0008-5472.CAN-07-6509.
• [611] Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer.Anticancer Res. 2017 May;37(5):2255-2263. doi: 10.21873/anticanres.11562.
• [612] Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.Int J Biol Markers. 2016 Dec 23;31(4):e402-e412. doi: 10.5301/jbm.5000221.
• [613] The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncol. 2008 Feb;44(2):180-6.
• [614] Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia.Cancer Epidemiol. 2016 Aug;43:112-8. doi: 10.1016/j.canep.2016.04.011. Epub 2016 Jun 2.
• [615] Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells.Biotechnol Appl Biochem. 2016 May;63(3):328-33. doi: 10.1002/bab.1383. Epub 2015 Jul 6.
• [616] Irreversible EGFR inhibitor EKB-569 targets low-LET -radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma. PLoS One. 2011;6(12):e29705. doi: 10.1371/journal.pone.0029705. Epub 2011 Dec 29.
• [617] CYP26B1 is a novel candidate gene for betel quid-related oral squamous cell carcinoma.Oral Oncol. 2011 Jul;47(7):594-600. doi: 10.1016/j.oraloncology.2011.04.024. Epub 2011 Jun 8.
• [618] 1,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.Horm Cancer. 2014 Apr;5(2):90-7. doi: 10.1007/s12672-014-0170-5. Epub 2014 Feb 5.
• [619] Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.Clin Cancer Res. 2005 Feb 1;11(3):993-9.
• [620] Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma.PLoS One. 2015 May 14;10(5):e0125976. doi: 10.1371/journal.pone.0125976. eCollection 2015.
• [621] The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma.Oncotarget. 2016 Apr 12;7(15):20574-83. doi: 10.18632/oncotarget.7827.
• [622] Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization.APMIS. 2004 Jan;112(1):11-20. doi: 10.1111/j.1600-0463.2004.apm1120103.x.
• [623] Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma.Otolaryngol Head Neck Surg. 2011 Oct;145(4):586-93. doi: 10.1177/0194599811408778. Epub 2011 Jun 25.
• [624] Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer.Med Sci Monit. 2018 May 29;24:3578-3590. doi: 10.12659/MSM.910026.
• [625] Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):626-32. doi: 10.1158/1055-9965.EPI-04-0343.
• [626] Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients.J Oral Pathol Med. 2019 Sep;48(8):712-719. doi: 10.1111/jop.12891. Epub 2019 Jun 25.
• [627] Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma.J Dermatol Sci. 2006 Mar;41(3):205-12. doi: 10.1016/j.jdermsci.2005.11.007. Epub 2005 Dec 19.
• [628] Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression.World J Gastroenterol. 2004 Jun 15;10(12):1716-21. doi: 10.3748/wjg.v10.i12.1716.
• [629] 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.Dermatology. 1993;187(2):95-9. doi: 10.1159/000247214.
• [630] Enhancement of cyclophosphamide sensitivity in squamous cell carcinoma transfected with cytochrome P-450 2B1.Am J Otolaryngol. 2005 Jan-Feb;26(1):22-7. doi: 10.1016/j.amjoto.2004.06.012.
• [631] Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.Pathology. 2018 Oct;50(6):642-647. doi: 10.1016/j.pathol.2018.06.002. Epub 2018 Aug 24.
• [632] Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.Oncol Res. 1997;9(4):167-72.
• [633] Ras gene mutation and amplification in human nonmelanoma skin cancers.Mol Carcinog. 1991;4(3):196-202. doi: 10.1002/mc.2940040306.
• [634] Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.Eur Arch Otorhinolaryngol. 2016 Feb;273(2):495-503. doi: 10.1007/s00405-015-3543-7. Epub 2015 Feb 7.
• [635] The balance between 4-hydroxynonenal and intrinsic glutathione/glutathione S-transferase A4 system may be critical for the epidermal growth factor receptor phosphorylation of human esophageal squamous cell carcinomas.Mol Carcinog. 2011 Oct;50(10):781-90. doi: 10.1002/mc.20699. Epub 2011 Jul 12.
• [636] N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males.Med Oncol. 2014 Aug;31(8):90. doi: 10.1007/s12032-014-0090-9. Epub 2014 Jul 9.
• [637] Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.Clin Oral Investig. 2019 Feb;23(2):829-838. doi: 10.1007/s00784-018-2497-8. Epub 2018 Jun 7.
• [638] CCT is a novel biomarker for diagnosis of laryngeal squamous cell cancer.Sci Rep. 2019 Aug 14;9(1):11823. doi: 10.1038/s41598-019-47895-x.
• [639] Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese.Carcinogenesis. 2009 Feb;30(2):286-94. doi: 10.1093/carcin/bgn283. Epub 2009 Jan 6.
• [640] Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.PLoS One. 2018 Aug 9;13(8):e0202432. doi: 10.1371/journal.pone.0202432. eCollection 2018.
• [641] Expression of the mammalian target of rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma.Pathobiology. 2012;79(2):84-93. doi: 10.1159/000334340. Epub 2012 Jan 27.
• [642] Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):489-98.
• [643] Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.Cancer Res. 1998 Mar 15;58(6):1291-7.
• [644] Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.Cancer Epidemiol. 2013 Oct;37(5):653-9. doi: 10.1016/j.canep.2013.04.010. Epub 2013 Jun 7.
• [645] Lipocalin-type prostaglandin D synthase-derived PGD(2) attenuates malignant properties of tumor endothelial cells.J Pathol. 2018 Jan;244(1):84-96. doi: 10.1002/path.4993. Epub 2017 Nov 10.
• [646] Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.Cytokine. 2019 Jun;118:160-167. doi: 10.1016/j.cyto.2018.03.001. Epub 2018 Mar 15.
• [647] Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.J Biol Chem. 2009 May 8;284(19):12633-44. doi: 10.1074/jbc.M809794200. Epub 2009 Feb 25.
• [648] A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.Int J Cancer. 2020 Jan 15;146(2):388-399. doi: 10.1002/ijc.32532. Epub 2019 Jul 8.
• [649] ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients.Am J Pathol. 2019 Jan;189(1):190-199. doi: 10.1016/j.ajpath.2018.09.003. Epub 2018 Oct 11.
• [650] Underexpression of -1-microglobulin/bikunin precursor predicts a poor prognosis in oral squamous cell carcinoma.Int J Oncol. 2018 Dec;53(6):2605-2614. doi: 10.3892/ijo.2018.4581. Epub 2018 Oct 1.
• [651] Frequent Alteration of Annexin A9 and A10 in HPV-Negative Head and Neck Squamous Cell Carcinomas: Correlation with the Histopathological Differentiation Grade.J Clin Med. 2019 Feb 10;8(2):229. doi: 10.3390/jcm8020229.
• [652] APOBEC3A Expression in Penile Squamous Cell Carcinoma.Pathobiology. 2018;85(3):169-178. doi: 10.1159/000479007. Epub 2017 Nov 23.
• [653] Co-expression of Rho guanine nucleotide exchange factor 5 and Src associates with poor prognosis of patients with resected non-small cell lung cancer.Oncol Rep. 2013 Dec;30(6):2864-70. doi: 10.3892/or.2013.2797. Epub 2013 Oct 14.
• [654] mASH1 is Highly Specific for Neuroendocrine Carcinomas: An Immunohistochemical Evaluation on Normal and Various Neoplastic Tissues.Arch Pathol Lab Med. 2017 Feb;141(2):288-292. doi: 10.5858/arpa.2015-0489-OA. Epub 2016 Sep 15.
• [655] Association of ATG4B and Phosphorylated ATG4B Proteins with Tumorigenesis and Prognosis in Oral Squamous Cell Carcinoma.Cancers (Basel). 2019 Nov 23;11(12):1854. doi: 10.3390/cancers11121854.
• [656] Markers of squamous cell carcinoma in sarco/endoplasmic reticulum Ca2+ ATPase 2 heterozygote mice keratinocytes.Prog Biophys Mol Biol. 2010 Sep;103(1):81-7. doi: 10.1016/j.pbiomolbio.2009.10.005. Epub 2009 Oct 17.
• [657] Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.EBioMedicine. 2019 Sep;47:44-57. doi: 10.1016/j.ebiom.2019.08.013. Epub 2019 Aug 10.
• [658] Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomas.Cancer Detect Prev. 2003;27(4):250-5. doi: 10.1016/s0361-090x(03)00098-9.
• [659] An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.Lasers Surg Med. 2018 Jul;50(5):552-565. doi: 10.1002/lsm.22809. Epub 2018 Mar 31.
• [660] Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.
• [661] MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression.PLoS One. 2012;7(4):e34943. doi: 10.1371/journal.pone.0034943. Epub 2012 Apr 13.
• [662] CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-B.Oral Dis. 2019 Nov;25(8):1886-1896. doi: 10.1111/odi.13157. Epub 2019 Oct 11.
• [663] Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.Oral Oncol. 2008 Feb;44(2):143-7. doi: 10.1016/j.oraloncology.2007.01.013. Epub 2007 Apr 5.
• [664] Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.Clin Lung Cancer. 2011 Jan;12(1):43-50. doi: 10.3816/CLC.2011.n.006.
• [665] Anti-proliferative effect of 8-tigloyloxyhirsutinolide-13-O-acetate (8TGH) isolated from Vernonia cinerea on oral squamous cell carcinoma through inhibition of STAT3 and STAT2 phosphorylation.Phytomedicine. 2019 Jan;52:238-246. doi: 10.1016/j.phymed.2018.09.211. Epub 2018 Sep 26.
• [666] Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.Hum Mol Genet. 2012 Nov 15;21(22):4980-95. doi: 10.1093/hmg/dds334. Epub 2012 Aug 16.
• [667] Transcriptomic analysis to affirm the regulatory role of long non-coding RNA in horn cancer of Indian zebu cattle breed Kankrej (Bos indicus).Funct Integr Genomics. 2020 Jan;20(1):75-87. doi: 10.1007/s10142-019-00700-4. Epub 2019 Jul 31.
• [668] CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.J Cell Physiol. 2018 Dec;233(12):9416-9425. doi: 10.1002/jcp.26815. Epub 2018 Jul 27.
• [669] High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.Onco Targets Ther. 2017 Dec 12;10:5907-5914. doi: 10.2147/OTT.S148250. eCollection 2017.
• [670] High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.BMC Gastroenterol. 2017 Feb 17;17(1):33. doi: 10.1186/s12876-017-0590-0.
• [671] CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics. 2010 Aug;11(8):1105-13. doi: 10.2217/pgs.10.76.
• [672] Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA.J Cell Physiol. 2019 Nov;234(11):20206-20216. doi: 10.1002/jcp.28620. Epub 2019 Apr 13.
• [673] Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.FASEB J. 2017 Aug;31(8):3412-3424. doi: 10.1096/fj.201601138RR. Epub 2017 Apr 24.
• [674] Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.Clin Cancer Res. 2002 Apr;8(4):1127-38.
• [675] Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.Lung Cancer. 2008 Nov;62(2):181-92. doi: 10.1016/j.lungcan.2008.06.018. Epub 2008 Aug 9.
• [676] Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.Cancer Manag Res. 2019 Nov 11;11:9553-9562. doi: 10.2147/CMAR.S223273. eCollection 2019.
• [677] LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5779-5786. doi: 10.26355/eurrev_201907_18316.
• [678] De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGF-deficient squamous cell carcinoma from transition zones.Elife. 2017 Feb 21;6:e22914. doi: 10.7554/eLife.22914.
• [679] Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.Eur J Cancer Prev. 2016 May;25(3):224-31. doi: 10.1097/CEJ.0000000000000159.
• [680] Dualism of FGF and TGF- Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.Cell Rep. 2019 Aug 27;28(9):2358-2372.e6. doi: 10.1016/j.celrep.2019.07.092.
• [681] Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).BMC Cancer. 2011 Apr 20;11:147. doi: 10.1186/1471-2407-11-147.
• [682] Quantitative Analysis of [(18)F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry.Mol Imaging Biol. 2017 Feb;19(1):120-129. doi: 10.1007/s11307-016-0975-4.
• [683] The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.Surg Today. 2018 Feb;48(2):229-235. doi: 10.1007/s00595-017-1577-8. Epub 2017 Aug 18.
• [684] Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas. Int J Cancer. 2009 Aug 15;125(4):807-15.
• [685] FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth.Exp Cell Res. 2017 Jan 1;350(1):267-278. doi: 10.1016/j.yexcr.2016.12.004. Epub 2016 Dec 2.
• [686] FOXE1 gene mutation screening by multiplex PCR/DHPLC in CHARGE syndrome and syndromic and non-syndromic cleft palate.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):39-46. doi: 10.1016/j.jchromb.2006.03.028. Epub 2006 Apr 11.
• [687] MicroRNA-299-3p/FOXP4 Axis Regulates the Proliferation and Migration of Oral Squamous Cell Carcinoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819874803. doi: 10.1177/1533033819874803.
• [688] Knockdown of Gab1 Inhibits Cellular Proliferation, Migration, and Invasion in Human Oral Squamous Carcinoma Cells.Oncol Res. 2018 May 7;26(4):617-624. doi: 10.3727/096504017X15043589260618. Epub 2017 Sep 6.
• [689] GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers.J Korean Med Sci. 2017 Nov;32(11):1784-1791. doi: 10.3346/jkms.2017.32.11.1784.
• [690] Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma.Am J Clin Pathol. 2018 May 31;150(1):74-83. doi: 10.1093/ajcp/aqy029.
• [691] Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer.Asian Pac J Cancer Prev. 2011;12(8):2039-43.
• [692] Prognostic value of histone H3 serine 10 phosphorylation and histone H4 lysine 12 acetylation in oral squamous cell carcinoma.Histopathology. 2019 Jan;74(2):227-238. doi: 10.1111/his.13713. Epub 2018 Oct 29.
• [693] Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer.Tumori. 2011 Jan-Feb;97(1):86-94. doi: 10.1177/030089161109700116.
• [694] Long Non-Coding RNA HCP5 Facilitates Cell Invasion And Epithelial-Mesenchymal Transition In Oral Squamous Cell Carcinoma By miR-140-5p/SOX4 Axis.Cancer Manag Res. 2019 Dec 12;11:10455-10462. doi: 10.2147/CMAR.S230324. eCollection 2019.
• [695] The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.Dis Markers. 2019 Apr 7;2019:5421985. doi: 10.1155/2019/5421985. eCollection 2019.
• [696] Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.Oncol Lett. 2018 Apr;15(4):4517-4522. doi: 10.3892/ol.2018.7898. Epub 2018 Jan 29.
• [697] Genetics and lung carcinoma in Okinawa Prefecture, Japan.Anticancer Res. 1999 Nov-Dec;19(6C):5611-4.
• [698] Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.Mol Cancer Ther. 2003 May;2(5):453-9.
• [699] Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.J Cell Sci. 2009 Jun 1;122(Pt 11):1788-99. doi: 10.1242/jcs.042895. Epub 2009 May 12.
• [700] TIP60 up-regulates Np63 to promote cellular proliferation.J Biol Chem. 2019 Nov 8;294(45):17007-17016. doi: 10.1074/jbc.RA119.010388. Epub 2019 Oct 10.
• [701] Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-B pathway.Biomed Pharmacother. 2019 Jan;109:1994-2004. doi: 10.1016/j.biopha.2018.07.144. Epub 2018 Nov 26.
• [702] MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):630-640. doi: 10.26355/eurrev_201901_16877.
• [703] KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition.Oncol Lett. 2017 Apr;13(4):2281-2289. doi: 10.3892/ol.2017.5734. Epub 2017 Feb 13.
• [704] Biochemical and functional characterization of the human tissue kallikrein 9.Biochem J. 2017 Jul 6;474(14):2417-2433. doi: 10.1042/BCJ20170174.
• [705] Macrophages Promote Growth of Squamous Cancer Independent of T cells.J Dent Res. 2019 Jul;98(8):896-903. doi: 10.1177/0022034519854734. Epub 2019 Jun 12.
• [706] A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.
• [707] LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.Br J Cancer. 2016 Jun 28;115(1):52-8. doi: 10.1038/bjc.2016.167. Epub 2016 Jun 9.
• [708] Absence of MGMT promoter methylation in endometrial cancer.Gynecol Oncol. 2009 Jan;112(1):224-8. doi: 10.1016/j.ygyno.2008.08.038. Epub 2008 Oct 29.
• [709] The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.Mol Oncol. 2019 Nov;13(11):2476-2492. doi: 10.1002/1878-0261.12579. Epub 2019 Oct 21.
• [710] Latent transforming growth factor -binding protein 4 is downregulated in esophageal cancer via promoter methylation.PLoS One. 2013 May 31;8(5):e65614. doi: 10.1371/journal.pone.0065614. Print 2013.
• [711] Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.Int J Oncol. 2008 Dec;33(6):1177-85.
• [712] Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas.Int J Oncol. 2003 Aug;23(2):297-302.
• [713] Loss of heterozygosity at APC and MCC genes of oral cancer and leukoplakia tissues from Indian tobacco chewers.J Oral Pathol Med. 2003 Sep;32(8):450-4. doi: 10.1034/j.1600-0714.2003.00132.x.
• [714] MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):120-125. doi: 10.1097/PAI.0000000000000397.
• [715] Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.Hum Pathol. 2011 May;42(5):669-78. doi: 10.1016/j.humpath.2010.07.022. Epub 2011 Jan 15.
• [716] Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma.Int J Biol Markers. 2007 Oct-Dec;22(4):265-73.
• [717] MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production.Cell Biol Int. 2020 Mar;44(3):821-829. doi: 10.1002/cbin.11278. Epub 2019 Dec 19.
• [718] The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.J Infect Public Health. 2018 Jan-Feb;11(1):105-110. doi: 10.1016/j.jiph.2017.06.012. Epub 2017 Jul 8.
• [719] NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma.Virchows Arch. 2016 Aug;469(2):163-72. doi: 10.1007/s00428-016-1955-4. Epub 2016 May 16.
• [720] The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.J Clin Med. 2019 Sep 3;8(9):1376. doi: 10.3390/jcm8091376.
• [721] The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma.J Oral Pathol Med. 2017 Oct;46(9):766-772. doi: 10.1111/jop.12586. Epub 2017 Jul 28.
• [722] Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosis.Lung Cancer. 2011 Dec;74(3):411-8. doi: 10.1016/j.lungcan.2011.05.001. Epub 2011 Jun 2.
• [723] Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma.Med Mol Morphol. 2019 Jun;52(2):99-105. doi: 10.1007/s00795-018-0207-x. Epub 2018 Oct 1.
• [724] High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma.Cancer Invest. 2018 Apr 21;36(4):246-253. doi: 10.1080/07357907.2018.1466896.
• [725] Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.Toxicol Lett. 2019 Oct 10;314:142-152. doi: 10.1016/j.toxlet.2019.07.017. Epub 2019 Jul 15.
• [726] Systemic therapy in non-conventional cancers of the larynx.Oral Oncol. 2018 Jul;82:61-68. doi: 10.1016/j.oraloncology.2018.05.005. Epub 2018 May 26.
• [727] Putative biomarkers of malignant transformation of sinonasal inverted papilloma into squamous cell carcinoma.J Int Med Res. 2019 Jun;47(6):2371-2380. doi: 10.1177/0300060519838385. Epub 2019 Apr 16.
• [728] PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23.Int J Biol Sci. 2019 May 7;15(6):1177-1186. doi: 10.7150/ijbs.33103. eCollection 2019.
• [729] Prognostic Significance of BMI-1 But Not MEL-18 Expression in Pulmonary Squamous Cell Carcinoma.Anticancer Res. 2017 Apr;37(4):1923-1929. doi: 10.21873/anticanres.11531.
• [730] Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells.Cell Oncol (Dordr). 2018 Oct;41(5):505-516. doi: 10.1007/s13402-018-0387-3. Epub 2018 Jul 25.
• [731] A loss of profilin-1 in late-stage oral squamous cell carcinoma.J Oral Pathol Med. 2017 Aug;46(7):489-495. doi: 10.1111/jop.12523. Epub 2016 Dec 18.
• [732] Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2.J Biomed Sci. 2005;12(1):65-77. doi: 10.1007/s11373-004-8185-5.
• [733] The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.Mol Cancer Res. 2005 Sep;3(9):483-92. doi: 10.1158/1541-7786.MCR-05-0019.
• [734] POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma.J Cancer. 2019 Jul 24;10(19):4473-4480. doi: 10.7150/jca.33368. eCollection 2019.
• [735] Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.Genes Chromosomes Cancer. 2008 Apr;47(4):353-62. doi: 10.1002/gcc.20539.
• [736] BLIMP1 transcriptionally induced by EGFR activation and post-translationally regulated by proteasome and lysosome is involved in keratinocyte differentiation, migration and inflammation.J Dermatol Sci. 2018 Nov;92(2):151-161. doi: 10.1016/j.jdermsci.2018.08.011. Epub 2018 Aug 31.
• [737] Overexpression of Dicer in precursor lesions of lung adenocarcinoma.Cancer Res. 2007 Mar 1;67(5):2345-50. doi: 10.1158/0008-5472.CAN-06-3533.
• [738] Esophageal cancer related gene-4 inhibits the migration and proliferation of oral squamous cell carcinoma through BC200 lncRNA/MMP-9 and -13 signaling pathway.Cell Signal. 2019 Oct;62:109327. doi: 10.1016/j.cellsig.2019.05.012. Epub 2019 May 29.
• [739] RP11-284F21.9 promotes oral squamous cell carcinoma development via the miR-383-5p/MAL2 axis.J Oral Pathol Med. 2020 Jan;49(1):21-29. doi: 10.1111/jop.12946. Epub 2019 Sep 27.
• [740] PA28 acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma.Cancer Lett. 2018 Aug 1;428:192-200. doi: 10.1016/j.canlet.2018.04.024. Epub 2018 Apr 24.
• [741] LncRNA PAPAS promotes oral squamous cell carcinoma by upregulating transforming growth factor-1.J Cell Biochem. 2019 Sep;120(9):16120-16127. doi: 10.1002/jcb.28893. Epub 2019 May 17.
• [742] Silencing Rab14 represses the proliferation and migration of oral squamous cell carcinoma, and enhances cisplatin sensitivity.Am J Transl Res. 2017 Sep 15;9(9):4195-4205. eCollection 2017.
• [743] Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin 1/Rac1 pathway.Oncotarget. 2016 Feb 2;7(5):5342-52. doi: 10.18632/oncotarget.6701.
• [744] Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.Mol Pathol. 2002 Jun;55(3):153-5. doi: 10.1136/mp.55.3.153.
• [745] Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth.Mol Cancer Ther. 2008 Jun;7(6):1355-64. doi: 10.1158/1535-7163.MCT-08-0104. Epub 2008 Jun 4.
• [746] Unusual jaw metastasis from squamous cell lung cancer in heavy smoker: Two case reports and review of the literature.Medicine (Baltimore). 2017 May;96(21):e6987. doi: 10.1097/MD.0000000000006987.
• [747] MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.J Cell Biochem. 2019 Jul;120(7):11432-11440. doi: 10.1002/jcb.28421. Epub 2019 Feb 12.
• [748] Investigation of the association of hRRM1 and p53R2 gene polymorphisms in head and neck squamous cell carcinomas.Med Oncol. 2014 Jul;31(7):12. doi: 10.1007/s12032-014-0012-x. Epub 2014 May 27.
• [749] Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.Proteomics Clin Appl. 2018 Sep;12(5):e1700180. doi: 10.1002/prca.201700180. Epub 2018 May 30.
• [750] The set gene is a potential oncogene in human colorectal adenocarcinoma and oral squamous cell carcinoma.Mol Med Rep. 2011 Sep-Oct;4(5):993-9. doi: 10.3892/mmr.2011.526. Epub 2011 Jul 1.
• [751] Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma.J Thorac Dis. 2017 Nov;9(11):4434-4440. doi: 10.21037/jtd.2017.10.43.
• [752] Is there a correlation between HPV and urinary bladder carcinoma?.Biomed Pharmacother. 2013 Apr;67(3):183-91. doi: 10.1016/j.biopha.2012.10.019. Epub 2012 Dec 7.
• [753] Siah-1 is associated with expression of hypoxia-inducible factor-1 in oral squamous cell carcinoma.Auris Nasus Larynx. 2017 Apr;44(2):213-219. doi: 10.1016/j.anl.2016.06.007. Epub 2016 Sep 8.
• [754] Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop.Cell Death Differ. 2020 Mar;27(3):919-933. doi: 10.1038/s41418-019-0423-5. Epub 2019 Sep 30.
• [755] High energy density LED-based photobiomodulation inhibits squamous cell carcinoma progression in co-cultures in vitro.J Photochem Photobiol B. 2019 Oct;199:111592. doi: 10.1016/j.jphotobiol.2019.111592. Epub 2019 Aug 14.
• [756] Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).Clin Epigenetics. 2019 Aug 12;11(1):116. doi: 10.1186/s13148-019-0715-0.
• [757] Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.J Oral Pathol Med. 2017 Oct;46(9):752-758. doi: 10.1111/jop.12566. Epub 2017 Mar 28.
• [758] LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3358-3365. doi: 10.26355/eurrev_201904_17699.
• [759] The investigation of hyaluronic acid and hyaluronidase-1 levels as tumour marker in larynx cancer.Clin Otolaryngol. 2019 Nov;44(6):914-918. doi: 10.1111/coa.13390. Epub 2019 Aug 1.
• [760] Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment.J Exp Clin Cancer Res. 2019 Sep 13;38(1):405. doi: 10.1186/s13046-019-1389-3.
• [761] [6]-Shogaol attenuates inflammation, cell proliferation via modulate NF-B and AP-1 oncogenic signaling in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis.Biomed Pharmacother. 2018 Feb;98:484-490. doi: 10.1016/j.biopha.2017.12.009. Epub 2017 Dec 27.
• [762] Overexpression of sprouty2 in human oral squamous cell carcinogenesis.Arch Oral Biol. 2018 Mar;87:131-142. doi: 10.1016/j.archoralbio.2017.12.021. Epub 2017 Dec 27.
• [763] Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix.Gynecol Oncol. 2001 Oct;83(1):121-7. doi: 10.1006/gyno.2001.6358.
• [764] Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.Cancer Res. 2009 Mar 15;69(6):2234-43. doi: 10.1158/0008-5472.CAN-08-3338. Epub 2009 Mar 3.
• [765] Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.Clin Cancer Res. 2012 Jul 15;18(14):3868-79. doi: 10.1158/1078-0432.CCR-11-3211. Epub 2012 May 18.
• [766] Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma.Anticancer Res. 2019 Mar;39(3):1293-1300. doi: 10.21873/anticanres.13241.
• [767] The high expression of TC1 (C8orf4) was correlated with the expression of -catenin and cyclin D1 and the progression of squamous cell carcinomas of the tongue.Tumour Biol. 2015 Sep;36(9):7061-7. doi: 10.1007/s13277-015-3423-1. Epub 2015 Apr 14.
• [768] Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.Cell Cycle. 2018;17(18):2284-2295. doi: 10.1080/15384101.2018.1526601. Epub 2018 Oct 9.
• [769] Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.Int J Cancer. 2008 May 15;122(10):2377-9. doi: 10.1002/ijc.23377.
• [770] Possible association between actinic keratosis and the rs7208422 (c.917AT, p.N306l) polymorphism of the EVER2 gene in patients without epidermodysplasia verruciformis.Clin Exp Dermatol. 2015 Apr;40(3):318-23. doi: 10.1111/ced.12506. Epub 2014 Dec 12.
• [771] TNF--induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.PLoS One. 2019 Mar 20;14(3):e0213463. doi: 10.1371/journal.pone.0213463. eCollection 2019.
• [772] Analysis of CD137 and CD137L expression in human primary tumor tissues.Croat Med J. 2008 Apr;49(2):192-200. doi: 10.3325/cmj.2008.2.192.
• [773] Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma.PLoS One. 2017 Feb 9;12(2):e0168900. doi: 10.1371/journal.pone.0168900. eCollection 2017.
• [774] Upregulation of tropomyosin alpha-4 chain in patients' saliva with oral squamous cell carcinoma as demonstrated by Phage display.Sci Rep. 2019 Dec 5;9(1):18399. doi: 10.1038/s41598-019-54686-x.
• [775] miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.Oncol Rep. 2017 May;37(5):2720-2726. doi: 10.3892/or.2017.5532. Epub 2017 Mar 27.
• [776] Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.Exp Cell Res. 2019 Nov 15;384(2):111622. doi: 10.1016/j.yexcr.2019.111622. Epub 2019 Sep 10.
• [777] Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer.J BUON. 2019 Jul-Aug;24(4):1626-1637.
• [778] CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.Sci Rep. 2016 Apr 1;6:24006. doi: 10.1038/srep24006.
• [779] Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma.Oncotarget. 2017 May 3;8(42):71759-71771. doi: 10.18632/oncotarget.17606. eCollection 2017 Sep 22.
• [780] ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.Cancer Cell. 2017 Jan 9;31(1):35-49. doi: 10.1016/j.ccell.2016.12.001. Epub 2016 Dec 29.
• [781] ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2013 Apr;139(4):585-94. doi: 10.1007/s00432-012-1361-5. Epub 2012 Dec 15.
• [782] Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression.Cancer Invest. 2011 Aug;29(7):478-84. doi: 10.3109/07357907.2011.597813.
• [783] End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.Clin Chim Acta. 2016 Aug 1;459:45-52. doi: 10.1016/j.cca.2016.05.012. Epub 2016 May 18.
• [784] Overexpression of Rho GDP-dissociation inhibitor alpha predicts poor survival in oral squamous cell carcinoma.Oral Oncol. 2011 Jun;47(6):452-8. doi: 10.1016/j.oraloncology.2011.03.025. Epub 2011 May 4.
• [785] Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1885-93. doi: 10.1007/s00405-015-3703-9. Epub 2015 Jul 3.
• [786] Overexpression of autophagy-related 16-like 1 in patients with oral squamous cell carcinoma.Pathol Oncol Res. 2015 Apr;21(2):301-5. doi: 10.1007/s12253-014-9821-7. Epub 2014 Jul 25.
• [787] Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.Int J Cancer. 2009 Aug 15;125(4):909-17. doi: 10.1002/ijc.24327.
• [788] RNA polymerase III transcription in cancer: the BRF2 connection.Mol Cancer. 2011 Apr 25;10:47. doi: 10.1186/1476-4598-10-47.
• [789] Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.J Pathol. 2013 Jul;230(3):298-309. doi: 10.1002/path.4173. Epub 2013 Mar 21.
• [790] The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas.PLoS One. 2013 Jun 21;8(6):e66975. doi: 10.1371/journal.pone.0066975. Print 2013.
• [791] Spindly and Bub3 expression in oral cancer: Prognostic and therapeutic implications.Oral Dis. 2019 Jul;25(5):1291-1301. doi: 10.1111/odi.13089. Epub 2019 Apr 4.
• [792] Differentiating cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia by multiplex qRT-PCR.Mod Pathol. 2013 Nov;26(11):1433-7. doi: 10.1038/modpathol.2013.82. Epub 2013 May 24.
• [793] Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7.Int J Cancer. 2010 Jul 15;127(2):332-44. doi: 10.1002/ijc.25060.
• [794] Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.Lung Cancer. 2012 Jan;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023. Epub 2011 Jun 14.
• [795] Analysis of the chromosomal aneuploidy by interphase fluorescence in situ hybridization (FISH) in Squamous cell carcinoma of the cervix in Jammu region of J and K state.J Cancer Res Ther. 2014 Apr-Jun;10(2):317-23. doi: 10.4103/0973-1482.136612.
• [796] The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.Tumour Biol. 2015 Dec;36(12):9487-97. doi: 10.1007/s13277-015-3618-5. Epub 2015 Jul 1.
• [797] Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma.Asian Pac J Cancer Prev. 2016;17(1):219-23. doi: 10.7314/apjcp.2016.17.1.219.
• [798] Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.Int J Clin Exp Pathol. 2015 Jul 1;8(7):8143-58. eCollection 2015.
• [799] Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.
• [800] Association of smoking with tumor size at diagnosis in non-small cell lung cancer.Lung Cancer. 2011 Dec;74(3):378-83. doi: 10.1016/j.lungcan.2011.04.020. Epub 2011 Jun 8.
• [801] Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas.Mod Pathol. 2007 Sep;20(9):947-54. doi: 10.1038/modpathol.3800835. Epub 2007 Jun 22.
• [802] Genetic variants in telomere-maintaining genes and skin cancer risk.Hum Genet. 2011 Mar;129(3):247-53. doi: 10.1007/s00439-010-0921-5. Epub 2010 Nov 30.
• [803] CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.Tumour Biol. 2015 Sep;36(10):7849-58. doi: 10.1007/s13277-015-3504-1. Epub 2015 May 7.
• [804] CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.Biochem Biophys Res Commun. 2014 May 2;447(2):304-10. doi: 10.1016/j.bbrc.2014.03.158. Epub 2014 Apr 8.
• [805] Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57.Mol Cancer Ther. 2008 May;7(5):1268-74. doi: 10.1158/1535-7163.MCT-07-2222.
• [806] A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.Anticancer Drugs. 2015 Jan;26(1):64-73. doi: 10.1097/CAD.0000000000000160.
• [807] Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.Lung Cancer. 2010 Apr;68(1):105-10. doi: 10.1016/j.lungcan.2009.05.010. Epub 2009 Jul 9.
• [808] KRT13, FAIM2 and CYP2W1 mRNA expression in oral squamous cell carcinoma patients with risk habits.Asian Pac J Cancer Prev. 2015;16(3):953-8. doi: 10.7314/apjcp.2015.16.3.953.
• [809] Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.J Clin Invest. 2010 Aug;120(8):2842-57. doi: 10.1172/JCI36125. Epub 2010 Jul 1.
• [810] Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.Cancer Biomark. 2015;15(1):11-7. doi: 10.3233/CBM-140436.
• [811] Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
• [812] The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.Oncogene. 2016 Jun 16;35(24):3114-24. doi: 10.1038/onc.2015.380. Epub 2015 Nov 2.
• [813] Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):292-7. doi: 10.1097/PAI.0b013e31826fd4f3.
• [814] Laser micro-dissection and qPCR for identifying specific HPV types responsible for malignancy in penile lesions.J Med Virol. 2015 Oct;87(10):1761-8. doi: 10.1002/jmv.24229. Epub 2015 Jun 25.
• [815] EEF1D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma.Clin Sci (Lond). 2016 May 1;130(10):785-99. doi: 10.1042/CS20150646. Epub 2016 Jan 28.
• [816] Ephrin-A1 is up-regulated by hypoxia in cancer cells and promotes angiogenesis of HUVECs through a coordinated cross-talk with eNOS.PLoS One. 2013 Sep 9;8(9):e74464. doi: 10.1371/journal.pone.0074464. eCollection 2013.
• [817] The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis.J Clin Pathol. 2011 Jan;64(1):25-9. doi: 10.1136/jcp.2010.082404. Epub 2010 Oct 27.
• [818] EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma.Cancer Lett. 2009 Feb 8;274(1):25-32. doi: 10.1016/j.canlet.2008.08.021. Epub 2008 Sep 26.
• [819] EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.PLoS One. 2015 Jul 1;10(7):e0132134. doi: 10.1371/journal.pone.0132134. eCollection 2015.
• [820] Differential expression of the human alpha-enolase gene in oral epithelium and squamous cell carcinoma.Cancer Sci. 2007 Apr;98(4):499-505. doi: 10.1111/j.1349-7006.2007.00411.x. Epub 2007 Jan 31.
• [821] Are XPD and XPG gene variants related to the mechanism of oral squamous cell carcinoma?.Cell Mol Biol (Noisy-le-grand). 2018 Dec 31;64(15):94-99.
• [822] Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.J Cancer Res Clin Oncol. 2013 Apr;139(4):533-42. doi: 10.1007/s00432-012-1356-2. Epub 2012 Dec 4.
• [823] Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.PLoS One. 2015 Oct 14;10(10):e0138801. doi: 10.1371/journal.pone.0138801. eCollection 2015.
• [824] Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas.J Gen Virol. 2011 Feb;92(Pt 2):395-401. doi: 10.1099/vir.0.025064-0. Epub 2010 Nov 3.
• [825] Friend leukaemia insertion (Fli)-1 is a prediction marker candidate for radiotherapy resistant oral squamous cell carcinoma.Int J Oral Maxillofac Surg. 2010 Nov;39(11):1115-9. doi: 10.1016/j.ijom.2010.02.027. Epub 2010 Aug 14.
• [826] Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas.Int J Cancer. 2009 Jan 15;124(2):272-9. doi: 10.1002/ijc.23944.
• [827] Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.Mol Cancer. 2010 Jan 5;9:1. doi: 10.1186/1476-4598-9-1.
• [828] Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.Clin Oral Investig. 2017 Jun;21(5):1777-1788. doi: 10.1007/s00784-016-1946-5. Epub 2016 Aug 23.
• [829] Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.Carcinogenesis. 2013 Mar;34(3):513-21. doi: 10.1093/carcin/bgs363. Epub 2012 Nov 19.
• [830] Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer.Biomarkers. 2013 Jun;18(4):297-303. doi: 10.3109/1354750X.2013.773380. Epub 2013 Apr 29.
• [831] Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25.
• [832] Nuclear entrapment of p33ING1b by inhibition of exportin-1: A trigger of apoptosis in head and neck squamous cell cancer.Cell Mol Biol (Noisy-le-grand). 2018 Apr 30;64(5):66-72.
• [833] Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.Oncotarget. 2013 Nov;4(11):2067-79. doi: 10.18632/oncotarget.1542.
• [834] Factors involved in the cisplatin resistance of KCP? human epidermoid carcinoma cells.Oncol Rep. 2014 Feb;31(2):719-26. doi: 10.3892/or.2013.2896. Epub 2013 Dec 5.
• [835] HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.Oncogene. 2018 Mar;37(12):1654-1668. doi: 10.1038/s41388-017-0083-1. Epub 2018 Jan 16.
• [836] Type XVIII Collagen Modulates Keratohyalin Granule Formation and Keratinization in Oral Mucosa.Int J Mol Sci. 2019 Sep 24;20(19):4739. doi: 10.3390/ijms20194739.
• [837] Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.Exp Dermatol. 2013 May;22(5):318-22. doi: 10.1111/exd.12118. Epub 2013 Mar 12.
• [838] FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.Virchows Arch. 2017 Sep;471(3):337-345. doi: 10.1007/s00428-017-2190-3. Epub 2017 Jul 18.
• [839] Squamous cell carcinoma arising in mature cystic teratoma of the ovary: an immunohistochemical analysis of its tumorigenesis.Histopathology. 2007 Jul;51(1):98-104. doi: 10.1111/j.1365-2559.2007.02727.x. Epub 2007 Jun 1.
• [840] Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.Asian Pac J Cancer Prev. 2015;16(4):1599-603. doi: 10.7314/apjcp.2015.16.4.1599.
• [841] Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas.Respir Res. 2014 Dec 31;15(1):160. doi: 10.1186/s12931-014-0160-8.
• [842] LTBP3 promotes early metastatic events during cancer cell dissemination.Oncogene. 2018 Apr;37(14):1815-1829. doi: 10.1038/s41388-017-0075-1. Epub 2018 Jan 19.
• [843] MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation.Anticancer Res. 2014 Dec;34(12):7021-7.
• [844] Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.Hum Pathol. 2013 Dec;44(12):2799-805. doi: 10.1016/j.humpath.2013.07.031. Epub 2013 Oct 14.
• [845] Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.PLoS One. 2013;8(3):e54643. doi: 10.1371/journal.pone.0054643. Epub 2013 Mar 5.
• [846] Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma.Br J Cancer. 2013 Apr 16;108(7):1460-9. doi: 10.1038/bjc.2013.27. Epub 2013 Mar 19.
• [847] AF1q enhancement of gamma irradiation-induced apoptosis by up-regulation of BAD expression via NF-kappaB in human squamous carcinoma A431 cells.Oncol Rep. 2010 Aug;24(2):547-54.
• [848] Microarray-assisted pathway analysis identifies MT1X & NFB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.PLoS One. 2012;7(12):e51413. doi: 10.1371/journal.pone.0051413. Epub 2012 Dec 10.
• [849] Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.Sci Rep. 2015 Mar 3;5:8649. doi: 10.1038/srep08649.
• [850] Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.Anticancer Res. 2009 Jul;29(7):2519-24.
• [851] Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma.Tumour Biol. 2015 Sep;36(9):7099-105. doi: 10.1007/s13277-015-3419-x. Epub 2015 Apr 16.
• [852] MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.Oncotarget. 2016 Sep 13;7(37):59987-60004. doi: 10.18632/oncotarget.11046.
• [853] Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.World J Surg Oncol. 2017 Aug 8;15(1):151. doi: 10.1186/s12957-017-1213-5.
• [854] NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.Clin Cancer Res. 2015 Jun 1;21(11):2499-505. doi: 10.1158/1078-0432.CCR-14-2206. Epub 2015 Mar 4.
• [855] MicroRNA-92b promotes tumor growth and activation of NF-B signaling via regulation of NLK in oral squamous cell carcinoma.Oncol Rep. 2015 Dec;34(6):2961-8. doi: 10.3892/or.2015.4323.
• [856] Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma.J Thorac Oncol. 2007 Sep;2(9):796-801. doi: 10.1097/JTO.0b013e318145af5e.
• [857] Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma.Oncol Rep. 2015 Dec;34(6):3077-87. doi: 10.3892/or.2015.4271. Epub 2015 Sep 11.
• [858] Expression of GLTSCR2/Pict-1 in squamous cell carcinomas of the skin.Arch Dermatol Res. 2013 Nov;305(9):797-804. doi: 10.1007/s00403-013-1388-8. Epub 2013 Aug 13.
• [859] Inhibition of Nox1 induces apoptosis by attenuating the AKT signaling pathway in oral squamous cell carcinoma cell lines.Oncol Rep. 2016 Nov;36(5):2991-2998. doi: 10.3892/or.2016.5068. Epub 2016 Sep 5.
• [860] Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.PLoS One. 2015 Nov 10;10(11):e0142252. doi: 10.1371/journal.pone.0142252. eCollection 2015.
• [861] Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell line.Exp Cell Res. 2012 Mar 10;318(5):593-602. doi: 10.1016/j.yexcr.2012.01.012. Epub 2012 Jan 13.
• [862] Identification of novel DNA methylation markers in cervical cancer.Int J Cancer. 2008 Jul 1;123(1):161-7. doi: 10.1002/ijc.23519.
• [863] PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia.Cancer Res. 2014 Nov 1;74(21):6306-17. doi: 10.1158/0008-5472.CAN-14-0749. Epub 2014 Sep 11.
• [864] Expression of Radioresistant Gene PEG10 in OSCC Patients and Its Prognostic Significance.Asian Pac J Cancer Prev. 2017 Jul 25;18(6):1513-1518. doi: 10.22034/APJCP.2017.18.6.1513.
• [865] Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.PLoS Genet. 2010 Oct 21;6(10):e1001168. doi: 10.1371/journal.pgen.1001168.
• [866] Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.Future Oncol. 2018 Feb;14(5):449-459. doi: 10.2217/fon-2017-0348. Epub 2018 Jan 11.
• [867] Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration.J Cancer. 2017 Jul 5;8(11):1943-1951. doi: 10.7150/jca.19278. eCollection 2017.
• [868] Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma.Int J Biochem Cell Biol. 2016 Aug;77(Pt A):155-164. doi: 10.1016/j.biocel.2016.05.016. Epub 2016 Jun 4.
• [869] Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.J Oral Pathol Med. 2017 Nov;46(10):998-1003. doi: 10.1111/jop.12609. Epub 2017 Jul 24.
• [870] Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2277-2285. doi: 10.1007/s00417-017-3738-2. Epub 2017 Jul 24.
• [871] MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas.Mol Med Rep. 2012 Oct;6(4):705-8. doi: 10.3892/mmr.2012.979. Epub 2012 Jul 5.
• [872] Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.Korean J Intern Med. 2011 Sep;26(3):304-13. doi: 10.3904/kjim.2011.26.3.304. Epub 2011 Sep 13.
• [873] Human papillomavirus genotyping among women with cervical abnormalities in Ulaanbaatar, Mongolia.Int J Infect Dis. 2018 Dec;77:8-13. doi: 10.1016/j.ijid.2018.09.018. Epub 2018 Sep 24.
• [874] Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.Tumour Biol. 2015 Dec;36(12):9829-37. doi: 10.1007/s13277-015-3758-7. Epub 2015 Jul 11.
• [875] Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.Oncotarget. 2015 Sep 8;6(26):21950-63. doi: 10.18632/oncotarget.4277.
• [876] Significant anti-invasive activities of -mangostin from the mangosteen pericarp on two human skin cancer cell lines.Anticancer Res. 2012 Sep;32(9):3805-16.
• [877] The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas.Cancers (Basel). 2019 Sep 11;11(9):1347. doi: 10.3390/cancers11091347.
• [878] RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.Oncogene. 2010 Jan 7;29(1):45-55. doi: 10.1038/onc.2009.307. Epub 2009 Oct 5.
• [879] Heterogeneous nuclear ribonucleoprotein G, nitric oxide, and oral carcinogenesis.Nitric Oxide. 2008 Sep;19(2):125-32. doi: 10.1016/j.niox.2008.04.012. Epub 2008 Apr 24.
• [880] Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis.J Invest Dermatol. 2016 Jun;136(6):1255-1266. doi: 10.1016/j.jid.2016.01.039. Epub 2016 Mar 2.
• [881] NRSF/REST regulates the mTOR signaling pathway in oral cancer cells.Oncol Rep. 2015 Mar;33(3):1459-64. doi: 10.3892/or.2014.3675. Epub 2014 Dec 18.
• [882] Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.J Oral Pathol Med. 2010 Jul;39(6):470-6. doi: 10.1111/j.1600-0714.2009.00869.x. Epub 2010 Apr 13.
• [883] Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling.Cancer Res. 2014 Apr 1;74(7):2082-93. doi: 10.1158/0008-5472.CAN-12-0452. Epub 2014 Feb 13.
• [884] Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line.Carcinogenesis. 2011 Jun;32(6):935-43. doi: 10.1093/carcin/bgr059. Epub 2011 Mar 31.
• [885] S100A16 is a prognostic marker for colorectal cancer.J Surg Oncol. 2018 Feb;117(2):275-283. doi: 10.1002/jso.24822. Epub 2017 Sep 6.
• [886] Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos.Genes Dev. 2013 Sep 15;27(18):1959-73. doi: 10.1101/gad.223339.113. Epub 2013 Sep 12.
• [887] Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.BMC Cancer. 2016 Aug 23;16(1):676. doi: 10.1186/s12885-016-2739-6.
• [888] Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation.Oncol Rep. 2013 May;29(5):1701-6. doi: 10.3892/or.2013.2318. Epub 2013 Mar 1.
• [889] Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.Acta Oncol. 2010 Oct;49(7):895-905. doi: 10.3109/02841861003614343.
• [890] Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China.Cancer Causes Control. 2007 Mar;18(2):143-52. doi: 10.1007/s10552-006-0097-4. Epub 2007 Jan 6.
• [891] Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.Int J Cancer. 2012 Dec 1;131(11):2499-508. doi: 10.1002/ijc.27550. Epub 2012 Apr 9.
• [892] SNX3-dependent regulation of epidermal growth factor receptor (EGFR) trafficking and degradation by aspirin in epidermoid carcinoma (A-431) cells.Cell Mol Life Sci. 2012 May;69(9):1505-21. doi: 10.1007/s00018-011-0887-z. Epub 2011 Dec 11.
• [893] Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility to wound- and carcinogen-induced tumorigenesis.Cancer Res. 2010 Nov 1;70(21):8507-16. doi: 10.1158/0008-5472.CAN-10-1213. Epub 2010 Oct 19.
• [894] SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.J Cell Mol Med. 2018 Jul;22(7):3582-3594. doi: 10.1111/jcmm.13638. Epub 2018 Apr 18.
• [895] Trichohyalin-like 1 protein, a member of fused S100 proteins, is expressed in normal and pathologic human skin.Biochem Biophys Res Commun. 2013 Mar 1;432(1):66-72. doi: 10.1016/j.bbrc.2013.01.084. Epub 2013 Jan 29.
• [896] TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma.Cancer Cell Int. 2018 Nov 12;18:178. doi: 10.1186/s12935-018-0675-z. eCollection 2018.
• [897] The potential functions of FAM46C in oral squamous cell carcinoma.Onco Targets Ther. 2018 Dec 10;11:8915-8923. doi: 10.2147/OTT.S185244. eCollection 2018.
• [898] Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.Int J Oral Maxillofac Surg. 2009 Jul;38(7):779-84. doi: 10.1016/j.ijom.2009.02.021. Epub 2009 Apr 25.
• [899] Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.Cancer Res. 2009 Dec 15;69(24):9439-47. doi: 10.1158/0008-5472.CAN-09-2976.
• [900] Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.Cell Oncol (Dordr). 2013 Jun;36(3):233-45. doi: 10.1007/s13402-013-0131-y. Epub 2013 Mar 26.
• [901] Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.Oncotarget. 2015 Sep 8;6(26):22375-96. doi: 10.18632/oncotarget.4296.
• [902] Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers.Mol Cancer. 2008 Jun 3;7:47. doi: 10.1186/1476-4598-7-47.
• [903] Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.Int J Cancer. 2017 Dec 1;141(11):2318-2328. doi: 10.1002/ijc.30915. Epub 2017 Aug 18.
• [904] Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression.Mol Carcinog. 2015 Oct;54(10):1026-36. doi: 10.1002/mc.22171. Epub 2014 May 5.
• [905] Expression of ADAM15 in lung carcinomas.Virchows Arch. 2005 Apr;446(4):421-9. doi: 10.1007/s00428-004-1193-z. Epub 2005 Mar 9.
• [906] ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.J Exp Clin Cancer Res. 2019 Jul 17;38(1):315. doi: 10.1186/s13046-019-1300-2.
• [907] Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma.Cancer Lett. 2006 Feb 28;233(2):265-70. doi: 10.1016/j.canlet.2005.03.018.
• [908] Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.Carcinogenesis. 2018 Mar 8;39(3):336-346. doi: 10.1093/carcin/bgx113.
• [909] Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.Biochem Biophys Res Commun. 2019 Jan 29;509(1):82-88. doi: 10.1016/j.bbrc.2018.12.066. Epub 2018 Dec 23.
• [910] Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):111-7. doi: 10.1158/1055-9965.EPI-07-0407.
• [911] Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.Asia Pac J Clin Oncol. 2017 Oct;13(5):e212-e223. doi: 10.1111/ajco.12586. Epub 2016 Aug 12.
• [912] Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.J Oral Pathol Med. 2015 Feb;44(2):109-14. doi: 10.1111/jop.12206. Epub 2014 Jul 24.
• [913] Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.Oncotarget. 2016 Mar 8;7(10):10879-90. doi: 10.18632/oncotarget.7681.
• [914] Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components.Cell Tissue Res. 2001 Dec;306(3):399-408. doi: 10.1007/s004410100462. Epub 2001 Oct 23.
• [915] Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer.Lung Cancer. 2001 Oct;34(1):53-7. doi: 10.1016/s0169-5002(01)00213-6.
• [916] Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.J Biol Chem. 2006 May 19;281(20):14026-40. doi: 10.1074/jbc.M507734200. Epub 2006 Mar 24.
• [917] ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.Cell Death Differ. 2020 Jun;27(6):1981-1997. doi: 10.1038/s41418-019-0475-6. Epub 2019 Dec 12.
• [918] Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):885-94. doi: 10.1080/15287390701285915.
• [919] Identification of differentially expressed genes in chemically induced skin tumors.Mol Carcinog. 1997 Sep;20(1):88-98.
• [920] Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.Cancer. 2007 Aug 15;110(4):867-75. doi: 10.1002/cncr.22861.
• [921] A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin.Am J Pathol. 2006 Apr;168(4):1354-64. doi: 10.2353/ajpath.2006.050871.
• [922] Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.J Dermatol Sci. 2008 Sep;51(3):210-5. doi: 10.1016/j.jdermsci.2008.04.008. Epub 2008 Jun 10.
• [923] Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.Oncol Rep. 2007 Jan;17(1):73-9.
• [924] Evaluation of Cd8+ and natural killer cells defense in oral and oropharyngeal squamous cell carcinoma.J Craniomaxillofac Surg. 2019 Apr;47(4):676-681. doi: 10.1016/j.jcms.2019.01.036. Epub 2019 Feb 1.
• [925] Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).Pathol Oncol Res. 2012 Oct;18(4):929-37. doi: 10.1007/s12253-012-9523-y. Epub 2012 Mar 28.
• [926] Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer.Arch Dermatol Res. 2004 Jul;296(2):59-66. doi: 10.1007/s00403-004-0481-4. Epub 2004 Jun 15.
• [927] Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.Ann Surg Oncol. 2013 Dec;20 Suppl 3(0 3):S701-8. doi: 10.1245/s10434-013-3184-2. Epub 2013 Aug 1.
• [928] Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.J Exp Clin Cancer Res. 2016 Jun 13;35(1):92. doi: 10.1186/s13046-016-0355-6.
• [929] Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.Genes Chromosomes Cancer. 2000 Feb;27(2):169-76.
• [930] Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium.Oral Oncol. 2001 Apr;37(3):225-33. doi: 10.1016/s1368-8375(00)00087-7.
• [931] Wnt/-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.EMBO J. 2013 Jul 17;32(14):1977-89. doi: 10.1038/emboj.2013.127. Epub 2013 Jun 4.
• [932] p63 Transcriptionally regulates BNC1, a Pol I and Pol II transcription factor that regulates ribosomal biogenesis and epithelial differentiation.Eur J Cancer. 2012 Jun;48(9):1401-6. doi: 10.1016/j.ejca.2011.06.032. Epub 2011 Jul 7.
• [933] BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.Surg Today. 2019 Feb;49(2):158-169. doi: 10.1007/s00595-018-1711-2. Epub 2018 Sep 4.
• [934] BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.Int J Mol Sci. 2015 Jul 3;16(7):15104-17. doi: 10.3390/ijms160715104.
• [935] Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.Int J Mol Med. 2006 Oct;18(4):547-57.
• [936] The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep. 2007 Sep;18(3):601-9.
• [937] CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.J Invest Dermatol. 2017 Feb;137(2):506-512. doi: 10.1016/j.jid.2016.09.027. Epub 2016 Oct 7.
• [938] Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.Cancer Cell Int. 2017 Nov 21;17:107. doi: 10.1186/s12935-017-0481-z. eCollection 2017.
• [939] CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.PLoS One. 2009 Jun 24;4(6):e6030. doi: 10.1371/journal.pone.0006030.
• [940] Tumor immune escape by the loss of homeostatic chemokine expression.Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19055-60. doi: 10.1073/pnas.0705673104. Epub 2007 Nov 19.
• [941] Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.Lung Cancer. 2011 Nov;74(2):164-9. doi: 10.1016/j.lungcan.2011.03.005. Epub 2011 Apr 22.
• [942] Dysregulation of -catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck.Clin Otolaryngol. 2019 May;44(3):263-272. doi: 10.1111/coa.13281. Epub 2019 Feb 5.
• [943] MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10332-10342. doi: 10.26355/eurrev_201912_19671.
• [944] Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.Br J Cancer. 2006 Apr 10;94(7):1041-4. doi: 10.1038/sj.bjc.6603036.
• [945] Identification of candidate radioresistant genes in human squamous cell carcinoma cells through gene expression analysis using DNA microarrays.Oncol Rep. 2005 Nov;14(5):1293-8.
• [946] CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.Sci Rep. 2019 Nov 6;9(1):16317. doi: 10.1038/s41598-019-50694-z.
• [947] Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma.Clin Cancer Res. 2005 Jun 1;11(11):4012-21. doi: 10.1158/1078-0432.CCR-05-0087.
• [948] Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy.Int J Gynecol Cancer. 2013 Jan;23(1):184-92. doi: 10.1097/IGC.0b013e31827a2003.
• [949] Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic.Oncotarget. 2017 Feb 28;8(9):14416-14427. doi: 10.18632/oncotarget.14796.
• [950] Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy.Yonsei Med J. 2011 May;52(3):463-8. doi: 10.3349/ymj.2011.52.3.463.
• [951] Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions.Anticancer Res. 2008 Nov-Dec;28(6A):3763-9.
• [952] CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.Oncotarget. 2017 Mar 21;8(12):19768-19779. doi: 10.18632/oncotarget.15519.
• [953] T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.Genes Cells. 2007 Jun;12(6):787-96. doi: 10.1111/j.1365-2443.2007.01092.x.
• [954] miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion.J Cell Biochem. 2011 Mar;112(3):872-80. doi: 10.1002/jcb.22995.
• [955] Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.Pathol Oncol Res. 2014 Oct;20(4):923-9. doi: 10.1007/s12253-014-9775-9. Epub 2014 Apr 9.
• [956] The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.Dis Esophagus. 2017 Mar 1;30(3):1-9. doi: 10.1093/dote/dow001.
• [957] Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?.J Clin Pathol. 2013 Feb;66(2):109-12. doi: 10.1136/jclinpath-2012-201138. Epub 2012 Oct 26.
• [958] RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma.Oncotarget. 2015 Dec 22;6(41):43620-34. doi: 10.18632/oncotarget.6204.
• [959] CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas.Head Neck. 2001 Feb;23(2):104-12. doi: 10.1002/1097-0347(200102)23:2<104::aid-hed1005>3.0.co;2-0.
• [960] Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity.Oncol Rep. 2006 Nov;16(5):1071-5.
• [961] Human papillomavirus types 16 E1 mRNA is transcribed from P14 early promoter in cervical neoplasms.Virology. 2016 Jan 15;488:196-201. doi: 10.1016/j.virol.2015.11.015. Epub 2015 Dec 2.
• [962] CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC.Cancers (Basel). 2019 Oct 17;11(10):1582. doi: 10.3390/cancers11101582.
• [963] Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.
• [964] Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.Respir Med. 2015 Jan;109(1):131-6. doi: 10.1016/j.rmed.2014.11.004. Epub 2014 Nov 21.
• [965] American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.Ann Diagn Pathol. 2020 Feb;44:151419. doi: 10.1016/j.anndiagpath.2019.151419. Epub 2019 Nov 15.
• [966] Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).J Cancer Res Clin Oncol. 2019 Sep;145(9):2285-2292. doi: 10.1007/s00432-019-02989-x. Epub 2019 Aug 1.
• [967] Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.Int J Oral Maxillofac Surg. 2008 Sep;37(9):847-52. doi: 10.1016/j.ijom.2008.05.017. Epub 2008 Jul 11.
• [968] High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 2001 Oct 1;61(19):7044-7.
• [969] Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.J Immunol. 2003 May 15;170(10):4980-5. doi: 10.4049/jimmunol.170.10.4980.
• [970] Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.Hum Pathol. 2018 Aug;78:63-71. doi: 10.1016/j.humpath.2018.04.006. Epub 2018 Apr 22.
• [971] Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma.Br J Cancer. 2006 Mar 13;94(5):698-709. doi: 10.1038/sj.bjc.6602986.
• [972] CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.Histol Histopathol. 2011 Jan;26(1):71-7. doi: 10.14670/HH-26.71.
• [973] CLDN1 induces autophagy to promote proliferation and metastasis of esophageal squamous carcinoma through AMPK/STAT1/ULK1 signaling.J Cell Physiol. 2020 Mar;235(3):2245-2259. doi: 10.1002/jcp.29133. Epub 2019 Sep 9.
• [974] CLIC4 is a tumor suppressor for cutaneous squamous cell cancer.Carcinogenesis. 2012 May;33(5):986-95. doi: 10.1093/carcin/bgs115. Epub 2012 Mar 1.
• [975] Research on circadian clock genes in non-small-cell lung carcinoma.Chronobiol Int. 2019 Jun;36(6):739-750. doi: 10.1080/07420528.2018.1509080. Epub 2019 Apr 24.
• [976] The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3 pathway in non-small cell lung cancer.Cell Biol Int. 2018 Aug;42(8):959-964. doi: 10.1002/cbin.10961. Epub 2018 Apr 17.
• [977] Collagen type XI 1 facilitates head and neck squamous cell cancer growth and invasion.Br J Cancer. 2013 Dec 10;109(12):3049-56. doi: 10.1038/bjc.2013.624. Epub 2013 Nov 14.
• [978] Aberrant expression of a hemidesmosomal protein, bullous pemphigoid antigen 2, in human squamous cell carcinoma.Lab Invest. 1996 Oct;75(4):589-600.
• [979] Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model.Oral Oncol. 2008 Dec;44(12):1118-26. doi: 10.1016/j.oraloncology.2008.01.017. Epub 2008 May 16.
• [980] The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma.Ann Surg Oncol. 2008 Feb;15(2):555-65. doi: 10.1245/s10434-007-9592-4. Epub 2007 Oct 23.
• [981] ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.Diagn Pathol. 2017 Jan 21;12(1):12. doi: 10.1186/s13000-017-0600-0.
• [982] Epidermal differentiation enhances CRABP II expression in human skin.J Invest Dermatol. 1994 Dec;103(6):785-90. doi: 10.1111/1523-1747.ep12413037.
• [983] Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.Pathol Int. 2015 Sep;65(9):476-85. doi: 10.1111/pin.12332. Epub 2015 Jul 27.
• [984] Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma.Clin Oral Investig. 2015 Dec;19(9):2273-83. doi: 10.1007/s00784-015-1467-7. Epub 2015 Apr 8.
• [985] Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.Cancer Biol Ther. 2009 May;8(10):907-16. doi: 10.4161/cbt.8.10.8132. Epub 2009 May 9.
• [986] Cloning and characterization of a tumor-associated antigen, beta-casein-like protein.Biochem Biophys Res Commun. 2001 Jun 8;284(2):340-5. doi: 10.1006/bbrc.2001.4966.
• [987] Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.Oncotarget. 2017 Dec 20;9(18):14084-14098. doi: 10.18632/oncotarget.23505. eCollection 2018 Mar 6.
• [988] [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].Zhonghua Yi Xue Za Zhi. 2004 Mar 17;84(6):464-8.
• [989] Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma.Cancers (Basel). 2019 Nov 7;11(11):1750. doi: 10.3390/cancers11111750.
• [990] -catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1.Sci Signal. 2011 May 24;4(174):ra33. doi: 10.1126/scisignal.2001823.
• [991] -Catulin marks the invasion front of squamous cell carcinoma and is important for tumor cell metastasis.Mol Cancer Res. 2012 Jul;10(7):892-903. doi: 10.1158/1541-7786.MCR-12-0169. Epub 2012 May 30.
• [992] Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene.Br J Dermatol. 2012 Oct;167(4):929-36. doi: 10.1111/j.1365-2133.2012.11075.x. Epub 2012 Sep 7.
• [993] Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer.Am J Respir Cell Mol Biol. 2013 Sep;49(3):418-25. doi: 10.1165/rcmb.2012-0396OC.
• [994] Down-regulation of CXCL5 inhibits squamous carcinogenesis.Cancer Res. 2006 Apr 15;66(8):4279-84. doi: 10.1158/0008-5472.CAN-05-4398.
• [995] CYB5D2 displays tumor suppression activities towards cervical cancer.Biochim Biophys Acta. 2016 Apr;1862(4):556-565. doi: 10.1016/j.bbadis.2015.12.013. Epub 2015 Dec 12.
• [996] Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies.Head Neck. 2017 Aug;39(8):1621-1630. doi: 10.1002/hed.24803. Epub 2017 May 12.
• [997] Phospho-Np63-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure.FEBS Lett. 2015 May 22;589(12):1352-8. doi: 10.1016/j.febslet.2015.04.020. Epub 2015 Apr 21.
• [998] DAP1 high expression increases risk of lymph node metastases in squamous cell carcinoma of the oral cavity.Genet Mol Res. 2015 Sep 8;14(3):10515-23. doi: 10.4238/2015.September.8.13.
• [999] Functional variants in DCAF4 associated with lung cancer risk in European populations.Carcinogenesis. 2017 May 1;38(5):541-551. doi: 10.1093/carcin/bgx033.
• [1000] DCC promoter hypermethylation in esophageal squamous cell carcinoma.Int J Cancer. 2008 Jun 1;122(11):2498-502. doi: 10.1002/ijc.23434.
• [1001] Serial transplantation in SCID mice of an epidermodysplasia verruciformis-associated squamous cell carcinoma without alteration of its histological and virological features.Virology. 1996 Mar 1;217(1):380-3. doi: 10.1006/viro.1996.0127.
• [1002] Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.Nat Commun. 2013;4:2873. doi: 10.1038/ncomms3873.
• [1003] Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.Oncotarget. 2016 Dec 20;7(51):85097-85108. doi: 10.18632/oncotarget.13197.
• [1004] Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.PLoS One. 2012;7(7):e40754. doi: 10.1371/journal.pone.0040754. Epub 2012 Jul 13.
• [1005] Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma.Int J Cancer. 2007 Apr 15;120(8):1618-26. doi: 10.1002/ijc.22306.
• [1006] Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.Int J Mol Med. 2005 Apr;15(4):585-9.
• [1007] Altered expression of dermokine in skin disorders.J Eur Acad Dermatol Venereol. 2013 Jul;27(7):867-75. doi: 10.1111/j.1468-3083.2012.04598.x. Epub 2012 May 31.
• [1008] Genome-wide identification of chromatin-enriched RNA reveals that unspliced dentin matrix protein-1 mRNA regulates cell proliferation in squamous cell carcinoma.Biochem Biophys Res Commun. 2018 Jan 15;495(3):2303-2309. doi: 10.1016/j.bbrc.2017.12.136. Epub 2017 Dec 24.
• [1009] Non-viral suicide gene therapy in cervical, oral and pharyngeal carcinoma cells with CMV- and EEV-plasmids.J Gene Med. 2018 Oct;20(10-11):e3054. doi: 10.1002/jgm.3054. Epub 2018 Oct 3.
• [1010] A putative oncogenic role for MPP11 in head and neck squamous cell cancer.Cancer Res. 2000 Oct 1;60(19):5529-35.
• [1011] Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.Oral Oncol. 2012 Jun;48(6):523-9. doi: 10.1016/j.oraloncology.2012.01.010. Epub 2012 Feb 15.
• [1012] Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.J Biol Chem. 2011 Mar 18;286(11):9127-35. doi: 10.1074/jbc.M110.191361. Epub 2010 Dec 16.
• [1013] Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer.Hum Pathol. 2009 Sep;40(9):1320-9. doi: 10.1016/j.humpath.2009.02.002. Epub 2009 Apr 22.
• [1014] Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One. 2010 Nov 12;5(11):e13974. doi: 10.1371/journal.pone.0013974.
• [1015] Coamplification and cooperation: toward identifying biologically relevant oncogenes.Clin Cancer Res. 2013 Oct 15;19(20):5549-51. doi: 10.1158/1078-0432.CCR-13-2117. Epub 2013 Sep 4.
• [1016] Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach.Pathol Int. 2000 Sep;50(9):690-5. doi: 10.1046/j.1440-1827.2000.01105.x.
• [1017] RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.Mol Cancer Ther. 2015 Aug;14(8):1939-50. doi: 10.1158/1535-7163.MCT-15-0076. Epub 2015 May 27.
• [1018] Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma.J Transl Med. 2014 May 6;12:112. doi: 10.1186/1479-5876-12-112.
• [1019] Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.Cancer Lett. 2019 Oct 1;461:56-64. doi: 10.1016/j.canlet.2019.07.005. Epub 2019 Jul 15.
• [1020] Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Oncol Rep. 2007 Oct;18(4):981-5.
• [1021] Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.Mol Carcinog. 2017 Mar;56(3):1189-1196. doi: 10.1002/mc.22574. Epub 2016 Nov 1.
• [1022] Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.J Oral Pathol Med. 2004 Nov;33(10):589-94. doi: 10.1111/j.1600-0714.2004.00209.x.
• [1023] Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.Eur J Cancer. 2018 Sep;101:165-180. doi: 10.1016/j.ejca.2018.07.001. Epub 2018 Aug 1.
• [1024] Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma.Eur Arch Otorhinolaryngol. 1995;252(7):433-9. doi: 10.1007/BF00167315.
• [1025] The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.Medicine (Baltimore). 2019 Aug;98(32):e16764. doi: 10.1097/MD.0000000000016764.
• [1026] Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma.Asia Pac J Clin Oncol. 2012 Dec;8(4):e77-81. doi: 10.1111/j.1743-7563.2011.01459.x. Epub 2012 Jan 12.
• [1027] Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.Int J Med Sci. 2017 Sep 4;14(11):1094-1100. doi: 10.7150/ijms.20414. eCollection 2017.
• [1028] SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.J Clin Invest. 2014 Apr;124(4):1636-45. doi: 10.1172/JCI71545. Epub 2014 Mar 3.
• [1029] Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.PLoS One. 2016 Oct 20;11(10):e0164870. doi: 10.1371/journal.pone.0164870. eCollection 2016.
• [1030] Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.Pathol Res Pract. 2019 Apr;215(4):772-778. doi: 10.1016/j.prp.2019.01.019. Epub 2019 Jan 14.
• [1031] Np63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.Nucleic Acids Res. 2016 Apr 20;44(7):3204-18. doi: 10.1093/nar/gkw036. Epub 2016 Jan 26.
• [1032] Fructose?,6bisphosphatase? decrease may promote carcinogenesis and chemoresistance in cervical cancer.Mol Med Rep. 2017 Dec;16(6):8563-8571. doi: 10.3892/mmr.2017.7665. Epub 2017 Sep 29.
• [1033] Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity.Genome. 2004 Oct;47(5):931-46. doi: 10.1139/g04-043.
• [1034] First hints for a correlation between amplification of the Int-2 gene and infection with human papillomavirus in head and neck squamous cell carcinomas.J Oral Pathol Med. 2000 Oct;29(9):432-7. doi: 10.1034/j.1600-0714.2000.290903.x.
• [1035] FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas.Oncol Lett. 2018 Jul;16(1):809-814. doi: 10.3892/ol.2018.8739. Epub 2018 May 18.
• [1036] Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.Genes Chromosomes Cancer. 2012 Jun;51(6):618-29. doi: 10.1002/gcc.21950. Epub 2012 Mar 2.
• [1037] Thymic carcinoma: is it a separate entity? From molecular to clinical evidence.Thorac Surg Clin. 2011 Feb;21(1):25-31. v-vi. doi: 10.1016/j.thorsurg.2010.08.010.
• [1038] TGF induces stemness through non-canonical AKT-FOXO3a axis in oral squamous cell carcinoma.EBioMedicine. 2019 Oct;48:70-80. doi: 10.1016/j.ebiom.2019.09.027. Epub 2019 Oct 16.
• [1039] Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.Epigenetics. 2018;13(3):214-227. doi: 10.1080/15592294.2016.1229730. Epub 2018 Apr 18.
• [1040] Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas.J Formos Med Assoc. 2017 Oct;116(10):782-789. doi: 10.1016/j.jfma.2016.12.003. Epub 2017 Jan 12.
• [1041] Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.Sci Rep. 2017 Aug 29;7(1):9830. doi: 10.1038/s41598-017-10366-2.
• [1042] Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.Pathol Int. 2019 Feb;69(2):76-85. doi: 10.1111/pin.12764. Epub 2019 Feb 6.
• [1043] Silver nanoparticles Clinacanthus Nutans leaves extract induced apoptosis towards oral squamous cell carcinoma cell lines.Artif Cells Nanomed Biotechnol. 2018;46(sup2):131-139. doi: 10.1080/21691401.2018.1452750. Epub 2018 Mar 21.
• [1044] Muscle-Specific FXR1 Isoforms in Squamous Cell Cancer.Trends Cancer. 2019 Feb;5(2):82-84. doi: 10.1016/j.trecan.2018.12.001. Epub 2018 Dec 21.
• [1045] Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.Oncology. 2004;67(1):73-80. doi: 10.1159/000080289.
• [1046] Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma.World J Surg Oncol. 2018 Jan 31;16(1):20. doi: 10.1186/s12957-018-1308-7.
• [1047] Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.Glycobiology. 1999 Jan;9(1):43-52. doi: 10.1093/glycob/9.1.43.
• [1048] The expression pattern of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus.Pathobiology. 2005;72(3):139-45. doi: 10.1159/000084117.
• [1049] Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma.Clin Oral Investig. 2020 Aug;24(8):2673-2682. doi: 10.1007/s00784-019-03129-y. Epub 2019 Nov 9.
• [1050] Expression and chromosomal localization of the gene for the human transcriptional repressor GCF.J Biol Chem. 1992 Jan 25;267(3):1689-94.
• [1051] Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.Mol Carcinog. 2016 May;55(5):499-513. doi: 10.1002/mc.22297. Epub 2015 Mar 1.
• [1052] Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck.Virchows Arch. 2009 May;454(5):549-55. doi: 10.1007/s00428-009-0771-5. Epub 2009 Apr 21.
• [1053] GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.Oncol Rep. 2017 May;37(5):2652-2662. doi: 10.3892/or.2017.5573. Epub 2017 Apr 11.
• [1054] Regulatory role for Krppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.J Invest Dermatol. 2006 Jan;126(1):49-60. doi: 10.1038/sj.jid.5700018.
• [1055] Heterotrimeric G-protein alpha-12 (G12) subunit promotes oral cancer metastasis.Oncotarget. 2014 Oct 30;5(20):9626-40. doi: 10.18632/oncotarget.2437.
• [1056] Alterations of GPI transamidase subunits in head and neck squamous carcinoma.Mol Cancer. 2007 Nov 21;6:74. doi: 10.1186/1476-4598-6-74.
• [1057] Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.
• [1058] Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.J Oral Pathol Med. 2013 Nov;42(10):761-8. doi: 10.1111/jop.12077. Epub 2013 May 7.
• [1059] Depletion of phospholipid hydroperoxide glutathione peroxidase up-regulates arachidonate metabolism by 12S-lipoxygenase and cyclooxygenase 1 in human epidermoid carcinoma A431 cells.FASEB J. 2003 Sep;17(12):1694-6. doi: 10.1096/fj.02-0847fje. Epub 2003 Jul 3.
• [1060] Up-regulation of growth factor receptor-bound protein 10 in cervical squamous cell carcinoma.Oncol Rep. 2005 Jun;13(6):1069-74.
• [1061] The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer.Biomed Res Int. 2017;2017:2013989. doi: 10.1155/2017/2013989. Epub 2017 May 18.
• [1062] Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression.Mol Diagn Ther. 2017 Apr;21(2):199-207. doi: 10.1007/s40291-017-0256-1.
• [1063] Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics. 2001 Dec;11(9):757-64. doi: 10.1097/00008571-200112000-00003.
• [1064] Immunohistochemical assessment of chromatin licensing and DNA replication factor 1, geminin, and -H2A.X in oral epithelial precursor lesions and squamous cell carcinoma.J Oral Pathol Med. 2019 Nov;48(10):888-896. doi: 10.1111/jop.12925. Epub 2019 Aug 16.
• [1065] Novel candidate tumor marker genes for lung adenocarcinoma.Oncogene. 2002 Oct 24;21(49):7598-604. doi: 10.1038/sj.onc.1205953.
• [1066] Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.J Cell Biochem. 2019 Jul;120(7):11510-11516. doi: 10.1002/jcb.28430. Epub 2019 Feb 20.
• [1067] Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.Laryngoscope. 2007 Feb;117(2):253-7. doi: 10.1097/01.mlg.0000248241.95357.a6.
• [1068] Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.Gynecol Oncol. 2010 Jan;116(1):99-104. doi: 10.1016/j.ygyno.2009.09.032.
• [1069] HLA-C -35kb expression SNP is associated with differential control of -HPV infection in squamous cell carcinoma cases and controls.PLoS One. 2014 Aug 1;9(8):e103710. doi: 10.1371/journal.pone.0103710. eCollection 2014.
• [1070] Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas.Virchows Arch. 2008 Nov;453(5):491-9. doi: 10.1007/s00428-008-0675-9. Epub 2008 Sep 30.
• [1071] The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.Tumour Biol. 2015 Feb;36(2):959-66. doi: 10.1007/s13277-014-2715-1. Epub 2014 Oct 15.
• [1072] A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.BMC Genomics. 2013;14 Suppl 6(Suppl 6):S5. doi: 10.1186/1471-2164-14-S6-S5. Epub 2013 Oct 25.
• [1073] Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.Oncogene. 2009 Jan 29;28(4):565-74. doi: 10.1038/onc.2008.404. Epub 2008 Nov 17.
• [1074] Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.Biomed Res Int. 2019 Nov 13;2019:9612425. doi: 10.1155/2019/9612425. eCollection 2019.
• [1075] Homeodomain-only protein HOP is a novel modulator of late differentiation in keratinocytes.Eur J Cell Biol. 2011 Apr;90(4):279-90. doi: 10.1016/j.ejcb.2010.11.001. Epub 2011 Jan 22.
• [1076] HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.BMC Cancer. 2012 Apr 12;12:146. doi: 10.1186/1471-2407-12-146.
• [1077] Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.BMC Cancer. 2014 May 21;14:353. doi: 10.1186/1471-2407-14-353.
• [1078] HOXB5 expression in oral squamous cell carcinoma.J Appl Oral Sci. 2011 Apr;19(2):125-9. doi: 10.1590/s1678-77572011000200008.
• [1079] HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma.J Cancer. 2019 Jul 25;10(19):4540-4551. doi: 10.7150/jca.30645. eCollection 2019.
• [1080] Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues.Oncol Res. 2006;16(5):217-24. doi: 10.3727/000000006783981080.
• [1081] Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas.World J Gastroenterol. 2005 Mar 14;11(10):1562-6. doi: 10.3748/wjg.v11.i10.1562.
• [1082] Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.Clin Cancer Res. 2005 Apr 15;11(8):2899-906. doi: 10.1158/1078-0432.CCR-04-0664.
• [1083] Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.Gynecol Oncol. 2010 Nov;119(2):225-31. doi: 10.1016/j.ygyno.2010.07.028. Epub 2010 Aug 13.
• [1084] Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues.Hum Pathol. 2009 Jan;40(1):41-9. doi: 10.1016/j.humpath.2008.06.010. Epub 2008 Aug 27.
• [1085] HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.PLoS One. 2008 Aug 22;3(8):e3031. doi: 10.1371/journal.pone.0003031.
• [1086] Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix.Calcif Tissue Int. 2003 Jul;73(1):9-14. doi: 10.1007/s00223-002-2108-0.
• [1087] Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.Oncol Lett. 2017 Sep;14(3):2813-2821. doi: 10.3892/ol.2017.6508. Epub 2017 Jun 30.
• [1088] ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!.Oral Oncol. 2005 Jul;41(6):580-8. doi: 10.1016/j.oraloncology.2005.01.002. Epub 2005 Apr 9.
• [1089] Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.Hum Pathol. 2011 Dec;42(12):1878-87. doi: 10.1016/j.humpath.2011.02.005. Epub 2011 Jun 12.
• [1090] Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.Histopathology. 2004 Dec;45(6):560-72. doi: 10.1111/j.1365-2559.2004.02000.x.
• [1091] IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.Oncogene. 2019 Apr;38(17):3232-3247. doi: 10.1038/s41388-018-0662-9. Epub 2019 Jan 9.
• [1092] IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.Mol Cancer Res. 2008 Sep;6(9):1431-9. doi: 10.1158/1541-7786.MCR-08-0141.
• [1093] Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.Int J Cancer. 2019 Apr 15;144(8):2020-2032. doi: 10.1002/ijc.31926. Epub 2018 Dec 8.
• [1094] Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.Gynecol Oncol. 2004 May;93(2):446-53. doi: 10.1016/j.ygyno.2004.02.012.
• [1095] Genome-wide association study of familial lung cancer.Carcinogenesis. 2018 Sep 21;39(9):1135-1140. doi: 10.1093/carcin/bgy080.
• [1096] WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):454-461. doi: 10.1097/PAI.0000000000000449.
• [1097] Invasive skin carcinoma--Ras and alpha6beta4 integrin lead the way.Cancer Cell. 2003 Mar;3(3):201-2. doi: 10.1016/s1535-6108(03)00049-7.
• [1098] IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3.Clin Cancer Res. 2019 Jul 1;25(13):4026-4037. doi: 10.1158/1078-0432.CCR-18-3458. Epub 2019 Apr 12.
• [1099] Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.Gene. 2005 Aug 15;356:109-17. doi: 10.1016/j.gene.2005.02.014.
• [1100] A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. Cancer. 2015 Jul 1;121(13):2222-9. doi: 10.1002/cncr.29291. Epub 2015 Mar 10.
• [1101] Polymorphisms associated with oral clefts as potential susceptibility markers for oral and breast cancer.Arch Oral Biol. 2019 Mar;99:9-14. doi: 10.1016/j.archoralbio.2018.12.004. Epub 2018 Dec 14.
• [1102] Interaction between Brk kinase and insulin receptor substrate-4.Oncogene. 2005 Aug 25;24(36):5656-64. doi: 10.1038/sj.onc.1208721.
• [1103] Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis.J Natl Cancer Inst. 2008 Nov 19;100(22):1592-605. doi: 10.1093/jnci/djn379. Epub 2008 Nov 11.
• [1104] Hypoxia-induced changes to integrin 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431.Mol Cell Proteomics. 2014 Nov;13(11):3126-37. doi: 10.1074/mcp.M114.038505. Epub 2014 Jul 30.
• [1105] Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.Med Oncol. 2016 Jul;33(7):75. doi: 10.1007/s12032-016-0791-3. Epub 2016 Jun 10.
• [1106] Significant Role of Collagen XVII And Integrin 4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells.Sci Rep. 2017 Mar 22;7:45057. doi: 10.1038/srep45057.
• [1107] Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.Int J Oncol. 2006 Apr;28(4):873-81.
• [1108] Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4542-4550. doi: 10.26355/eurrev_201807_15509.
• [1109] Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.Biol Chem. 2006 Jun;387(6):783-8. doi: 10.1515/BC.2006.098.
• [1110] Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.J Oral Pathol Med. 2020 Feb;49(2):126-136. doi: 10.1111/jop.12969. Epub 2019 Nov 19.
• [1111] Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma.Nat Genet. 2014 Oct;46(10):1060-2. doi: 10.1038/ng.3091. Epub 2014 Sep 7.
• [1112] Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.BMC Cancer. 2014 Dec 20;14:988. doi: 10.1186/1471-2407-14-988.
• [1113] A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing 5-integrin/c-met signaling pathway.J Exp Clin Cancer Res. 2019 Feb 19;38(1):89. doi: 10.1186/s13046-019-1091-5.
• [1114] Evidence of proliferative activity in human Merkel cells: implications in the histogenesis of Merkel cell carcinoma.Arch Dermatol Res. 2019 Jan;311(1):37-43. doi: 10.1007/s00403-018-1877-x. Epub 2018 Nov 20.
• [1115] Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line.Proteomics. 2017 Apr;17(7). doi: 10.1002/pmic.201600254.
• [1116] Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer.Clin Proteomics. 2019 May 10;16:20. doi: 10.1186/s12014-019-9240-6. eCollection 2019.
• [1117] The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity.Br J Cancer. 2003 May 19;88(10):1543-8. doi: 10.1038/sj.bjc.6600952.
• [1118] Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway.Cell Signal. 2019 Nov;63:109359. doi: 10.1016/j.cellsig.2019.109359. Epub 2019 Jul 11.
• [1119] Human galectin-8 isoforms and cancer.Glycoconj J. 2002;19(7-9):557-63. doi: 10.1023/B:GLYC.0000014086.38343.98.
• [1120] High PINCH1 Expression in Human Laryngeal Carcinoma Associates with Poor Prognosis.Anal Cell Pathol (Amst). 2018 Mar 20;2018:2989635. doi: 10.1155/2018/2989635. eCollection 2018.
• [1121] Elevated Lin28B expression is correlated with lymph node metastasis in oral squamous cell carcinomas.J Oral Pathol Med. 2015 Nov;44(10):823-30. doi: 10.1111/jop.12314. Epub 2015 Feb 27.
• [1122] Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma.Cancer Res. 2007 Oct 15;67(20):9643-8. doi: 10.1158/0008-5472.CAN-07-1911.
• [1123] LOXL4 as a selective molecular marker in primary and metastatic head/neck carcinoma.Anticancer Res. 2010 Nov;30(11):4567-71.
• [1124] HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell.Front Microbiol. 2018 Mar 26;9:546. doi: 10.3389/fmicb.2018.00546. eCollection 2018.
• [1125] Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.Cancer Sci. 2006 Oct;97(10):1070-4. doi: 10.1111/j.1349-7006.2006.00283.x.
• [1126] ORAOV1 is amplified in oral squamous cell carcinoma.J Oral Pathol Med. 2012 Jan;41(1):54-60. doi: 10.1111/j.1600-0714.2011.01053.x. Epub 2011 May 28.
• [1127] Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of 7 nicotinic acetylcholine receptors.PLoS One. 2019 May 31;14(5):e0217339. doi: 10.1371/journal.pone.0217339. eCollection 2019.
• [1128] Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer.Mol Cancer Ther. 2017 May;16(5):893-904. doi: 10.1158/1535-7163.MCT-16-0474. Epub 2017 Mar 14.
• [1129] MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma.Front Oncol. 2019 Aug 27;9:816. doi: 10.3389/fonc.2019.00816. eCollection 2019.
• [1130] MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma.Oncol Rep. 2017 Oct;38(4):2369-2377. doi: 10.3892/or.2017.5889. Epub 2017 Aug 8.
• [1131] C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.Anticancer Res. 2003 Mar-Apr;23(2B):1489-93.
• [1132] Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).Carcinogenesis. 2004 Feb;25(2):269-76. doi: 10.1093/carcin/bgh006. Epub 2003 Nov 6.
• [1133] Induction of p97MAPK expression regulates collagen mediated inhibition of proliferation and migration in human squamous cell carcinoma lines.Int J Oncol. 2004 May;24(5):1159-63.
• [1134] Management of Non-melanoma Skin Cancer in Transplant Recipients.Clin Oncol (R Coll Radiol). 2019 Nov;31(11):779-788. doi: 10.1016/j.clon.2019.08.005. Epub 2019 Sep 26.
• [1135] Effect of silencing of mediator of DNA damage checkpoint protein 1 on the growth of oral squamous cell carcinoma in vitro and in vivo.Eur J Oral Sci. 2019 Dec;127(6):494-499. doi: 10.1111/eos.12662. Epub 2019 Dec 1.
• [1136] DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women.Immunol Cell Biol. 1987 Feb;65 ( Pt 1):77-84. doi: 10.1038/icb.1987.9.
• [1137] MICA and MICB overexpression in oral squamous cell carcinoma.J Oral Pathol Med. 2007 Jan;36(1):43-7. doi: 10.1111/j.1600-0714.2006.00471.x.
• [1138] Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.J Pathol. 2004 Jan;202(1):14-22. doi: 10.1002/path.1479.
• [1139] Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.Anticancer Res. 2017 Jan;37(1):1-7. doi: 10.21873/anticanres.11282.
• [1140] No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.Br J Cancer. 2018 Jan;118(2):e1. doi: 10.1038/bjc.2017.410. Epub 2018 Jan 11.
• [1141] Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.Br J Dermatol. 2006 Nov;155(5):999-1005. doi: 10.1111/j.1365-2133.2006.07487.x.
• [1142] Involvement of repair genes in oral cancer: A systematic review.Cell Biochem Funct. 2019 Dec;37(8):572-577. doi: 10.1002/cbf.3428. Epub 2019 Sep 9.
• [1143] Moesin Involvement in Oral Carcinogenesis of the Lower Lip.Anticancer Res. 2018 May;38(5):2755-2760. doi: 10.21873/anticanres.12518.
• [1144] Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.Mol Cancer. 2005 Dec 13;4:42. doi: 10.1186/1476-4598-4-42.
• [1145] Mucin 21 in esophageal squamous epithelia and carcinomas: analysis with glycoform-specific monoclonal antibodies.Glycobiology. 2012 Sep;22(9):1218-26. doi: 10.1093/glycob/cws082. Epub 2012 May 19.
• [1146] MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.Sci Rep. 2018 Jan 9;8(1):134. doi: 10.1038/s41598-017-18545-x.
• [1147] From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes.Int J Cancer. 2000 Apr 15;86(2):162-8. doi: 10.1002/(sici)1097-0215(20000415)86:2<162::aid-ijc3>3.0.co;2-r.
• [1148] MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.J Hum Genet. 2002;47(9):460-4. doi: 10.1007/s100380200065.
• [1149] Qualitative and quantitative changes in nuclear DNA and phenotypic gene expression in human malignant skin tumors during their progression.Eur J Histochem. 1992;36(3):289-302.
• [1150] Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.J Oral Pathol Med. 2019 Sep;48(8):686-695. doi: 10.1111/jop.12886. Epub 2019 Jun 9.
• [1151] Nerve growth factor-induced migration in oral and salivary gland tumour cells utilises the PI3K/Akt signalling pathway: Is there a link to perineural invasion?.J Oral Pathol Med. 2020 Mar;49(3):227-234. doi: 10.1111/jop.12979. Epub 2019 Dec 22.
• [1152] Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein.Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):273-8. doi: 10.1016/j.ijrobp.2006.09.019.
• [1153] Coactivator-mediated estrogen response in human squamous cell carcinoma lines.J Endocrinol. 2007 Apr;193(1):147-55. doi: 10.1677/JOE-06-0029.
• [1154] Mitochondrial DNA mutations in oral squamous cell carcinoma.Carcinogenesis. 2006 May;27(5):945-50. doi: 10.1093/carcin/bgi326. Epub 2006 Jan 10.
• [1155] Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.Cancer Res. 2017 May 1;77(9):2363-2374. doi: 10.1158/0008-5472.CAN-16-2114. Epub 2017 Feb 16.
• [1156] REG I gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms.Oncol Rep. 2013 Dec;30(6):2625-31. doi: 10.3892/or.2013.2739. Epub 2013 Sep 19.
• [1157] Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.Cancer Gene Ther. 2007 Aug;14(8):738-47. doi: 10.1038/sj.cgt.7701062. Epub 2007 May 25.
• [1158] Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx.Clin Cancer Res. 2008 Jul 1;14(13):4345-52. doi: 10.1158/1078-0432.CCR-07-5282.
• [1159] NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4.Oncotarget. 2019 Mar 19;10(23):2306-2319. doi: 10.18632/oncotarget.26774. eCollection 2019 Mar 19.
• [1160] Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.Cancer Med. 2018 May;7(5):1756-1765. doi: 10.1002/cam4.1434. Epub 2018 Mar 25.
• [1161] Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.Oncol Rep. 2009 Oct;22(4):789-98. doi: 10.3892/or_00000501.
• [1162] NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2018 May;144(5):875-882. doi: 10.1007/s00432-018-2612-x. Epub 2018 Feb 20.
• [1163] Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray.Neoplasma. 2008;55(5):447-54.
• [1164] Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.Oncol Rep. 2007 Jul;18(1):93-7.
• [1165] Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma.Oral Oncol. 1999 May;35(3):321-5. doi: 10.1016/s1368-8375(98)00089-x.
• [1166] P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma.J Oral Pathol Med. 2008 Mar;37(3):151-6. doi: 10.1111/j.1600-0714.2007.00604.x.
• [1167] Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.Int J Cancer. 2008 Oct 15;123(8):1816-23. doi: 10.1002/ijc.23710.
• [1168] NUDT1: A potential independent predictor for the prognosis of patients with oral squamous cell carcinoma.J Oral Pathol Med. 2020 Mar;49(3):210-218. doi: 10.1111/jop.12974. Epub 2019 Dec 3.
• [1169] Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites.Sci Rep. 2016 Aug 30;6:32579. doi: 10.1038/srep32579.
• [1170] Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines.Jpn J Cancer Res. 2001 Jan;92(1):42-50. doi: 10.1111/j.1349-7006.2001.tb01046.x.
• [1171] Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.Int J Biochem Cell Biol. 2016 Jan;70:68-75. doi: 10.1016/j.biocel.2015.11.006. Epub 2015 Nov 10.
• [1172] Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma.Front Oncol. 2019 Sep 11;9:862. doi: 10.3389/fonc.2019.00862. eCollection 2019.
• [1173] Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.Mod Pathol. 2017 Jul;30(7):919-927. doi: 10.1038/modpathol.2016.169. Epub 2017 Mar 24.
• [1174] The role of the OVOL1-OVOL2 axis in normal and diseased human skin.J Dermatol Sci. 2018 Jun;90(3):227-231. doi: 10.1016/j.jdermsci.2018.02.005. Epub 2018 Feb 12.
• [1175] PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.Cancer Res. 2015 Apr 1;75(7):1287-97. doi: 10.1158/0008-5472.CAN-14-2444.
• [1176] Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.BMC Cancer. 2015 May 19;15:418. doi: 10.1186/s12885-015-1411-x.
• [1177] Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.BMC Cancer. 2018 Jul 6;18(1):723. doi: 10.1186/s12885-018-4622-0.
• [1178] HnRNP E2 is downregulated in human oral cancer cells and the overexpression of hnRNP E2 induces apoptosis.Mol Carcinog. 2007 Mar;46(3):198-207. doi: 10.1002/mc.20265.
• [1179] miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.Int J Cancer. 2018 Dec 1;143(11):2892-2904. doi: 10.1002/ijc.31638. Epub 2018 Oct 4.
• [1180] Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.Int J Oncol. 2007 Jan;30(1):97-103.
• [1181] Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.Cancer Lett. 2002 Oct 28;184(2):189-95. doi: 10.1016/s0304-3835(02)00204-5.
• [1182] Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma.PLoS One. 2016 Jan 8;11(1):e0146530. doi: 10.1371/journal.pone.0146530. eCollection 2016.
• [1183] Co-Incidence of Epstein-Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women.Front Oncol. 2018 Jul 2;8:250. doi: 10.3389/fonc.2018.00250. eCollection 2018.
• [1184] Association of the co-expression of SOX2 and Podoplanin in the progression of oral squamous cell carcinomas - an immunohistochemical study.J Appl Oral Sci. 2019 Sep 9;27:e20180348. doi: 10.1590/1678-7757-2018-0348.
• [1185] Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice.Pain. 2010 May;149(2):254-262. doi: 10.1016/j.pain.2010.02.009. Epub 2010 Mar 4.
• [1186] Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer.Int J Oncol. 2018 Jan;52(1):279-287. doi: 10.3892/ijo.2017.4180. Epub 2017 Oct 31.
• [1187] P-glycoprotein expression in the squamous cell carcinoma of the tongue base.Laryngoscope. 1995 Dec;105(12 Pt 1):1294-9. doi: 10.1288/00005537-199512000-00006.
• [1188] Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G(2)/M arrest.Cancer Chemother Pharmacol. 1999;44(6):444-52. doi: 10.1007/s002800051117.
• [1189] PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.Mol Oncol. 2015 Feb;9(2):450-62. doi: 10.1016/j.molonc.2014.09.009. Epub 2014 Oct 13.
• [1190] Low PHLDA3 expression in oesophageal squamous cell carcinomas is associated with poor prognosis.Anticancer Res. 2015 Feb;35(2):949-54.
• [1191] Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.PLoS One. 2015 Mar 20;10(3):e0119405. doi: 10.1371/journal.pone.0119405. eCollection 2015.
• [1192] PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.Thorac Cancer. 2019 Nov;10(11):2124-2132. doi: 10.1111/1759-7714.13196. Epub 2019 Sep 30.
• [1193] The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.Br J Cancer. 2007 May 7;96(9):1425-32. doi: 10.1038/sj.bjc.6603745. Epub 2007 Apr 17.
• [1194] PINK1 Expression Is Associated with Poor Prognosis in Lung Adenocarcinoma.Tohoku J Exp Med. 2018 Jun;245(2):115-121. doi: 10.1620/tjem.245.115.
• [1195] GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.
• [1196] De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma.Cell Stem Cell. 2019 Mar 7;24(3):390-404.e8. doi: 10.1016/j.stem.2019.01.003. Epub 2019 Jan 31.
• [1197] Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues.Differentiation. 1999 Jun;64(5):277-90. doi: 10.1046/j.1432-0436.1999.6450277.x.
• [1198] Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.Cancer Res. 2007 Nov 15;67(22):10720-6. doi: 10.1158/0008-5472.CAN-07-2411.
• [1199] The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin.Int J Mol Med. 2007 Apr;19(4):589-96.
• [1200] No association of the POLI Thr706Ala polymorphism with the risk of cervical carcinoma.Eur J Surg Oncol. 2008 Aug;34(8):916-920. doi: 10.1016/j.ejso.2007.11.008. Epub 2008 Jan 14.
• [1201] Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.Anticancer Res. 2017 Mar;37(3):1075-1082. doi: 10.21873/anticanres.11419.
• [1202] Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin.Proteomics. 2006 Feb;6(3):1011-8. doi: 10.1002/pmic.200500262.
• [1203] DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma.Br J Cancer. 2004 Jul 5;91(1):119-23. doi: 10.1038/sj.bjc.6601899.
• [1204] PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix.Anticancer Res. 2005 May-Jun;25(3B):2187-92.
• [1205] Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol.Apoptosis. 2006 Jan;11(1):47-56. doi: 10.1007/s10495-005-3348-z.
• [1206] Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.Int J Oral Maxillofac Surg. 2005 Dec;34(8):915-20. doi: 10.1016/j.ijom.2005.04.015. Epub 2005 Jun 13.
• [1207] Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.Exp Cell Res. 2008 Feb 15;314(4):914-26. doi: 10.1016/j.yexcr.2007.10.025. Epub 2007 Nov 12.
• [1208] PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene. 2007 Dec 13;26(57):7921-32. doi: 10.1038/sj.onc.1210589. Epub 2007 Jun 18.
• [1209] Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.J Invest Dermatol. 2019 Nov;139(11):2263-2271.e5. doi: 10.1016/j.jid.2019.03.1163. Epub 2019 Jun 15.
• [1210] Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.J Exp Clin Cancer Res. 2014 Dec 18;33(1):100. doi: 10.1186/s13046-014-0100-y.
• [1211] Expression of prothymosin in lung cancer is associated with squamous cell carcinoma and smoking.Oncol Lett. 2019 Jun;17(6):5740-5746. doi: 10.3892/ol.2019.10248. Epub 2019 Apr 12.
• [1212] Prothymosin- and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.Oncol Lett. 2018 Apr;15(4):4485-4494. doi: 10.3892/ol.2018.7824. Epub 2018 Jan 19.
• [1213] Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.Genes Chromosomes Cancer. 2007 Jul;46(7):661-9. doi: 10.1002/gcc.20447.
• [1214] Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.Tumour Biol. 2017 May;39(5):1010428317708267. doi: 10.1177/1010428317708267.
• [1215] Prognostic role of Rab27A and Rab27B expression in patients with non-small cell lung carcinoma.Thorac Cancer. 2019 Feb;10(2):143-149. doi: 10.1111/1759-7714.12919. Epub 2018 Nov 27.
• [1216] Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.BMC Cancer. 2002 Mar 21;2:4. doi: 10.1186/1471-2407-2-4.
• [1217] RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia.PLoS One. 2015 Apr 9;10(4):e0123531. doi: 10.1371/journal.pone.0123531. eCollection 2015.
• [1218] The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.Oncogene. 2011 Aug 25;30(34):3661-71. doi: 10.1038/onc.2011.93. Epub 2011 Mar 28.
• [1219] Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.Am J Pathol. 2006 Feb;168(2):585-96. doi: 10.2353/ajpath.2006.050132.
• [1220] The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.Oncogene. 2011 Oct 20;30(42):4339-49. doi: 10.1038/onc.2011.141. Epub 2011 May 2.
• [1221] Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma.Int J Gynecol Cancer. 2006 Mar-Apr;16(2):763-71. doi: 10.1111/j.1525-1438.2006.00352.x.
• [1222] DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.BMC Cancer. 2008 Aug 14;8:238. doi: 10.1186/1471-2407-8-238.
• [1223] DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.Cancer Sci. 2005 Sep;96(9):571-7. doi: 10.1111/j.1349-7006.2005.00082.x.
• [1224] The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.Clin Sci (Lond). 2019 Mar 5;133(5):681-695. doi: 10.1042/CS20181023. Print 2019 Mar 15.
• [1225] A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.Oncogene. 1997 Sep 4;15(10):1161-70. doi: 10.1038/sj.onc.1201269.
• [1226] Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.Oncol Rep. 2007 Jul;18(1):267-72.
• [1227] The Ki67+ proliferation index correlates with increased cellular retinol-binding protein-1 and the coordinated loss of plakophilin-1 and desmoplakin during progression of cervical squamous lesions.Histopathology. 2007 Jul;51(1):87-97. doi: 10.1111/j.1365-2559.2007.02724.x.
• [1228] Regulation of p27 by ubiquitin ligases and its pathological significance in human lung carcinomas.Hum Pathol. 2017 Aug;66:67-78. doi: 10.1016/j.humpath.2017.05.022. Epub 2017 Jun 7.
• [1229] Analysis of APC allelic imbalance/loss of heterozygosity and APC protein expression in cutaneous squamous cell carcinomas.Cancer Genomics Proteomics. 2011 May-Jun;8(3):149-55.
• [1230] Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma.Int J Mol Med. 2007 Jun;19(6):915-23.
• [1231] Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.J Cancer Res Clin Oncol. 2006 Jan;132(1):19-27. doi: 10.1007/s00432-005-0033-0. Epub 2005 Sep 17.
• [1232] Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.Lung Cancer. 2010 Aug;69(2):232-8. doi: 10.1016/j.lungcan.2009.10.010. Epub 2009 Nov 14.
• [1233] Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma.J Oral Maxillofac Surg. 2004 Jun;62(6):702-7. doi: 10.1016/j.joms.2004.02.002.
• [1234] The 434(G>C) polymorphism in the eosinophil cationic protein gene and its association with tissue eosinophilia in oral squamous cell carcinomas.J Oral Pathol Med. 2010 Jan;39(1):56-62. doi: 10.1111/j.1600-0714.2009.00795.x. Epub 2009 Jun 28.
• [1235] Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung.Biochem Cell Biol. 2019 Oct;97(5):589-599. doi: 10.1139/bcb-2018-0252. Epub 2019 Jan 23.
• [1236] Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.Medicine (Baltimore). 2017 Jan;96(4):e5975. doi: 10.1097/MD.0000000000005975.
• [1237] Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus.Gene. 2006 Jan 17;366(1):161-8. doi: 10.1016/j.gene.2005.09.025. Epub 2005 Nov 28.
• [1238] Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.Head Neck. 2017 Sep;39(9):1876-1887. doi: 10.1002/hed.24854. Epub 2017 Jul 4.
• [1239] The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice.Cancer Lett. 2007 Jan 8;245(1-2):321-30. doi: 10.1016/j.canlet.2006.01.025. Epub 2006 Mar 13.
• [1240] Clinical significance of TC21 overexpression in oral cancer.J Oral Pathol Med. 2010 Jul;39(6):477-85. doi: 10.1111/j.1600-0714.2009.00854.x. Epub 2009 Dec 16.
• [1241] Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells.Mol Cell Biochem. 2012 Jan;359(1-2):323-32. doi: 10.1007/s11010-011-1026-8. Epub 2011 Aug 23.
• [1242] HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.Histol Histopathol. 2004 Jan;19(1):119-28. doi: 10.14670/HH-19.119.
• [1243] Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.PLoS One. 2010 Feb 11;5(2):e9162. doi: 10.1371/journal.pone.0009162.
• [1244] Identification of the autoantigen SART-1 as a candidate gene for the development of atopy.Hum Mol Genet. 2002 Sep 1;11(18):2143-6. doi: 10.1093/hmg/11.18.2143.
• [1245] SATB2 suppresses non-small cell lung cancer invasiveness by G9a.Clin Exp Med. 2018 Feb;18(1):37-44. doi: 10.1007/s10238-017-0464-3. Epub 2017 Jun 30.
• [1246] SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus.Biochem Biophys Res Commun. 2001 Aug 24;286(3):559-65. doi: 10.1006/bbrc.2001.5428.
• [1247] Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.J Bone Miner Res. 1998 Sep;13(9):1378-83. doi: 10.1359/jbmr.1998.13.9.1378.
• [1248] Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):661-71. doi: 10.1016/0360-3016(94)90552-5.
• [1249] HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.Gynecol Oncol. 2010 May;117(2):297-301. doi: 10.1016/j.ygyno.2010.02.003. Epub 2010 Mar 6.
• [1250] DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.Hum Pathol. 2017 Feb;60:137-146. doi: 10.1016/j.humpath.2016.10.018. Epub 2016 Nov 4.
• [1251] Identification of semaphorin E as a non-MDR drug resistance gene of human cancers.Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14713-8. doi: 10.1073/pnas.94.26.14713.
• [1252] The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma.Cell Mol Biol Lett. 2017 Dec 28;22:32. doi: 10.1186/s11658-017-0064-y. eCollection 2017.
• [1253] Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.Cancer Res. 1991 Dec 1;51(23 Pt 1):6346-50.
• [1254] Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.Oncol Rep. 2008 Nov;20(5):1041-5.
• [1255] Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.Int J Cancer. 2009 Oct 1;125(7):1542-50. doi: 10.1002/ijc.24507.
• [1256] Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions.Oncogene. 2003 Nov 27;22(54):8677-87. doi: 10.1038/sj.onc.1207127.
• [1257] Overexpression of protease nexin-1 mRNA and protein in oral squamous cell carcinomas.Oral Oncol. 2008 Mar;44(3):309-13. doi: 10.1016/j.oraloncology.2007.02.009. Epub 2007 Apr 30.
• [1258] Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.Oncol Rep. 2007 Feb;17(2):417-23.
• [1259] Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).Biochemistry. 2005 Oct 11;44(40):13246-56. doi: 10.1021/bi0504658.
• [1260] Bioinformatic screening and experimental analysis identify SFRP1 as a prognostic biomarker for tongue squamous cell carcinomas.Arch Oral Biol. 2020 Feb;110:104587. doi: 10.1016/j.archoralbio.2019.104587. Epub 2019 Nov 8.
• [1261] DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.Exp Lung Res. 2015 Mar;41(2):93-102. doi: 10.3109/01902148.2014.976298. Epub 2014 Dec 16.
• [1262] A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.Neoplasia. 2010 Oct;12(10):789-96. doi: 10.1593/neo.10396.
• [1263] Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.Genes Chromosomes Cancer. 2006 Feb;45(2):118-25. doi: 10.1002/gcc.20270.
• [1264] SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.Exp Cell Res. 2017 Mar 15;352(2):357-363. doi: 10.1016/j.yexcr.2017.02.026. Epub 2017 Feb 22.
• [1265] Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.Int J Cancer. 2004 Mar 1;108(6):818-24. doi: 10.1002/ijc.11651.
• [1266] Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking.Br J Cancer. 1994 Oct;70(4):704-8. doi: 10.1038/bjc.1994.378.
• [1267] Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging.Mol Med Rep. 2011 Nov-Dec;4(6):1289-93. doi: 10.3892/mmr.2011.572. Epub 2011 Aug 24.
• [1268] Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.Oncol Rep. 2018 Apr;39(4):1793-1804. doi: 10.3892/or.2018.6251. Epub 2018 Feb 7.
• [1269] Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma.Cancer Res. 2020 Jan 15;80(2):276-290. doi: 10.1158/0008-5472.CAN-19-0637. Epub 2019 Nov 6.
• [1270] SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.
• [1271] The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.BMC Cancer. 2018 Apr 7;18(1):398. doi: 10.1186/s12885-018-4321-x.
• [1272] Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma.Head Neck. 2020 Feb;42(2):163-170. doi: 10.1002/hed.25975. Epub 2019 Nov 9.
• [1273] Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.Int J Clin Oncol. 2018 Apr;23(2):321-328. doi: 10.1007/s10147-017-1210-2. Epub 2017 Nov 3.
• [1274] Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.Clin Transl Oncol. 2017 Apr;19(4):489-497. doi: 10.1007/s12094-016-1555-4. Epub 2016 Oct 7.
• [1275] Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.J Cancer Res Clin Oncol. 2018 Oct;144(10):1921-1932. doi: 10.1007/s00432-018-2722-5. Epub 2018 Aug 3.
• [1276] LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.IUBMB Life. 2019 Jul;71(7):882-890. doi: 10.1002/iub.2012. Epub 2019 Feb 26.
• [1277] IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.Mol Oncol. 2016 Jun;10(6):895-909. doi: 10.1016/j.molonc.2016.03.001. Epub 2016 Mar 22.
• [1278] SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.Respir Res. 2018 Dec 4;19(1):241. doi: 10.1186/s12931-018-0952-3.
• [1279] MicroRNA?99a?p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMTrelated transcription factor SOX4.Int J Mol Med. 2019 Jul;44(1):185-195. doi: 10.3892/ijmm.2019.4174. Epub 2019 Apr 25.
• [1280] Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.Oncol Rep. 2018 Nov;40(5):2487-2496. doi: 10.3892/or.2018.6665. Epub 2018 Aug 22.
• [1281] Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.Cancer. 2009 Dec 15;115(24):5688-99. doi: 10.1002/cncr.24658.
• [1282] A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.J Med Chem. 2019 Oct 24;62(20):9008-9025. doi: 10.1021/acs.jmedchem.9b00562. Epub 2019 Oct 15.
• [1283] An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.Oncol Rep. 2018 Nov;40(5):2637-2647. doi: 10.3892/or.2018.6702. Epub 2018 Sep 12.
• [1284] Localization and expression of cornifin-alpha/SPRR1 in mouse epidermis, anagen hair follicles, and skin neoplasms.J Invest Dermatol. 1996 Apr;106(4):647-54. doi: 10.1111/1523-1747.ep12345463.
• [1285] Exogenous expression of Esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis.Int J Cancer. 2008 Jan 15;122(2):260-6. doi: 10.1002/ijc.23104.
• [1286] Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.Cancer Chemother Pharmacol. 2019 Nov;84(5):1133-1143. doi: 10.1007/s00280-019-03945-9. Epub 2019 Sep 12.
• [1287] SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1161-1172. doi: 10.1016/j.bbamcr.2018.05.017. Epub 2018 May 30.
• [1288] Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.Eur J Oral Sci. 2017 Apr;125(2):95-101. doi: 10.1111/eos.12333. Epub 2017 Feb 2.
• [1289] HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.
• [1290] Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract.J Oral Pathol Med. 1990 Oct;19(9):408-13. doi: 10.1111/j.1600-0714.1990.tb00869.x.
• [1291] STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.Clin Cancer Res. 2012 Jan 1;18(1):127-39. doi: 10.1158/1078-0432.CCR-11-1889. Epub 2011 Nov 16.
• [1292] Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma.Biochem Biophys Res Commun. 2020 Feb 5;522(2):408-414. doi: 10.1016/j.bbrc.2019.11.107. Epub 2019 Nov 23.
• [1293] The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.J Thorac Oncol. 2019 Jul;14(7):1213-1222. doi: 10.1016/j.jtho.2019.03.021. Epub 2019 Apr 9.
• [1294] Genetic variation in Transaldolase 1 and risk of squamous cell carcinoma of the head and neck.Cancer Detect Prev. 2008;32(3):200-8. doi: 10.1016/j.cdp.2008.08.008. Epub 2008 Sep 20.
• [1295] Delivery of MTH1 inhibitor (TH287) and MDR1 siRNA via hyaluronic acid-based mesoporous silica nanoparticles for oral cancers treatment.Colloids Surf B Biointerfaces. 2019 Jan 1;173:599-606. doi: 10.1016/j.colsurfb.2018.09.076. Epub 2018 Sep 29.
• [1296] Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.
• [1297] TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.Cell Biol Int. 2019 Dec;43(12):1416-1424. doi: 10.1002/cbin.11189. Epub 2019 Jul 11.
• [1298] p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer.Cancer Res. 2019 Apr 15;79(8):1758-1768. doi: 10.1158/0008-5472.CAN-18-1234. Epub 2019 Jan 8.
• [1299] Connective tissue growth factor decreases mitochondrial metabolism through ubiquitin-mediated degradation of mitochondrial transcription factor A in oral squamous cell carcinoma.J Formos Med Assoc. 2018 Mar;117(3):212-219. doi: 10.1016/j.jfma.2017.04.003. Epub 2017 Apr 21.
• [1300] TGFBI Promotes Tumor Growth and is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma.J Cancer. 2019 Aug 27;10(20):4902-4912. doi: 10.7150/jca.29958. eCollection 2019.
• [1301] Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.Cell Biol Toxicol. 2016 Oct;32(5):419-35. doi: 10.1007/s10565-016-9343-z. Epub 2016 Jun 15.
• [1302] The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretnn.Pathol Oncol Res. 2017 Jul;23(3):487-491. doi: 10.1007/s12253-016-0135-9. Epub 2016 Oct 19.
• [1303] HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.Cancer Med. 2014 Oct;3(5):1185-96. doi: 10.1002/cam4.313. Epub 2014 Jul 26.
• [1304] Frequent TLE1 Expression in Cutaneous Neoplasms.Am J Dermatopathol. 2019 Jan;41(1):1-6. doi: 10.1097/DAD.0000000000001186.
• [1305] Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression.Head Neck. 2006 May;28(5):432-40. doi: 10.1002/hed.20346.
• [1306] ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17969-74. doi: 10.1073/pnas.1309362110. Epub 2013 Oct 14.
• [1307] TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.J Invest Dermatol. 2017 Jun;137(6):1322-1332. doi: 10.1016/j.jid.2016.12.026. Epub 2017 Jan 25.
• [1308] Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.Blood. 2009 May 7;113(19):4595-603. doi: 10.1182/blood-2008-07-165456. Epub 2008 Dec 12.
• [1309] Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.Cancer Sci. 2006 May;97(5):380-6. doi: 10.1111/j.1349-7006.2006.00192.x.
• [1310] Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.
• [1311] RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.Carcinogenesis. 2004 Feb;25(2):157-67. doi: 10.1093/carcin/bgh003. Epub 2003 Oct 24.
• [1312] Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor.Oncogene. 2004 Aug 19;23(37):6199-208. doi: 10.1038/sj.onc.1207851.
• [1313] Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas.Int J Cancer. 2002 Jun 20;99(6):771-5. doi: 10.1002/ijc.10442.
• [1314] Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.Cancer Gene Ther. 2013 Jul;20(7):413-20. doi: 10.1038/cgt.2013.32. Epub 2013 Jun 14.
• [1315] Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.PLoS One. 2018 Nov 19;13(11):e0207483. doi: 10.1371/journal.pone.0207483. eCollection 2018.
• [1316] BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.J Pathol. 2010 Jun;221(2):229-37. doi: 10.1002/path.2707.
• [1317] CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.Dis Markers. 2014;2014:619273. doi: 10.1155/2014/619273. Epub 2014 Dec 7.
• [1318] Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.Ann Diagn Pathol. 2013 Aug;17(4):331-40. doi: 10.1016/j.anndiagpath.2013.03.003. Epub 2013 May 3.
• [1319] Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.Oncol Rep. 2005 Apr;13(4):703-7.
• [1320] Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
• [1321] Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.Neoplasma. 2014;61(4):468-75. doi: 10.4149/neo_2014_058.
• [1322] The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.Oncotarget. 2016 Aug 23;7(34):54596-54615. doi: 10.18632/oncotarget.10519.
• [1323] KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.Clin Cancer Res. 2007 Jun 1;13(11):3229-34. doi: 10.1158/1078-0432.CCR-07-0393.
• [1324] High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.Biochem Biophys Res Commun. 2018 Feb 26;497(1):65-72. doi: 10.1016/j.bbrc.2018.02.020. Epub 2018 Feb 7.
• [1325] Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis.Histopathology. 2011 Mar;58(4):531-42. doi: 10.1111/j.1365-2559.2011.03759.x. Epub 2011 Mar 3.
• [1326] Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.Pathol Res Pract. 2017 Sep;213(9):1134-1138. doi: 10.1016/j.prp.2017.07.006. Epub 2017 Jul 6.
• [1327] Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas.Int J Cancer. 1996 Apr 10;66(2):274-9. doi: 10.1002/(SICI)1097-0215(19960410)66:2<274::AID-IJC23>3.0.CO;2-B.
• [1328] Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.Biomed Pharmacother. 2015 Jul;73:97-101. doi: 10.1016/j.biopha.2015.05.015. Epub 2015 Jun 1.
• [1329] Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.Clin Lung Cancer. 2013 Jan;14(1):45-9. doi: 10.1016/j.cllc.2012.04.004. Epub 2012 Jun 1.
• [1330] Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.Ann Surg Oncol. 2007 Dec;14(12):3593-601. doi: 10.1245/s10434-007-9562-x. Epub 2007 Sep 25.
• [1331] Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.PLoS One. 2015 May 11;10(5):e0123369. doi: 10.1371/journal.pone.0123369. eCollection 2015.
• [1332] Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.J Proteome Res. 2008 May;7(5):2078-87. doi: 10.1021/pr7007797. Epub 2008 Apr 12.
• [1333] SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y. Epub 2008 Jul 9.
• [1334] Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.Oral Dis. 2013 Nov;19(8):775-80. doi: 10.1111/odi.12068. Epub 2013 Jan 28.
• [1335] SZRD1 is a Novel Protein that Functions as a Potential Tumor Suppressor in Cervical Cancer.J Cancer. 2017 Jul 14;8(11):2132-2141. doi: 10.7150/jca.18806. eCollection 2017.
• [1336] High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.Cancer Immunol Immunother. 2019 Aug;68(8):1263-1272. doi: 10.1007/s00262-019-02362-4. Epub 2019 Jun 25.
• [1337] Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.World J Gastroenterol. 2006 Nov 28;12(44):7104-12. doi: 10.3748/wjg.v12.i44.7104.
• [1338] Negative implication of C-MYC as an amplification target in esophageal cancer.Cancer Genet Cytogenet. 2006 Feb;165(1):20-4. doi: 10.1016/j.cancergencyto.2005.07.009.